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Abstract 
 
Over the past decade, there has been increasing scientific interest in the occurrence, 
fate and effects of pharmaceuticals in the environment. To date, the majority of this 
research has focussed on the aquatic environment whilst the terrestrial environment 
has remained relatively unexplored. Research carried out in the terrestrial 
environment has primarily focussed on the fate of pharmaceuticals in soils as well as 
the uptake of pharmaceuticals into plants. Less information is available on the uptake 
of pharmaceuticals into other soil dwelling species.  
The studies presented in the thesis were therefore performed to investigate the uptake 
of pharmaceuticals into earthworm species (Eisenia fetida and Lumbricus terrestris) 
and plant species (radish and ryegrass). Experiments were designed to explore the 
effect of pharmaceutical physico-chemical properties, soil parameters and species 
traits on the uptake of pharmaceuticals from soils into terrestrial species. 
Understanding the factors and processes involved in the uptake of these compounds 
from soils, is vital to adequately assess the risks of pharmaceuticals in the 
environment.  
Initial experimental studies evaluated the uptake of four pharmaceuticals, namely 
carbamazepine, diclofenac, fluoxetine and orlistat into the earthworm, Eisenia fetida. 
Pore water based bioconcentration factors (BCFs) increased in the order of 
carbamazepine < diclofenac < fluoxetine and orlistat.  
As well as experimental research, a desk based investigation was perfomed to assess 
the applicability of a minimised design approach to estimate bioconcentration factors 
(BCFs) in terrestrial and aquatic species. A significant regression between 
BCFminimised and BCFtraditional was found and this approach was therefore adopted to 
calculate earthworm BCFs in the soil parameters and species traits studies described 
below. 
The uptake of the four study pharmaceuticals by E. fetida was therefore further 
evaluated in different soil types. The uptake and accumulation of pharmaceuticals 
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into E. fetida changed depending on soil type. Orlistat exhibited the highest pore 
water based bioconcentration factors (BCFs) and displayed the largest differences in 
uptake between soil types as BCFs ranged between 30.51 – 115.92. For 
carbamazepine, diclofenac and fluoxetine BCFs ranged between 1.05 – 1.61, 7.02 – 
69.57 and 16.78 – 20.42 respectively.  
Supplementary studies compared the uptake of the study pharmaceuticals in two 
earthworms (Lumbricus terrestris and E. fetida). All four pharmaceuticals were 
taken up by both L. terrestris and E. fetida tissue after 21 d exposure to spiked soil. 
Pore water based bioconcentration factors (BCFs) ranged between 6.69 and 83.79 for 
L. terrestris and 1.14 and 63.03 for E. fetida.  
The effect of species type on the uptake of pharmaceuticals (carbamazepine, 
diclofenac, fluoxetine, propranolol, sulfamethazine) and a personal care product 
(triclosan) was also investigated in plant species (radish, Raphanus sativus and 
ryegrass, Lolium perenne). Five of the six chemicals were taken up into plant tissue, 
carbamazepine to the greatest extent in both the radish (52 µg/g) and ryegrass (33 
µg/g) whereas sulfamethazine uptake was below the limit of quantitation (LOQ).  
The results demonstrate the ability of plant species and earthworms to accumulate 
pharmaceuticals from soils with uptake apparently specific to both species, chemical 
and soil type. However the influence of these individual parameters does not affect 
BCFs to a significant amount. The research also highlights that a combination of 
factors and processes appear to be driving the uptake into soil dwelling species as 
further analysis was unable to find a single parameter to adequately explain 
pharmaceutical uptake into terrestrial species. For example, for plant uptake, results 
could only be partly explained by the hydrophobicity and extent of ionisation of each 
chemical in the soil.  
Even though these chemicals are taken up by earthworms and plants, further analysis 
showed that the risk to predatory birds is minimal based on the current 
environmental scenarios as thousands of worms would have to be consumed by a 
bird to receive a single dose. Similarly, the potential risk to humans consuming crops 
contaminated with pharmaceutical residues is also minimal. However with 
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increasing loadings of pharmaceuticals to soils this may result in potential problems 
for human health and predatory birds in the future.
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Chapter 1 Literature Review 
1.1 Introduction 
Pharmaceuticals are a group of chemicals used for diagnosis, treatment, alteration or 
prevention of diseases, health conditions or functions in the human body (Daughton 
and Ternes, 1999). Human medicines can be categorised according to their intended 
mode of action in the body. Pharmaceuticals have specialised properties and are 
designed to affect a specific target at a given concentration. Worldwide, 
pharmaceutical use has been on the increase for the past century (OECD, 2011). This 
trend is set to continue into the future with the development of new medicines to 
cure recently discovered diseases as well as previously untreatable problems and as a 
result of an ageing population (The Royal Commission on Environmental Pollution, 
2011). Over the past fifteen years, there has been increasing interest in the potential 
effects of pharmaceutical in the natural environment. This Chapter reviews the 
current knowledge on the inputs, occurrence and fate of pharmaceuticals in the 
environment with primary focus on the terrestrial environment which is the subject 
of this PhD thesis. 
1.1.1 Current situation in the environment 
Although pharmaceuticals have been released into the environment for decades, 
researchers have only recently begun to quantify their levels and potential effects in 
the environment. Previously, studies into the uptake and effects of chemicals in the 
environment focussed on the presence of pesticides (e.g. Dieldrin) (De Silva and van 
Gestel, 2009; Lew- et al., 2009; Matsumoto et al., 2009) and metals (Mdegela et al., 
2009; Nahmani et al., 2009) amongst other contaminants. A key example emerged 
during the period of 1932 – 1968 where it was established that a Japanese 
petrochemical plant was releasing methyl mercury into Minamata Bay. As a result, 
both total mercury and methyl mercury were seen to biomagnify through the 
Northwater Polynya food web, which caused many problems for wildlife especially 
for top predator mammals (Campbell et al., 2005). 
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However, pharmaceuticals are now a growing topic of scientific interest (Kummerer, 
2001) and recently have been defined as emerging environmental contaminants 
(Beausse, 2004; Nikolaou et al., 2007). Studies have already highlighted the effects 
of pharmaceutical residues on terrestrial wildlife after they are taken up by a variety 
of species. Experimental evidence demonstrates that diclofenac is strongly 
responsible for the rapid decline in vulture populations in Asia (Green et al., 2007, 
2006; Oaks et al., 2004). Examination of the dead vultures revealed they had died 
from visceral gout, a condition caused by renal failure. It appeared that the vultures 
had scavenged on carcasses that had previously been given veterinary doses of 
diclofenac and that the uptake of diclofenac had caused kidney failure in several 
vulture species. The vulture populations are now classed as critically endangered 
after suffering a 97 % population decline, this may not be solely attributable to the 
presence of diclofenac residues in the environment but many scientists argue that it 
plays a substantial role. 
Another important problem associated with the presence of pharmaceuticals in the 
environment is the selection of antibiotic resistance in bacterial populations (Levy, 
2002). The emergence of resistant bacteria has led to widespread coverage in the 
scientific media. There is growing evidence that resistance to antibiotics (AR) is 
posing an emerging threat to both public and the future environmental health. Knapp 
et al., (2010) were able to extract DNA from a series of archived historic soils from 
the Netherlands (1940 – 2008). Results showed that the AR gene from all classes of 
the 18 antibiotics tested had significantly increased since 1940. This was especially 
true of the group of antibiotics known as tetracyclines, where in some cases 
individual AR genes were more than 15 times more abundant now than in the 1970s. 
Concern is now focussed, amongst scientists, environmental regulators and the 
pharmaceutical industry as to the risks and potential adverse effects of these agents 
on non-target organisms (GSK, 2011; Jorgensen and Halling-Sorensen, 2000; Pomati 
et al., 2004; Stuer-Lauridsen et al., 2000; Ternes, 1998). The detection of varying 
concentrations of numerous pharmaceuticals in all environmental compartments and 
incidents such as the vulture population decline as described above, has escalated 
this concern. As a result there has also been a noteworthy increase in the number of 
published studies on pharmaceuticals in the environment since 2001 (Figure 1.1). 
Although as Figure 1.1 also highlights the majority of studies have predominantly 
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focussed on the aquatic environment with the terrestrial environment being relatively 
unexplored in comparison. 
 
Figure 1.1 Number of publications regarding pharmaceuticals in both the aquatic (white) and terrestrial (black) 
environment. Graph obtained from web of knowledge citation report service on publications of environmental 
research, search terms were ‘aquatic pharmaceutical’ and ‘terrestrial pharmaceutical.’ 
 
1.2 How do pharmaceuticals enter the terrestrial environment? 
The various routes by which pharmaceuticals enter the soil compartment have been 
extensively documented (Diaz-Cruz et al., 2003; Oppel et al., 2004; Ruhoy and 
Daughton, 2008; Thiele-Bruhn, 2003). Land application of manure is the primary 
pathway for the release of veterinary pharmaceuticals into the terrestrial environment 
(Baguer et al., 2000). The presence of veterinary pharmaceuticals in manure 
intended for land application has been demonstrated by Jacobsen and Halling-
Sorensen (2006) with the detection of various tetracyclines (< 30 mg/kg dry weight) 
and sulphonamides (< 2 mg/kg dry weight). The two key pathways by which human 
pharmaceuticals enter the soil environment include via the use of reclaimed waste 
water (effluent) for irrigation and through the application of digested sewage sludge 
as a fertiliser onto agricultural fields (Diaz-Cruz et al., 2003; Oppel et al., 2004). 
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Sewage sludge and reclaimed wastewater are both by products of the sewage 
treatment plant (STP) process.  
1.2.1 Sewage treatment 
Because most pharmaceuticals are designed to not bioaccumulate and instead be 
rapidly eliminated from the body of the treated patient after administration, domestic 
raw sewage contains pharmaceuticals which have been excreted in urine and faeces 
to the wastewater system (Hirsch et al., 1999). Pharmaceuticals may also be 
metabolised in the patient so raw sewage will also contain metabolites of 
pharmaceuticals (Dollery, 1991; Huschek et al., 2004; Khan and Ongerth, 2002; 
Moffat, 2004; Ternes, 1998; Zuccato et al., 2005). Once released to the sewerage 
system, the pharmaceuticals and metabolites will typically be transported to a STP 
where the sewage will be treated (Lindqvist et al., 2005; Zorita et al., 2009). 
Several in-depth studies have explored the fate of pharmaceuticals in STPs with 
different removal processes being investigated, including sorption to sludge (Kim et 
al., 2005), hydrolysis and aerobic and anaerobic biodegradation in sludge (Stumpf et 
al., 1999; Ternes, 1998; Wang et al., 1993; Xia et al., 2005). Different 
pharmaceuticals will behave differently in different treatment processes depending 
on their chemical functionality and physico-chemical properties (Castiglioni et al., 
2006; Clara et al., 2005; Heberer, 2002; Stackelberg et al., 2004).  
Whilst pharmaceuticals can be removed in STPs, as a result of complete 
mineralisation, on the whole, the elimination of pharmaceuticals is generally 
incomplete. Pharmaceuticals tend to not be removed from the raw sewage simply 
because the treatment processes are not designed to do this (Thomas and Hilton, 
2004). Thus, the final effluent is likely to contain hydrophilic pharmaceuticals as 
these will remain in the aqueous phase whilst more hydrophobic pharmaceuticals 
may sorb to the sewage sludge. 
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1.2.2 Reclaimed wastewater effluent 
Concentrations of pharmaceuticals in effluent are typically in the low µg/L range but 
have been recorded up to 200 µg/L for ketoprofen in Switzerland (Ollers et al., 
2001). The anti-epileptic drug carbamazepine is consistently detected in effluent 
samples with highest concentrations measured in Wales, United Kingdom < 4.59 
µg/L (Kasprzyk-Hordern et al., 2009). A small number of studies have also 
investigated the detection of metabolites in sewage effluent with total mean 
concentrations of diclofenac metabolites ranging from 13 – 52 % of the measured 
parent compound concentrations. STP effluent is primarily emitted to water bodies 
such as rivers. However, recently effluent has been used to irrigate fields, a process 
which is sometimes described as ‘reclaimed wastewater irrigation’ or ‘recycled 
wastewater irrigation.’ 
Irrigation comprises 65 % of all water use worldwide (Gielen et al., 2009) and this 
demand is a growing year by year. Irrigation with effluent is a particularly attractive 
option to satisfy the demand for irrigation sources (Hamilton et al., 2007). Many 
countries including the United States, Australia, Singapore, South Africa, Japan, 
China, Mexico and New Zealand have already adopted this strategy to cope with 
their water shortages (Levine and Asano, 2004). The Mezquital Valley in Mexico 
began using effluent for irrigation in 1912 (Siemens et al., 2008). This is one of the 
oldest and largest examples of irrigation using municipal wastewater and is still in 
operation today, irrigating approximately 900 km
2
 of land (Jimenez and Chavez, 
2004). 
With droughts and irrigation strains resulting from population pressures, the future 
use of recycled water is set to increase (Asano and Levine, 1996; Hamilton et al., 
2007). The Californian Government, for example, has set out aims to move towards 
a more sustainable management of water resources, including the increased use of 
recycled water over 2002 levels by a minimum of 1233 million cubic meters per year 
by 2020 and by at least 2467 million cubic meters per year by 2030 (California 
Water Resources Board, 2009). The increasing use of wastewater for irrigation will 
result in greater loads of pharmaceuticals reaching the soil. 
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1.2.3 Sewage sludge 
Previously, sewage sludge was primarily disposed of at sea. However since 31 
December 1998 when a ban was put in place prohibiting such actions in the 
European Union under the Urban Wastewater Directive (Section 1.4), the amount of 
sewage sludge applied to land has substantially increased (Andrews et al., 1998) 
(e.g. Figure 1.2). Sewage sludge, produced from STPs, is now usually treated before 
it is used as a soil amendment (Jones-Lepp and Stevens, 2007). This treatment 
process typically involves digestion through biological, chemical and physical 
processes and then de-watering (Xia et al., 2005). The sewage sludge can then be 
applied to fields either in a cake form, typically containing 30 % solids, or a slurry 
which comprises approximately 3 % solids (USEPA, 1999). In European countries, 
an average of 37 % of sewage sludge is land applied onto agricultural soils, 
equivalent to 2.39 x 10
6 
dry tonnes per year (Chang et al., 2002). Specifically, in the 
UK, over 60 % of the 1.4 million tonnes of sewage sludge produced annually is 
recycled to agricultural land (WATER UK, 2010). Recycling of sewage sludge 
occurs on a larger scale in the US with 60 % of the 6.2 x 10
9
 kg of the sewage sludge 
generated in 1998 being land-applied (e.g. landfill cover, fertilizer, or soil 
amendments in land reclamation) and remaining disposed of via incineration for 
example (USEPA, 1999). 
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Figure 1.2 Primary disposal methods of sewage sludge in the United Kingdom between 1991 and 2004. Disposal 
methods include farmland (black) landfill (grey) and sea (white). Graph constructed with data obtained from e-
Digest Statistics about Waste and Recycling from the defra website. Data was unable to be obtained for the 
period 2000 / 2001. Date accessed 30.09.12. 
 
Sewage sludge is applied to agricultural fields for a number of reasons. From an 
agricultural perspective it is an inexpensive source of nitrogen, phosphorus, organic 
matter and other nutrients all of which can enhance soil physical properties and 
ultimately crop yield (Chitdeshwari and Savithri, 2007; Joshua et al., 1998; Webber 
et al., 1996). From a STP point of view land utilisation is desirable because it is an 
economic way of disposal. Land application of sewage sludge does however have its 
draw backs; it is also a source of many soil contaminants including organic 
compounds, pathogens and heavy metals (Rogers, 1996). Therefore through the use 
of the sewage sludge as a fertiliser there is the potential for pharmaceuticals to be 
added to soils. Recently studies have detected pharmaceutical compounds in sewage 
sludge destined for land application (Kinney et al., 2006; Metcalfe et al., 2003) as 
well in sewage sludge amended soils (Golet et al., 2002; Kinney et al., 2008, 2006) 
(Table 1.1). 
The most frequently detected pharmaceuticals in sewage sludge include 
carbamazepine, diclofenac, ibuprofen and trimethoprim which have been measured 
in µg – mg/kg range. Carbamazepine was detected in all of the nine sewage sludge 
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samples studied by Kinney et al., (2006) along with fluoxetine and diphenydramine 
of which three of the sludge samples were due to be applied to agricultural land. 
Acidic pharmaceuticals such as naproxen have been measured in a number of sludge 
samples however concentrations tend to be low and can often remain undetected. In 
contrast, triclocarban and triclosan  sorb particularly well to sludge, in some cases it 
is retained completely, resulting in concentrations < 441 mg/kg  (Barron et al., 2009; 
McAvoy et al., 2002; Thompson et al., 2005; USEPA, 2009; Ying and Kookana, 
2007). Sulfonamide antibiotics are frequently detected in sewage sludge and recently 
sulphonamide metabolites have also been detected in sludge samples (< 9.81 ng/g; 
García-Galán et al. (2012).  
1.3 Concentrations of Pharmaceuticals in Soil 
Concentrations of pharmaceuticals tend to be lower in the soil environment than in 
sewage sludge and effluent. For example, ibuprofen has been detected in sewage 
sludge between 99.5 to 11 900 µg/kg dry weight and in soil at only 0.25 ± 0.04 ng/g 
(Durán-Alvarez et al., 2009). This is primarily because when sewage sludge and 
effluent are applied to fields they are diluted within the soil matrix. Other potential 
loss mechanisms include leaching into nearby groundwater, photolytic processes or 
degradation by soil microbes for example, all of which would result in a reduction of 
the compound. In comparison to concentrations of pharmaceuticals in the aquatic 
environment and in sewage sludge, there are relatively few published studies that 
have shown concentrations in the soil environment. A list of measured 
concentrations has been compiled in Table 1.1 and a few key examples will be 
discussed in more detail below. 
Kinney and colleagues (2006) published one of the earliest studies that detailed the 
presence of pharmaceuticals in soil samples after irrigation with wastewater effluent 
from Colorado City’s WWTP. Individual pharmaceuticals were detected in the soils 
with concentrations typically ranging between 0.02 and 15 µg/kg (dw). A number of 
pharmaceuticals appeared to be persistent (acetaminophen, caffeine, carbamazepine, 
erythromycin, sulfamethazole, 1, 7-dimethylaxanthine and dehydronifedipine) and 
acetaminophen, fluoxetine, caffeine, erythromycin and carbamazepine were found to 
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accumulate in the soil in mass amounts consistently higher than the estimated mass 
applied in any month. 
Durán-Alvarez and colleagues (2009) were able to detect pharmaceuticals in field 
soil samples from Tula Valley, Mexico which had been irrigated with untreated 
wastewater for 90 years. Very low concentrations of ibuprofen and naproxen were 
found in both the soil types (< 1 ng/g). This low build-up of pharmaceutical 
compound is indicative of degradation in the soil environment and possibly the high 
temperatures of the area. Meanwhile carbamazepine showed evidence of persistence 
in both the Phaeozem (6.48 ng/g) and the Leptosol (5.14 ng/g) soil (Durán-Alvarez 
et al., 2009). Similar to the results from Duran-Alvarez et al., (2009), carbamazepine 
was also detected in field soil samples obtained from marsh lands in Spain  
(Vazquez-Roig et al., 2010). In fact carbamazepine was the only compound detected 
in both soil samples with concentrations in the range of 1.43 - 5.77 ng/g.  
Even though the concentrations of pharmaceuticals in sewage sludge and effluent are 
often at low levels, pharmaceuticals can build up in the soil compartment through 
long term, repeated, application (Dalkmann et al., 2012; Kinney et al., 2006; 
Redshaw et al., 2008a; Xu et al., 2009b). This is especially true of persistent 
pharmaceuticals that are known to not easily degrade in the environment, such as 
fluoxetine and carbamazepine (Clara et al., 2004; Durán-Alvarez et al., 2009; 
Monteiro and Boxall, 2009). 
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Table 1.1 Measured concentrations of pharmaceuticals in various soil matrices, ± standard deviations where 
reported in literature. 
Pharmaceutical 
Concentration 
(µg/kg) Soil type Reference 
Acetaminophen < 1.8 Pego-Oliva (1) 
Benzafibrate 0.67 Mezquital Valley (2) 
Bisphenol A 14.8 ± 3.2 Leptosol (3) 
 5.3 ± 0.9 Fangcun 0-10cm (4) 
 3.6 ± 2.2 Fangcun10-20 cm (4) 
Carbamazepine < 6.96 ± 1.80 Mezquital Valley (2) 
 < 1.5  Pego-Oliva (1) 
 
6.48 ± 0.59 Phaeozem (3) 
 
5.14 ± 0.48 Leptosol (3) 
 5.77 Prat soil (5) 
Ciprofloxacin < 2.82 ± 0.82 Mezquital Valley (2) 
 < 4.6 Pego-Oliva (1) 
Clarithromycin < 3.89 ± 2.19 Mezquital Valley (2) 
Clofibric acid 0.49 ± 0.3 Fangcun20-30 cm (4) 
Codeine < 1.7  Pego-Oliva (1) 
Diazepam 4.65 Prat soil (5) 
 < 0.3 Pego-Oliva (1) 
Diclofenac 0.40 Mezquital Valley (2) 
Enrofloxacin < 0.64 ± 0.54 Mezquital Valley (2) 
Ibuprofen 0.25 ± 0.04 Phaeozem (3) 
Metoprolol < 0.3 Pego-Oliva (1) 
Naproxen 2.86 Mezquital Valley (2) 
 
0.55 ± 0.01 Phaeozem (3) 
 
0.73 ± 0.2 Leptosol (3) 
Norfloxacin < 8.4  Pego-Oliva (1) 
Ofloxacin < 3.3 Pego-Oliva (1) 
Propranolol < 0.4 Pego-Oliva (1) 
Sulfamethazine 11 - (6) 
Sulfamethoxazole < 5.31 ± 0.22 Mezquital Valley (2) 
Triclosan 4.4 ± 0.1 Phaeozem (3) 
 
18.6 ± 1.2 Leptosol (3) 
3.2 ± 7.1  Fangcun10-20 cm (4) 
Trimethoprim < 2.39 ± 0.29 Mezquital Valley (2) 
 < 0.2 Pego-Oliva (1) 
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References: (1) (Vazquez-Roig et al., 2012); (2) (Dalkmann et al., 2012); (3) 
(Durán-Alvarez et al., 2009); (4) (Chen et al., 2010); (5) (Vazquez-Roig et al., 
2010); (6) (Hoper et al., 2002). 
 
1.4 Fate of pharmaceuticals in the soil environment 
Several reviews have highlighted the current scientific knowledge on the fate of 
pharmaceutical compounds in the environment (Halling-Sørensen et al., 1998; 
Heberer, 2002; Kummerer, 2004, 2001; Monteiro and Boxall, 2010; Thiele-Bruhn, 
2003). The fate of pharmaceuticals in the terrestrial environment depends heavily on 
the physico-chemical properties of the pharmaceutical as well as the properties of the 
surrounding soil matrices.  
The loss of pharmaceuticals from the soil can be broadly attributable to a number of 
processes, namely degradation, leaching and uptake by soil dwelling organisms. In 
general, the major processes that govern the fate of these compounds in the soil 
environment are sorption and degradation (Pignatello and Xing, 1996). These 
processes are important because they determine the overall persistence of 
pharmaceuticals which can therefore influence the potential for uptake of these 
compounds by terrestrial organisms. 
1.4.1 Persistence 
The chemical properties of human pharmaceuticals, such as high water solubility, 
high polarity and low volatility are largely responsible for their environmental 
persistence and thus their occurrence in terrestrial environments (Kummerer, 2008). 
Persistence in the environment is an inevitable result of the way most current 
medicines work. Pharmaceuticals need to be able to resist rapid metabolism in the 
body to ensure an adequate pharmacological effect (Richman and Castensson, 2008) 
and be stable enough to have a useful shelf life. Pharmaceuticals are developed with 
the intention of performing a biological effect; therefore they must be lipophillic to 
pass membranes whilst also being persistent to avoid the substance becoming 
inactivated (Halling-Sørensen et al., 1998). It is these specific properties which mean 
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that pharmaceuticals which are present in the terrestrial environment could 
potentially bio-accumulate in organisms. 
Persistence of a pharmaceutical in soil mostly depends on the photo-stability of the 
medicine, its binding and adsorption capability, its biodegradation rate and potential 
to leach into nearby water bodies (Diaz-Cruz et al., 2003). Studies have shown that 
pharmaceuticals can accumulate and persist in soil after application of sewage sludge 
or manure. For example, Hamscher et al. (2002) demonstrated that tetracyclines 
occur in soil which had been repeatedly fertilised with liquid manure. The 
persistence of each pharmaceutical is specific to the chemical and soil properties and 
thus persistence can vary across soil types. For example the persistence of the same 
antibiotic in the soil environment may range from less than one day to several 
months (Gavalchin and Katz, 1994).  
1.4.2 Degradation 
A number of studies have explored the degradation of human pharmaceuticals in the 
terrestrial environment (Monteiro and Boxall, 2009; Topp et al., 2008a, 2006; Xu et 
al., 2009a). 
Xu et al., (2009a) established that the degradation of pharmaceuticals differs 
between soil types and the pharmaceutical compound in agreement to the findings by 
Monterio and Boxall (2009). Whilst ibuprofen had a half-life of 6.09 days in a silt 
clay soil it also had a considerably shorter half-life in loamy sand soil at 0.91 days. 
Only triclosan was observed to exhibit similar degradation patterns in all of the 
agricultural soils investigated. Regression data from Xu et al., (2009a) demonstrates 
that degradation rate constants were negatively correlated with soil clay content, with 
the exception of clofibric acid (r
2 
between 0.42 – 0.56).  
The degradation of organic chemicals can also be affected by organic carbon (OC) 
content of the soil, soil microbial activity as well as physico-chemical properties of 
the chemical (Monteiro, 2009; Topp et al., 2008b; Xu et al., 2009c). Specifically, a 
soil with a high organic matter content may inhibit organic compound 
(pharmaceutical) degradation due to increased adsorption of the chemical and thus 
reduced bioavailability (Johnson and Sims, 1993; Xu et al., 2009). Alvey and 
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Crowley (1995) have also postulated that soil organic matter may also serve as an 
alternative nutritional source for microorganisms involved in degradation.  
The presence of sewage sludge can also affect the degradation of organic chemicals 
in soils. Sewage sludge alters the soil pH whilst also increasing the input of organic 
carbon (OC) (dissolved and solid) and microbial activity in the soil (Furczak and 
Joniec, 2007; Tsadilas et al., 1995). Specifically, pesticide degradation has been 
shown to be influenced by OC input and microbial activity (Kah et al., 2007). 
Monteiro and Boxall (2009) hypothesised that the presence of biosolids may result in 
the formation of bound residues between pharmaceuticals and the biosolid, thus 
decreasing its mobility and its potential for degradation. However conflicting results 
were observed in other studies where the degradation of pharmaceuticals increased 
with the introduction of biosolids (Topp et al., 2008a, 2006). In the 2006 paper by 
Topp et al., caffeine degradation was shown to be influenced by temperature, 
moisture, addition of liquid, the presence of caffeine degrading bacteria and soil 
type. 
Whilst it is clear pharmaceuticals can be degraded in the soil environment, the 
continual input of these pharmaceuticals ensures that some chemicals are persistent 
and thus may present a threat to soil inhabiting organisms. 
1.4.3 Sorption 
The sorption of organic compounds such as pharmaceuticals is the partitioning of the 
chemical between the water and solid phase, i.e. soil (Schwarzenbach et al., 2003). 
Sorption can be characterised by a soil–water partition coefficient (Kd) which is 
defined as the ratio of the concentration in the solid phase to the concentration in the 
solution phase at equilibrium.  
In terms of the environmental implications, the sorption behaviour of 
pharmaceuticals is critical because this regulates the transfer and distribution of 
compounds between phases which ultimately determines the mobility, bioavailability 
and availability of the compound for degradation (Thiele-Bruhn et al., 2003). It is the 
bioavailable fractions which have the potential for uptake into terrestrial organisms. 
A high Kd would suggest strong retardation in soils (Table 1.2; e.g. triclosan and 
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bisphenol A), whilst smaller Kd’s (Table 1.2; e.g. ibuprofen) would infer that these 
pharmaceuticals could move downwards with percolating water, leaching possibly 
into groundwater or nearby streams thus posing less of a risk to terrestrial organisms 
(Chefetz et al., 2008; Oppel et al., 2004; Topp et al., 2008).  
Physico-chemical properties specific to the pharmaceutical, including for example 
the octanol-water partition coefficient (Kow), the degree of ionisation, the charge of 
molecule and its hydrophobicity are important in determining the adsorption of the 
chemical to soil (Diaz-Cruz et al., 2003). Specifically, Kow indicates the tendency of 
a chemical to partition between the organic phase and the aqueous phase. Therefore 
compounds with a high Kow are hydrophobic with low water solubility and should 
sorb, to a greater extent to the soil, thus generating larger Kd values than compounds 
with a low Kow. For example triclosan has an extremely high Kd of 127 L/kg (Barron 
et al., 2009) and also a high log Kow at 4.8 (Aranami and Readman, 2007).  
This simple relationship between the Kd and Kow does however not always hold as 
there are a number of different mechanisms which are fundamental to the way in 
which pharmaceuticals sorb to soils. Sorption can occur through the direct and 
induced ion-dipole and dipole-dipole interactions. These interactions arise from the 
reciprocal attraction of two permanent dipoles or an induced dipole and can be 
responsible for the sorption of polar and ionic compounds (Von Oepen et al., 1991). 
Other mechanisms of sorption can include chemisorption, hydrogen bonding, 
 
ion 
exchange (including cation exchange), cation
 
bridging and formation of complexes 
with ions such as Ca
2+
, Mg
2+
, Fe
2+
 or Al
3+
, (Diaz-Cruz and Barcelo, 2004; Tolls, 
2001; Xia et al., 2005). For example the group of antibiotics, tetracyclines, have 
particularly low Kow’s (e.g. Chlortetracyline log Kow -0.62) yet bind strongly to soil 
because they form complexes with the metal ions present in the soil (Ca
2+
/ Mg
2+
) 
(Avisar et al., 2010; Bui and Choi, 2010). 
  
                                                                                                                                  Literature Review 
32 
Table 1.2 Reported sorption coefficients (Kd) in published literature for pharmaceuticals in various soil matrices, 
± standard deviations where reported in literature. 
Pharmaceutical Kd soil (L/kg) Soil type Reference 
Atenolol 15 Sandy mud (1) 
Benzafibrate 14 Sandy mud (1) 
Bisphenol A 17.00 ± 3.05 Loamy sand (2) 
 
27.89 ± 3.93 Sandy loam (2) 
 
42.22 ± 15.92 Silt loam (2) 
 
15.93 ± 4.77 Silt clay (2) 
 
20 Average of soils (3) 
Caffeine 25 Sandy mud (1) 
Carbamazepine 37  ± 1.6 High OC
a
 (4) 
 
0.49  ± 0.01 Low OC
a
 (4) 
 
13 Sandy mud (1) 
Chloramphenicol 42 Sandy mud (1) 
Cimetidine 11 Sandy mud (1) 
Ciprofloxacin 427 Centric Flurisol (5) 
Citalopram 250 Sandy mud (1) 
 
42579 Loamy sand (6) 
 
20691 Sandy loam (6) 
 17540 Loamy sand (6) 
Clofibric acid 9 Sandy mud (1) 
 
5.36 ± 1.49 Loamy sand (2) 
 
4.54 ± 1.68 Sandy loam (2) 
 
3.36 ± 1.55 Silt loam (2) 
 
200.73 ± 59.93 Silt clay (2) 
 
5.38 ± 0.17 High OC
a
 (4) 
Clotrimazole 1029 Sandy mud (1) 
Diazepam 30 Sandy mud (1) 
Diclofenac 164.5 ± 6.6 High OC
a
 (4) 
 
0.45 ± 0.03 Low OC
a
 (4) 
 
1.21 ± 0.36 Loamy sand (2) 
 
3.47 ± 0.73 Sandy loam (2) 
 
17.72 ± 7.45 Silt loam (2) 
 
2.83 ± 1.05 Silt clay (2) 
Enrofloxacin 3037 Rhodic Ferralsol (5) 
 
5612 Glegic Cambisol (5) 
 
1230 Haplic Podsol (5) 
 
260 Rendzic Leptosol (5) 
 
496 Centric Flurisol (5) 
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Pharmaceutical Kd soil (L/kg) Soil type Reference 
Erythromycin 68 Sandy mud (1) 
Flurbiprofen 11 Sandy mud (1) 
Fluoxetine 12546 Loamy sand (6) 
 
2602 Sandy loam (6) 
 
992 Loamy sand (6) 
Ibuprofen 0.56 ± 0.22 Loamy sand (2) 
 
0.56 ± 0.17 Sandy loam (2) 
 
3.71 ± 0.46 Silt loam (2) 
 
1.24 ± 0.26 Silt clay (2) 
Indomethacin 32 Sandy mud (1) 
Ketoprofen 9 Sandy mud (1) 
Methadone 82 Sandy mud (1) 
Metoprolol 20 Sandy mud (1) 
Metronidazole 0.67±0.10 (mL/g) Sandy loam (7) 
 
0.54±0.02 (mL/g) Sand soil (7) 
 
0.62±0.02 (mL/g) Sandy loam (7) 
 0.57±0.05 (mL/g) Loamy sand (7) 
Naproxen 11 Sandy mud (1) 
 
1.24 ± 0.31 Loamy sand (2) 
 
1.65 ± 0.52 Sandy loam (2) 
 
16.49 ± 5.17 Silt loam (2) 
 
6.99 ± 2.33 Silt clay (2) 
Ofloxacin 309 Centric Flurisol (5) 
 
3554 ± 194 High OC
a
 (4) 
 
1192 ± 122 Low OC
a
 (4) 
Oxytetracycline 680 ± 69 (mL/g) Sandy loam (7) 
 
670 ± 149 (mL/g) Sand soil (7) 
 
1026 ± 374 (mL/g) Sandy loam (7) 
 
417 ± 97 (mL/g) Loamy sand (7) 
Paracetamol 32 Sandy mud (1) 
Paroxetine 6386 Loamy sand (6) 
 
886 Sandy loam (6) 
 
355 Loamy sand (6) 
Propranolol 199 ± 9.6 High OC
a
 (4) 
 
16.3 Low OC
a
 (4) 
Salbutamol 26 Sandy mud (1) 
Salicyclic acid 82 Sandy mud (1) 
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Pharmaceutical Kd soil (L/kg) Soil type Reference 
Sertraline 787 Loamy sand (6) 
 
270 Sandy loam (6) 
 
149 Loamy sand (6) 
Sulfadiazine 2 Silt loam (8) 
Sulfamethazine 9 Sandy mud (1) 
Sulfamethoxazole 8 Sandy mud (1) 
 
37.6 ± 1.2 High OC
a
 (4) 
 
0.23 ± 0.08 Low OC
a
 (4) 
Tamoxifen 1626 Sandy mud (1) 
Triclocarban 438 Sandy mud (1) 
Triclosan 127 Sandy mud (1) 
 
9.72 ± 3.82 Loamy sand (2) 
Triclosan contd. 132.83 ± 30.01 Sandy loam (2) 
 
273.22 ± 78.43 Silt loam (2) 
 
51.67 ± 24.37 Silt clay (2) 
Trimethoprim 26 Sandy mud (1) 
a
 Organic carbon is described as OC 
References: (1) (Barron et al., 2009); (2) (Xu et al., 2009b); (3) (Ying and Kookana, 
2005); (4) (Drillia et al., 2005); (5) (Nowara et al., 1997); (6) (Kwon and Armbrust, 
2008); (7) (Rabolle and Spliid, 2000); (8) (Thiele-Bruhn and Aust, 2004).  
 
Soil components are important in the sorption of organic compounds, (Kah and 
Brown, 2006) as well as soil pore water distribution (Tsai et al., 2006) and soil 
particle size (Casey et al., 2003). For example clofibric acid in a silt clay soil has a 
Kd of 200.73 ± 59.93 (L/kg) which is larger than the Kd of 3.36 ± 1.55 (L/kg) 
obtained for the same compound in a silt loam soil (Xu et al., 2009) (Table 1.1). 
Therefore in addition to pharmaceutical physico-chemical properties, the extent to 
which a pharmaceutical sorbs to soils is determined by soil parameters such as the 
cation exchange capacity (CEC), solution chemistry (pH) and type of mineral and 
organic sorbents, (Boxall et al., 2002; Drillia et al., 2005; Tolls, 2001; Williams et 
al., 2006). Key soil parameters affecting sorption will be discussed further in 
sections 1.4.3.1 - 1.4.3.4. 
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1.4.3.1 pH 
Ionisable chemcials posess either weak acidic or basic functional groups and their 
behaviour depends on paramters such as surrounding medium pH and chemical pKa, 
where pKa is the negative log of the acid dissociation constant (pH at which 50 % of 
the chemical is dissociated). As a result of their potential to protonate or deprotonate 
they will either be positively or negatively charged molecules. The pH of the soil is 
therefore important in determining the sorption of pharmaceuticals because most 
pharmaceuticals are ionisable. 
For example, the sorption of acidic pharmaceuticals (e.g. naproxen) is pH dependant 
and it follows such that at typical soil pH most of these compounds are in their 
anionic state hence why their sorption to soils is particularly low. Conversely, at low 
pH, strong adsorption of basic chemicals is observed because the neutral species are 
present in high amounts (Monteiro, 2009). The pH of the soil solution has also been 
shown to affect the sorption of triclosan. An increase in pH (4 – 8) caused a decrease 
in the sorption of triclosan (Wu et al., 2009). Increasing pH decreased the amount of 
triclosan existing in the neutral from 100 to 39 % and the anionic form of triclosan 
was less attracted to the negative soil particles. Additional studies have also found 
that the sorption of sulphonamides is affected by pH (Boxall et al., 2002; Thiele-
Bruhn et al., 2004). 
1.4.3.2 Soil organic matter 
Soil organic matter (SOM) consists of varying proportions of raw plant residues and 
microorganisms, an active organic fraction and humus (stable organic matter) 
(Lickacz and Penny, 2001). The concentration and type of SOM is a very important 
factor in determining sorption of a pharmaceutical compound and thus its fate in the 
terrestrial environment. A positive correlation between SOM and sorption of 
pharmaceuticals to soil has been found on several occasions (Chefetz et al., 2008; 
Williams et al., 2006; Xu et al., 2009a). When a substance is neutral and in its un-
dissociated form, for example carbamazepine, it is quite likely to interact with SOM 
and it follows that with higher SOM there will be higher pharmaceutical retardation 
(Williams et al., 2006; Chefetz et al., 2008). However, if carbamazepine was in a 
poor SOM environment it would be significantly less retained by the soil. For neutral 
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organic compounds soil organic carbon has been postulated as the most important 
property to describe sorption in soils (Monteiro, 2009). 
In comparison, the retardation of a charged compound, for example naproxen 
(negatively charged because the carboxyl functional group is deprotonated), will be 
less influenced by SOM and thus the compound will be highly mobile (Chefetz et 
al., 2008). However, there are exceptions, diclofenac is a negatively charged 
pharmaceutical but it is slightly retarded in soils (Scheytt et al., 2006). This can be 
attributable it’s more hydrophobic nature meaning that it interacts more with SOM.  
1.4.3.3 Clay content 
The adsorption of some pharmaceuticals has been previously shown to be dependent 
on the clay content of the soil (Chen et al., 2006; Rai et al., 2000; Zheng and 
Cooper, 1996). Wu et al., (2009) postulated that high clay content might hinder the 
interaction between the chemical and SOM. In one particular soil, characterised by 
high clay content, the average Kd for triclosan was 178 L/kg whilst the remaining 
three soils, with lower clay contents, all had Kd values over 200 L/kg. Contrastingly, 
the clay content of soils has been shown to be positively correlated with the sorption 
of clofibric acid (Wu et al., 2009). This can be explained by the low pKa of clofibric 
acid (as previously discussed) which means that there are more hydrogen ions 
available for interaction with the negative clay particles.  
1.4.3.4 Dissolved organic matter  
Treated wastewater contains high levels of dissolved organic matter (DOM) (Fine et 
al., 2002). When this wastewater is used to irrigate fields then correspondingly the 
DOM will be transferred to the soil compartment. If the pharmaceutical compound 
forms a complex with DOM or the organic and inorganic suspended materials 
present in treated wastewater, this can enhance the mobility of pharmaceutical 
compounds in soils as DOM behaves as a water-soluble carrier. Interactions between 
DOM and pharmaceuticals have, in the past, been also shown to affect transport and 
sorption and thus mobility of pharmaceuticals (Chefetz et al., 2008; Nelson et al., 
1998; Totsche and Kogel-Knabner, 2004).  
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The presence of DOM can reduce the sorption of pharmaceuticals by competing for 
sorption sites in the soil (Celis et al., 1998; Flores-Cespedes et al., 2006, 2002; 
Nelson et al., 2000). The presence of DOM can also decrease the mobility of 
chemicals due to cumulative sorption and co-sorption where two chemicals with 
different preferences on surface sorbent both interact with DOM (Flores-Cespedes et 
al., 2006; Chefetz et al., 2008). 
1.5 Uptake of pharmaceuticals in the terrestrial environment 
The bioavailable fraction of the pharmaceutical is the portion of pharmaceutical that 
is available for uptake, specifically in the terrestrial environment this would be 
uptake by soil dwelling organisms such as plants and invertebrates. Bioavailability is 
influenced by the fate of pharmaceuticals in soils, for example by sorption and 
mobility. If a chemical is degraded this can also influence its bioavailability (Jjemba, 
2006); a more persistent pharmaceutical will remain in the environment for longer, 
and therefore have the potential to accumulate to higher concentrations and thus have 
a greater potential to be taken up by an organism. As discussed in section 1.4 the fate 
of pharmaceuticals in the terrestrial environment is extremely complex and depends 
on numerous soil properties; and thus it follows that the bioavailability and uptake of 
pharmaceuticals in the soil environment is also multifaceted. 
Previous research has postulated that chemicals have to be in a dissolved state to be 
bioavailable to earthworms (Belfroid et al., 1993; Oste et al., 2001; Peijnenburg et 
al., 1999; Saxe et al., 2001; Vijver et al., 2003) and additional studies has concluded 
that plant uptake of chemicals from soil are mediated by uptake from soil pore water 
during transpiration (Schrèoder and Collins, 2011). Therefore how the chemical 
behaves in the soil environment is important in determining the ultimate fate and 
uptake into terrestrial species.  
1.5.1 Previous research on the uptake of pharmaceuticals in 
terrestrial organisms 
Studies have explored the uptake of pharmaceuticals into plants from hydroponic 
culture mediums (Herklotz et al., 2010; Kong et al., 2007; Redshaw et al., 2008b; 
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Shenker et al., 2011) as well as from soils (Boxall et al., 2006; Dolliver et al., 2007; 
Holling et al., 2012; Shenker et al., 2011; Wu et al., 2012, 2010). A number of 
pharmaceuticals with different physico-chemical properties and a range of 
therapeutic uses are taken up by a variety of crop species including soybean, carrot, 
lettuce and potato. Studies have also revealed variations in plant uptake between 
different species exposed to pharmaceuticals (Boxall et al., 2006; Herklotz et al., 
2010; Wu et al., 2012). Recent studies have also investigated uptake into plants with 
the addition of sewage sludge to test systems and uptake following the application of 
reclaimed waste water effluent to soils to simulate realistic environmental exposures 
(Holling et al., 2012; Shenker et al., 2011; Wu et al., 2012, 2010). Results indicate 
that plant uptake is higher in the biosolid amended soils, probably a result of higher 
exposure concentrations, however, pharmaceuticals introduced by irrigation water 
appear to be more available for translocation (Wu et al., 2010). 
Very little research has demonstrated the uptake of pharmaceuticals into terrestrial 
invertebrates. One published study assessed the bioaccumulation of anthropogenic 
waste indicators (including the pharmaceuticals: trimethoprim, caffeine, 
carbamazepine, thiabendazole and diphenhydramine) into earthworms from 
agricultural soil amended with biosolid or swine manure (Kinney et al., 2008). In 
this study, trimethoprim was the only pharmaceutical detected in the earthworms at 
concentrations of 127 µg kg
-1
 (dw) in a biosolid amended field and 61 µg kg
-1 
(dw) 
in the manure amended field. More recently, Kinney et al., (2012) continued their 
research with earthworms and investigated the effect of biosolids containing 
pharmaceuticals on earthworm  reproduction and survival. Observations included 
biosolid toxicity to earthworm increased with biosolid aging and both survival and 
reproduction were sensitive at agronomic rates. 
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1.6 Aims and objectives of research 
It is crucial that we understand how pharmaceutical physico-chemical properties, 
species traits and the distribution of pharmaceuticals between the soil and pore water 
and relate to the degree of uptake and depuration (including how metabolism can 
affect uptake)  in the terrestrial environment (Figure 1.3). 
The main aim of the PhD research was therefore to explore the factors and processes 
which affect the uptake of pharmaceuticals in the terrestrial environment. The 
specific objectives were to: 
1) Explore the effects of chemical properties (e.g. pKa, log Kow) on the uptake 
and depuration behaviour of pharmaceuticals in earthworms, Eisenia fetida 
(Chapter 2) 
2) Explore the use of a minimised design approach to estimate bioconcentration 
factors in terrestrial and aquatic invertebrates, using reduced sampling points 
and kinetic definitions (Chapter 3) 
3) Investigate the effects of soil properties on the fate of pharmaceuticals in the 
soil and pore water and the subsequent uptake and depuration of 
pharmaceuticals in earthworms, Eisenia fetida (Chapter 4). 
4) Compare the uptake and depuration of pharmaceuticals between Eisenia 
fetida and Lumbricus terrestris earthworm species in order to establish the 
importance of species traits (Chapter 5). 
5) Determine the impacts physico-chemical properties and plant type on the 
uptake of pharmaceuticals into plant species (Chapter 6). 
Data from such investigations presented in the following chapters will be useful 
for risk assessment purposes as it will allow for the accurate prediction of uptake 
of chemicals into terrestrial species and mean that risks can be better 
characterised. 
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Figure 1.3 A conceptual model of uptake into terrestrial organisms from pore water exposure, where Kin and Kout 
are the uptake and depuration rates respectively. 
Soil 
Pore 
water 
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1.7 Study compounds 
The study compounds were chosen specifically to provide a range of pharmaceutical 
physico-chemical properties (log Kow, pKa) and different therapeutic uses. 
Chemicals used in the earthworm uptake and depuration experiments (Chapter 2, 
Chapter 4 and Chapter 5) were 
14
C radiolabelled (carbamazepine, diclofenac, 
fluoxetine and orlistat) (Table 1.4). Radiolabelled pharmaceuticals were used to 
allow for lower limits of detection and thus environmentally relevant concentrations 
could be used in the experiments. Additional studies, using cold compounds, were 
performed to determine any potential metabolism in the earthworm studies. Plant 
studies were carried out using unlabelled pharmaceuticals (carbamazepine, 
diclofenac, fluoxetine, propranolol, sulfamethazine and triclosan) (Chapter 6). 
Carbamazepine is in a class of medications called anticonvulsants. It can be used to 
control certain types of epileptic seizures in patients, as well as in the treatment of 
trigeminal neuralgia (a condition that causes facial nerve pain) (Dale and Rang, 
2011). Carbamazepine is the most widely used anti-epileptic drug (Dale and Rang, 
2011). In England, 2256 x 10
3
 carbamazepine prescription items were dispensed in 
2000 resulting in an annual use of over 40 thousand kg of this drug (Jones et al., 
2002). Due to its wide use and thus potential to transfer to the environment, 
carbamazepine has been detected in numerous soil profiles throughout the world, in 
concentrations ranging up to 6.69 ± 1.80 µg/kg (Dalkmann et al., 2012; Durán-
Alvarez et al., 2009; Vazquez-Roig et al., 2012, 2010). With regards to the terrestrial 
environment, studies have explored the uptake of carbamazepine into cucumber and 
soybean plants (Shenker et al., 2011; Wu et al., 2010). Carbamazepine however has 
remained undetected in research into the bioaccumulation of anthropogenic waste 
indicators in earthworms after it was detected in soils receiving biosolid amendment 
(Kinney et al., 2012). 
Diclofenac is a non-steroidal anti-inflammatory (NSAID) taken to ease pain and 
reduce inflammation in patients suffering with, amongst other problems, rheumatoid 
arthritis, migraines and musculoskeletal injuries and pain for example (Dale and 
Rang, 2011). NSAIDs are drugs that suppress prostanoid synthesis in the 
inflammatory cells by the inhibition of the cyclo-oxygenase (COX)-2 isoform of the 
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arachidonic acid COX enzyme and in doing so provides three major therapeutic 
actions; anti-inflammatory action, analgesic effects and antipyretic effects (Dale and 
Rang, 2011). Diclofenac is a widely used pharmaceutical and statistics in 2000 
indicated that 26 121 kg was consumed in England on an annual basis (Jones et al., 
2002). Diclofenac has been detected in soils in the Mezquital Valley, Mexico at low 
concentrations (0.4 µg/kg) after irrigation using wastewater (Dalkmann et al., 2012). 
However research on the uptake of this pharmaceutical is limited; one recent study 
was unable to detect diclofenac in either wheat or soybean crops after 110 days 
grown in soil treated with sewage sludge containing NSAIDs. In terms of the wider 
environmental impacts of diclofenac, experimental evidence indicates that the casual 
factor in the decline of vulture populations in the Indian sub-continent is from these 
birds scavenging on cattle carcasses containing high levels of diclofenac (Green et 
al., 2007, 2006; Oaks et al., 2004). Therefore further research is needed to explore 
the uptake and effects of this pharmaceutical in the environment.  
Fluoxetine (also known by the trade name Prozac) is used in the treatment of 
depression. It is a selective serotonin (5-HT) reuptake inhibitor (SSRI). Statistics 
from Spain indicate that it is a highly used drug as over three thousand kilograms of 
fluoxetine were consumed in 2003(Carballa et al., 2008). Fluoxetine has been 
detected in soil samples across the U.S. which were previously irrigated with 
reclaimed wastewater irrigation (Kinney et al., 2006). The uptake of fluoxetine has 
been comprehensively explored in the aquatic environment (Brooks et al., 2005; 
Meredith-Williams et al., 2012) and the compound has been demonstrated to be 
taken up by plants from a hydroponic culture medium (Redshaw et al., 2008b) as 
well as from soil (Wu et al., 2010). 
Propranolol belongs to a group of pharmaceuticals called beta blockers that primarily 
work on the heart and blood vessels. It can be used to treat a number of symptoms 
such as high blood pressure, irregular heartbeats, angina and anxiety. Propranolol is 
a non-selective β antagonist; it targets the beta receptor which can usually be found 
on cells of heart muscles, arteries and other tissues of the sympathetic nervous 
system. When stimulated by adrenaline (epinephrine) these receptors can lead to 
stress responses. Beta blockers interfere with the binding between epinephrine and 
other stress hormones to the receptor and thus weaken the effects of stress hormones 
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(Dale and Rang, 2011). Even though propranolol has been detected in soils at 
concentrations < 0.4 µg/kg (Vazquez-Roig et al., 2012) very little research has 
investigated the uptake of this pharmaceutical into terrestrial species. In a large scale 
experiment looking at the potential uptake of 118 pharmaceuticals into four crop 
species after biosolid amendment of soil resulted in no detection of propranolol 
residues in any of the plant material (Sabourin et al., 2012). 
Sulfamethazine has antibacterial properties and comes from a well-known group of 
pharmaceuticals called sulfonamides. Recently, sulfamethazine is more commonly 
used for veterinary purposes however in the past it has been prescribed to treat a 
variety of bacterial diseases in humans. This has resulted in the detection of 
sulfamethazine in concentrations up to 11 µg/kg (Hoper et al., 2002) in soils. Some 
of the first plant uptake research with regards to pharmaceutical exposure 
demonstrated that sulfamethazine could be taken up into plant material and 
accumulate to concentrations in the range of 0.1 % of the amount applied to the soil 
in manure (Dolliver et al., 2007). 
Triclosan is a synthetic anti-microbial agent that is commonly used in consumer 
products such as soaps, deodorants and toothpastes. It should be noted that triclosan 
is not strictly a pharmaceutical and is more often referred to as a personal care 
product. In a U.S. Geological Survey study of 95 different organic wastewater 
contaminants in U.S. streams, triclosan was one of the most frequently detected 
compounds, with some of the highest concentrations (Kolpin et al., 2002). Since its 
detection in soil (Chen et al., 2010; Durán-Alvarez et al., 2009) work has been 
undertaken to explore the uptake of triclosan into various plant species 
(Karnjanapiboonwong et al., 2011; Wu et al., 2010) with bioconcentration factors up 
to 12 reported in plant roots. 
Orlistat is the only drug currently licensed in the UK for the treatment of obesity. 
(2010) (Dale and Rang, 2011). It works in interfering with the way that fat is 
digested and absorbed in the body. Specifically, the presence of orlistat in the 
intestine prevents the breakdown of dietary fat to fatty acids and glycerols by 
reacting with the serine residues at the active sites of gastric and pancreatic lipases 
and in doing so irreversibly inhibiting these enzymes (Dale and Rang, 2011). Whilst 
it has been available on the market as a prescription drug since 2001, under the sale 
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name of Xenical, it has been difficult to obtain usage and consumption statistics on 
this particular pharmaceutical. Orlistat has yet to be detected in soils. However its 
high log Kow suggests a large affinity for sorption to soil and potential 
bioaccumulation into terrestrial species if it makes its way into the soil environment 
and thus further research on this pharmaceutical is important. 
    
 
Table 1.3 Physico-chemical properties for selected study compounds 
Test chemical Therapeutic use Chemical 
formula 
Molecular 
weight 
(g/mol) 
pKa
a
 Log 
Kow
b
 
Soil-water 
distribution 
coefficient 
(Kd) (L/kg)
c
 
Structure  
Carbamazepine Anticonvulsant C15H12N2O 236.27 N/A 2.25 4.83 
 
Diclofenac Anti-
inflammatory 
C14H11Cl2NO2 318.13 4.12 4.02 28.65 
 
Fluoxetine Anti-depressant C17H18F3NO 345.79  9.53 
 
4.65 608.42 
 
Propranolol Beta-blocker C16H21NO2 259.34 8.99 3.5 - 
 
 
4
5
 
    
 
 
Table 1.3 Continued 
Test chemical Therapeutic use Chemical 
formula 
Molecular 
weight 
(g/mol) 
pKa
a
 Log 
Kow
b
 
Soil-water 
distribution 
coefficient 
(Kd) (L/kg)
c
 
Structure  
Sulfamethazine Antibacterial C12H14N4O2S 278.32 6.0,1.55 0.9 - 
 
Triclosan Antimicrobial  C12H7Cl3O2 289.54 8.1 4.8 - 
 
Orlistat Weight loss aid C29H53NO5 497.74 N/A 8.19 1493.98 
 
a
 pKa values were predicted using the University of Georgia SPARC database v. 4.2 (http://ibmlc2.chem.uga.edu/sparc) Accessed: 25/05/2012 
b
 Log Kow values obtained from KOWWIN v. 1.68 database, USEPA EPI suite 4.1 programme 
c
 Soil water distribution coefficients (Kd) for selected pharmaceuticals were determined experimentally following OECD 106 for study soil 280 
used in earthworm uptake studies in Chapter 2 (2.3.1) (unpublished data). 
4
6
 
    
 
Table 1.4 Radiolabelled chemical properties of selected study compounds 
Test chemical name Specific Activity 
(GBq/mmol) 
Structure (including position of 
radiolabel) 
Carbamazepine [carbonyl-
14
C] 0.74  
Diclofenac sodium, [phenylacetic acid ring – 14C (U)]- 2.294  
Fluoxetine [N-methyl-
14
C] hydrochloride 2.035 
 
Orlistat [tridecanyl-2-
14
C] 2.051  
 
4
7
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1.8 Study species 
1.8.1 Earthworms  
Earthworms can be split into three categories; endogeic, anecic and epigeic species 
(Edwards, 1996). The descriptions are largely based on their habitats in the soil. 
Endogeic species rarely come to the surface of the soil preferring to reside in a series 
of complex lateral burrow systems through the soil layers. Meanwhile anecic worms, 
such as Lumbircus terrestris, also form deep burrows however these tend to be 
vertical from the soil surface and go deep into the mineral soil layers. In comparison, 
to endogeic species which eat soil, anecic species feed primarily on decaying surface 
litter and therefore come to the soil surface more regularly. Worms which are 
typically used in vermicomposting, including E. fetida, tend to be epigeic species. 
Epigeic worms inhabit the top soil layers or can be found on the soil surface residing 
in loose organic litter and debris (Bouche, 1992; Edwards, 2004; Edwards, 1996). 
Earthworms can comprise of 60 – 90 % of total soil biomass in a selection of 
locations (Bouche, 1992; Lee, 1985). Earthworms are key organisms in the terrestrial 
environment; their presence is central to a healthy and sustainable soil environment, 
for example earthworms help to establish and maintain the structure and fertility of 
the soil (Edwards, 2004; Killham, 1994). The physical motion of earthworm 
burrowing can bury plants deep in the soil which is crucial for the recycling of 
nutrients whilst the structure of the burrows is important in draining and aerating the 
soil (Edwards and Bohlen, 1992; Edwards and Lofty, 1972; Edwards, 2004). 
Earthworms being at the base of a food chain hold an integral position. Uptake and 
accumulation of contaminants into earthworms not only poses a risk to the 
earthworm directly, but may also result in far wider reaching ecosystem effects due 
to bioaccumulation and contaminant transfer through the food chain to top predators 
such as birds where there is the potential for secondary poisoning (Romijn et al., 
1994; Spurgeon and Hopkin, 1996).  
Earthworms are known to bio-magnify inorganic and organic soil contaminants, 
including polycyclic aromatic hydrocarbons (PAHs), brominated flame retardants, 
pesticides and metals (Giovanetti et al., 2010; Grumiaux et al., 2010; Harris et al., 
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2000; Heikens et al., 2001; Hinton and Veiga, 2008; Jager et al., 2005; Janssen et 
al., 1997; Ma et al., 1998, 1995; Matscheko et al., 2002; Qi and Chen, 2010; 
Sellstrom et al., 2005; Van Gestel and Ma, 1988). Earthworms take up contaminants 
in a number of ways: through living in the soil environment, earthworms are in direct 
contact with the soil and therefore the ingestion of soil particles may lead to 
chemicals passing across the gut wall and into the earthworm tissue. Uptake via 
diffusion across the earthworm skin from chemicals in the pore water is also 
possible.  
1.8.1.1 Earthworm biological properties 
The uptake and accumulation of chemicals in the soil environment can vary between 
species as a result of species specific traits, a number of studies have highlighted 
these differences. Work by Kelsey et al., (1997) demonstrated the bioavailability of 
atrazine and phenanthrene to bacteria was far greater than that to earthworms. In an 
early study; the earthworm Lumbricus rubellus accumulated more calcium and zinc 
but less lead and cadmium than the earthworm Dendrobaena rubida living in the 
same soil environment (Morgan and Morris, 1982). Further work regarding 
earthworms established that E. fetida, had BCFs that were approximately ten-fold 
higher than those for the other species in the study including the anecic species 
Lumbricus terrestris, and the endogeic species Aporrectodea caliginosa after 
exposure to 2,2-bis (p-chlorophenyl)-1,1-dichloroethylene (p,p’-DDE) (Kelsey and 
White, 2005). Diﬀerences in their processing of soil organic matter, ecological 
strategy, and lipid content are potential explanations as to the observed variation 
among earthworm BCFs (Kelsey et al., 2005). 
1.8.1.2 Biotransformation 
As well bioaccumulation of chemicals in earthworms, biotransformation of 
chemicals can also occur. Biotransformation is the chemical modification made by 
an organism on a chemical compound. Biotransformation together with 
bioaccumulation are key toxicokinetic processes that can modify the toxicity of 
chemicals and sensitivity of organisms (Ashauer et al., 2012). Metabolism of 
chemicals, such as pharmaceuticals, is an example of biotransformation. The 
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metabolites may reach higher concentrations in the organism that that of the parent 
compounds. 
The biotransformation of soil contaminants, such as polychlorobiphenyls, polycyclic 
aromatic hydrocarbons, pesticides and metals in a number of earthworm species has 
been extensively studied (Button et al., 2009; Lydy and Linck, 2003; Belfroid et al., 
1995; Stroomberg et al., 2004). Pharmaceuticals can remain unchanged during 
urinary excretion and leave the human body as parent compounds (Bound and 
Voulvoulis, 2005).  However, it is well known that pharmaceuticals can undergo 
metabolism in the human body, including the study compounds selected in this thesis 
(Pearson and Wiehkers, 2008). For example, fluoxetine is extensively metabolized in 
the liver. The only identified active metabolite, norfluoxetine, is formed by 
demethylation of fluoxetine (Dale and Rang, 2011).  Biotransformaton of diclofenac 
has also been demonstrated after uptake into fish (Lahti et al., 2011). There is 
therefore the potential for pharmaceuticals to undergo biotransformation after being 
taken up by earthworms. 
Understanding the uptake of chemicals into earthworms is a prerequisite to 
understanding the risks chemicals pose to earthworm populations, as well as the 
potential effects of secondary poisoning to predators like birds. Earthworms are at 
the base of many food chains and thus if chemicals are taken up into the earthworms 
they can facilitate the movement of chemicals into the food web via bioaccumulation 
and bio-magnification processes. The two earthworm study species are discussed in 
detail below. 
1.8.1.3 Eisenia fetida 
 
The typical species of earthworm outlined in standard test guidelines and used for 
terrestrial bioaccumulation and toxicity testing is Eisenia fetida (International 
Standard Organisation, 1998, Organisation for Economic Cooperation and 
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Development, (OECD) guidelines 207, 222, 317 (OECD, 2010, 2004, 1984). This 
primarily reflects its ease of laboratory culture as it is a robust species, has a fast 
reproduction time (8 weeks) and a shorter generation time than many other 
earthworm species. 
E. fetida belongs to the Lumbricidae family of earthworms, characterised by their 
segmented body. There are typically 80 -120 segments and each E. fetida is 
approximately 60 – 120 mm in length (Sims and Gerard, 1985). E. fetida are known 
under various common names including redworm, red wiggler and brandling worm. 
Interestingly the name ‘fetida’ originates from the Latin word meaning ‘fetid’ which 
refers to a foul smelling odour. When they are roughly handled or in fear of 
predation E. fetida release a pungent liquid from their body. It is the release of this 
coelomic fluid from which the name originates. 
E. fetida is a particularly robust species of earthworm, they are found in a number of 
soil environments throughout the world. It is therefore a suitable species to work 
with in laboratory experiments as they can tolerate a wide range of environmental 
conditions such as soil pH, moisture, temperature and soil types (Edwards, 1996). 
For example Edwards (1988) reported that E. fetida can tolerate a pH range from 4.0 
-7.0. E. fetida typically thrive in organic rich habitats such as rotting vegetation, 
compost and manure piles.  
1.8.1.4 Lumbricus terrestris  
 
Similar to E. fetida, Lumbricus terrestris belongs to the Lumbricidae family of 
earthworms however it is a larger species. Compared to other earthworms in its 
genus, L. terrestris is the longest having approximately 140 - 155 segments and 
reaching a maximum length of 160 mm (Sims and Gerard, 1985). It is commonly 
known as the night crawler as this species tends to crawl to the soil surface through 
permanent constructed burrows during the night to feed. 
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Whilst E. fetida is a species of earthworm commonly used in terrestrial uptake and 
toxicity testing it has been suggested that Lumbricus terrestris is a more ecologically 
relevant and sensitive species (Dean-Ross, 1983). One of the key issues is that E. 
fetida is a manure compost worm and does not naturally inhabit the soil 
environment. Additionally some authors observed differences in the sensitivity of 
Eisenia species with E. fetida being less sensitive to contaminants than other 
earthworm species (Edwards and Bohlen, 1992; Edwards and Coulson, 1992; 
Langdon et al., 2005; Spurgeon and Weeks, 1998). Yet in a more recent study, after 
exposure to imidacloprid, E. fetida were more sensitive concerning cellular 
alterations and mortality than both Aporrectodea caliginosa and L. terrestris 
(Dittbrenner, 2012). L. terrestris which are commonly found in the soil environment 
may therefore be a more useful species in terms of the risk assessment of chemicals. 
However L. terrestris worms have a long generation time, do not do well in high 
density cultures and require a stable burrow environment in order to thrive. Cultures 
must also allow sufficient burrowing depth for the worms, and this is difficult to 
achieve with burrow depths for L. terrestris reported to easily exceed 40 cm below 
the soil surface (Shipitalo and Butt, 1999). Without access to this burrow, anecic 
worms will encounter difficulties in both breeding and growing which are necessary 
for a successful standardised laboratory experiment.  
In terms of the thesis, uptake studies began with E. fetida as optimised cultures were 
easier to obtain. Later research then explored, in a small number of studies, the 
uptake of pharmaceuticals into L. terrestris. 
1.8.2 Plants 
Plants were specifically chosen to provide enough biomass for extraction and 
analysis at time of harvest. Radish also provided the opportunity to differentiate 
between above and below ground crop concentrations by separating the leaf from the 
root material. 
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1.8.2.1 Radish (Raphanus sativus) 
Radish (Raphanus sativus, Cherry belle variety) is an edible root vegetable of the 
Brassicaceae family. Specifically cherry belle is a bright red-skinned (‘cherry’ 
colour) round variety of radish with a firm white interior. Cherry belle germinate in 4 
- 6 days and are fully grown in approximately 21 days where they typically reach a 
diameter of 2 cm and the leafy green tops can reach up to 15 cm. Previous research 
has predominantly explored the uptake of metals, polychlorinated biphenyls and 
pesticides in radish plants (Davies, 1992; Mikes et al., 2009; Zhou et al., 2005). 
Apart from research investigating the phytotoxicity to and uptake of the 
fluoroquinolone antibiotic, enrofloxacin in a variety of vegetable crops, including 
radish, the uptake of pharmaceuticals into radish species has been relatively 
unexplored.   
1.8.2.2 Ryegrass (Lolium perenne) 
Ryegrass (Lolium perenne, Guard variety) is a commonly used plant species in 
toxicity and uptake testing in the terrestrial environment (Gu et al., 2013; Li et al., 
2002; Winker et al., 2010). It is a cool-season perennial grass native to Europe, 
temperate Asia, and North Africa and widely distributed throughout the world. 
Perennial ryegrass is important for forage and livestock farming in temperate regions 
of the world. It has a shallow root system which is highly branched and can be 
characterised by its fast growing and rapid establishment properties making it a high 
yielding species. Previous work with pharmaceuticals has demonstrated that 
carbamazepine can be taken up into ryegrass aerial plants and roots however 
ibuprofen remained undetected in any plant material (Winker et al., 2010). 
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Chapter 2 Uptake and Depuration of Pharmaceuticals in 
the Earthworm, Eisenia fetida 
2.1 Introduction 
A number of studies have explored the uptake of pharmaceuticals into aquatic 
invertebrates and fish (Brooks et al., 2005; Karlsson, 2013; Meredith-Williams et al., 
2012; Paterson and Metcalfe, 2008; Schultz et al., 2010). However, much less work 
has been done to assess uptake of pharmaceuticals in the terrestrial environment; 
work that has been done has focused on the uptake of human and veterinary 
pharmaceuticals into plants (Boxall et al., 2006; Shenker et al., 2011; Winker et al., 
2010; Wu et al., 2010) with very few studies looking at uptake into terrestrial 
invertebrates such as earthworms.  
Earthworms are known to bio-magnify inorganic and organic soil contaminants, 
including polycyclic aromatic hydrocarbons (PAHs), brominated flame retardants, 
pesticides and metals (Giovanetti et al., 2010; Grumiaux et al., 2010; Heikens et al., 
2001; Hinton and Veiga, 2008; Jager et al., 2005; Janssen et al., 1997; Ma et al., 
1998, 1995; Matscheko et al., 2002; Sellstrom et al., 2005; Van Gestel and Ma, 
1988). Through living in the soil environment, earthworms are in direct contact with 
the soil and soil pore water and therefore uptake of chemicals from these two media 
is possible. The ingestion of soil particles may also lead to chemicals passing across 
the gut wall and into the tissue.  
Only one published study so far has explored the uptake of pharmaceuticals into 
earthworms (as previously discussed in section 1.5) (Kinney et al., 2008). Additional 
research is required to fully characterise the potential for pharmaceutical uptake into 
terrestrial invertebrates as this is something which we currently know little about. 
Pharmaceuticals are emerging contaminants and there have already been a number of 
notable effects on non-target organisms as a result of their presence in the 
environment (see section 1.1.1). 
Earthworms are key organisms in the terrestrial environment (section 1.8.1). 
Earthworms, being at the base of a food chain, hold an integral position. Uptake and 
accumulation of contaminants into earthworms not only poses a risk to the 
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earthworm directly, but bioaccumulation and contaminant transfer through the food 
chain to top predators such as birds has the potential to cause secondary poisoning 
(Romijn et al., 1994; Spurgeon and Hopkin, 1996).  
To assess the potential for chemicals to be taken up by earthworms, a number of 
quantitative structure-activity relationships (QSARs) allow for the prediction 
earthworm pore water based bioconcentration BCFs. QSARs can be used for initial 
screening purposes or to avoid lengthy experiments whilst still providing a measure 
of potential chemical uptake and thus wider environmental implications. Belfroid 
and colleagues (Belfroid et al., 1993) were one of the first to develop a QSAR based 
on water exposure of chlorobenzenes and work by Jager (1998) followed, which is 
included in the Technical Guidance Document (TGD) on Risk Assessment Part 2. 
Both of these QSARs utilise log Kow as the primary descriptor in BCF determination, 
mimicking the partitioning between the aqueous and lipid phases. The applicability 
of these relationships for pharmaceuticals is currently unknown. 
The aim of this study therefore was to investigate the uptake and depuration of a 
range of pharmaceuticals, including carbamazepine, diclofenac, fluoxetine and 
orlistat (Table 1.3) into the earthworm Eisenia fetida. The results would then be used 
to evaluate existing predictive models, such as QSARs for estimating uptake of 
pharmaceuticals into earthworms.  
2.2 Experimental materials 
2.2.1 Pharmaceutical compounds and reagents 
14
C labelled compounds were used in the uptake studies. Labelled fluoxetine 
[methyl-
14
C] and carbamazepine [carbonyl-
14
C] were obtained from American 
Radiolabelled Chemicals (Missouri, USA), diclofenac [U – 14C] was obtained from 
Perkin Elmer (Boston, USA) and orlistat [tridecanyl-2-
14
C] was provided by 
GlaxoSmithKline (GSK, UK). Unlabelled fluoxetine, carbamazepine and diclofenac 
were obtained from Sigma Aldrich (UK) and unlabelled orlistat was provided by 
GSK.  Acetonitrile (99.9 %), methanol (99.9 %) and ethyl acetate (99.9 %) were 
obtained from Fisher Scientific (Loughborough, UK).  
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2.2.2 Test soil 
The study soil was a clay loam soil obtained from LandLook (Midlands, U.K.). Prior 
to use in experimental studies, the soil was air dried for 48 hours then sieved to 2 
mm to ensure homogeneity within the soil matrix. Detailed characteristics of the 
study soil are given in Table 2.1. 
Table 2.1 Test soil characteristics provided ± standard deviation where provided (n = 6). († Analysis completed 
at INRA [Arras, France] *Analysis completed at Fera [York, U.K.]). 
 
 
 
 
 
 
2.2.3 Test organism  
E. fetida were obtained from Blades Biological Ltd (Kent, UK) and cultured in a 
medium of peat and cow manure (50:50), kept moist with deionised water at room 
temperature (20 ± 3 
o
C). The animals were fed twice weekly with homogenised 
mashed potato powder which was added to the surface of the culture. The E. fetida 
were obtained from a single species culture and cultures were maintained for at least 
four generations before being used in the studies. The lipid content of E. fetida, 
determined using the method of Folch et al., (1957), was 5.11 ± 0.29 % (wet weight 
± standard deviation). 
Fine sand (50/200 µm) (g/kg) † 272 
Coarse sand (200/2000 µm) (g/kg) † 136 
Fine silt (2/20 µm) (g/kg) † 197 
Coarse silt (20/50 µm) (g/kg) † 164 
Clay (< 2 µm) (g/kg) † 231 
pH (water) †* 6.31 ± 0.15 
Cation exchange capacity cmol +/kg † 10.3  
Organic carbon (%) † 1.89 
C/N † 11.2 
Organic matter (%) † 3.27 
Water holding capacity (%w/w) * 17.25  ± 2.52 
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2.3 Experimental methods 
2.3.1 Sorption of study compounds to test soil 
The sorption behaviour of the study pharmaceuticals in the test soil was assessed 
using a batch equilibrium method based on OECD guideline 106. Study 
pharmaceuticals were applied to a mixture of soil and a 0.1 M CaCl2 solution 
contained in PTFE centrifuge tubes in triplicate. The soil solution ratios, selected 
based on preliminary investigations, were 1:5, 1:20, 1:30 and 1:30 for diclofenac, 
carbamazepine, fluoxetine and orlistat respectively. The resulting soil/solution 
mixtures were shaken in the dark (250 oscillations/min) at a temperature of 4 
o
C on a 
side-to-side shaker for 48 h as preliminary studies showed that this was sufficient 
time for the test pharmaceuticals to reach equilibrium between the soil and liquid 
phase. The samples were then removed and centrifuged at 3500 rpm for 10 minutes 
(Heremle Z 513K Bench Top Centrifuge). A 1 mL aliquot of supernatant was then 
taken and mixed with 10 mL of Ecoscint A scintillation cocktail (National 
Diagnostics, Atlanta, Georgia) and the radioactivity remaining in solution was 
determined as per  section 2.3.3.2. Soil sorption coefficients (Kd) values were then 
determined based on the amount of radioactive pharmaceutical applied and the 
amount remaining in the supernatant at equilibrium. 
2.3.2 Toxicity of study compounds to Eisenia fetida 
Toxicity experiments were performed to ensure that the test concentrations used in 
the uptake studies were not toxic to the E. fetida. Earthworms were individually 
exposed to soil containing ten times and a hundred times the proposed test 
concentration for the main uptake study. The experimental set up was similar to the 
main uptake and depuration studies as described in section 2.3.3. Burrowing 
behaviour, potential weight change and mortality were compared to that observed in 
solvent controls and blank controls to see if the pharmaceuticals had any effect on 
the earthworms. 
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2.3.3 Uptake and Depuration study 
The uptake and depuration experiments followed OECD Guideline 317 
‘Bioaccumulation in Terrestrial Oligochaetes’. Tests were performed in glass jars 
containing 50 ± 1 g of test soil as this was an adequate amount to allow sufficient 
burrowing depth (approximately 4 -5 cm) for E. fetida. All exposures were 
performed in a growth chamber at 20 ± 2 
o
C, using a 16:8 light/dark cycle, and at 60 
% humidity. Prior to exposure to test chemicals, worms were acclimated to the 
experimental conditions in the growth chamber for 48 hours using a non-treated test 
soil.  
Exposure soils were prepared by adding the labelled pharmaceuticals to the soil 
using 100 – 200 l of a carrier solvent to give concentrations of 39, 49, 80 and 65 g 
kg
-1
 of carbamazepine, diclofenac, fluoxetine and orlistat respectively (wet weight). 
For carbamazepine and fluoxetine, ethanol was used as the carrier; for diclofenac, 
methanol was used and orlistat was applied in acetonitrile. After spiking, each test 
beaker was left for 2 hours and then mixed to allow for even distribution of the 
pharmaceutical within the soil sample. Following spiking and mixing, the carrier 
solvents were allowed to evaporate off for a period of 48 hours. For each study, 
blank study soils and test soils spiked with carrier solvent only were prepared as 
controls. Following preparation, the moisture content of the exposure and control 
soils was adjusted to between 40 – 60 % of the MWHC by addition of deionised 
water. 
For each compound, 45 beakers of spiked soil were prepared along with solvent and 
non-solvent controls (Figure 2.1). At the start of the exposure one mature adult E. 
fetida (200 – 500 mg), with a visible clitellum, was added to each test beaker and the 
burrowing time of each of the worms was recorded. Beakers were then covered with 
garden fleece, attached with an elastic band to prevent earthworms from escaping 
while allowing sufficient air supply to be maintained. The uptake phase of the 
experiment lasted for 21 days with samples taken at 0 and 6 hour and 1, 3, 7, 10, 14, 
21 day. E. fetida in the remaining beakers were then transferred to clean soil for a 21 
day depuration phase with samples taken at 6 hour and 1, 3, 7, 10, 14, 21 day after 
transfer.  Soil moisture content of the soil in each of the test beakers was monitored 
Chapter 2                                                   Uptake and Depuration of Pharmaceuticals in Earthworms 
59 
throughout both phases, and adjusted, where necessary, by adding deionised water to 
ensure that it remained between 40 – 60 % of the MWHC.  The pH of the soils was 
measured at the beginning and end of the uptake phase and at the end of the 
depuration phase. Worms were fed weekly with mashed potato powder (Norr and 
Riepert, 2007). 
 
 
 
 
 
 
 
Figure 2.1 Test beakers for earthworm exposures in growth chamber (A) and single beaker containing 
earthworm before sampling (B). 
 
At each sampling time point, three replicate beakers were taken of the 
pharmaceutical exposed worms. At the start of the uptake phase and end of both the 
uptake and depuration phases’ four replicates were sampled from the solvent 
controls to obtain analytical background values.  The earthworms were then 
removed, rinsed with deionised water, blot dried then weighed and placed on moist 
filter paper for 24 hours to allow the earthworm to void its gut contents (Dalby et al., 
1996) (Figure 2.2). After 24 hours, earthworms were reweighed and then frozen (-20 
o
C) prior to analysis. A supplementary study indicated that maximum purging of gut 
contents occurred over 24 h with 77 % of the soil gut contents being eliminated so a 
correction had to be applied to the final worm concentration measurements 
(Appendix 1). Samples of soil were also taken for soil analysis and for immediate 
extraction of soil pore water.  
A B 
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Figure 2.2 Earthworms purging their guts on moist filter paper after sampling. 
 
Three replicates of soil spiked with radiolabelled pharmaceutical but containing no 
earthworm were also prepared and sampled at the end of the uptake phase to check 
for changes in concentrations of the pharmaceuticals in soil and pore water in the 
absence of the test organism.  
2.3.3.1 Preparation of samples for analysis 
To extract pore water, test soil (25 ± 2 g) was placed in a disposable syringe with a 
layer of 3 cm of glass wool inserted into the bottom. The syringe was centrifuged for 
40 minutes (2 x 20 minute runs) at 3000 rpm after which the pore water was 
collected from the bottom of the tube and transferred to a 2 mL Eppendorf tube. The 
Eppendorf tubes containing the sampled pore water were then further centrifuged at 
12000 rcf for four minutes to sediment any loose particles. A 500 L sample of pore 
water was the-n added to 10 mL of EcoScint A scintillation cocktail for analysis.  
Soil samples were extracted by liquid extraction. For the carbamazepine study, 5  
0.5 g of soil was extracted twice for 45 minutes on a side to side shaker (250 
oscillations min
-1
) with 2 x 10 ml of methanol. A similar method was used in the 
fluoxetine and orlistat studies except that for fluoxetine a mixture of acetonitrile and 
water (7:3 v/v) was used as the solvent and for orlistat, acetonitrile was used. For the 
diclofenac study, 10 g samples of soil were extracted three times for 45 minutes with 
3 x 20 ml ethyl acetate. Samples (1 mL) of extracts were then added to 10 mL of 
EcoScint A for analysis of the radioactivity present.  
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Even with the high extraction recoveries for diclofenac, after solvent extraction, the 
concentration in the test soils at the start of the experiment was significantly lower 
than what was expected. Combustion analysis of these soil samples was performed 
to determine i-f there was any radioactivity remaining in the soil which may account 
for the discrepancies. A large amount of dissipation of orlistat from the test beakers 
was seen which unlike the other test compounds could not be explained by uptake 
into E. fetida. It was theorised that due to orlistat’s particularly hydrophobic nature 
and high Kd value then it would have a strong sorption capacity to the soil, to such 
an extent that a fraction of the compound may have become irreversibly bound to the 
soil. Combustion analysis of the orlistat soils was also performed to check this. 
Combustion analysis was performed on a Perkin Elmer 307 Sample Oxidiser. After 
solvent extraction to determine the total extractable residues, the dried soils were 
homogenised into a fine powder. Each soil sample was prepared in triplicate in 
combusto-cones where 300 ± 25 mg of soil was mixed with equal amounts of 
cellulose powder. After combustion consisting of a 1.5 minute burn per sample, the 
14
C carbon dioxide was trapped by a vapour phase reaction with CarboSorb E 
forming carbamate which was mixed with PermaFluor E + a scintialltion cocktail 
ready for counting the radioactivity present on the Liquid Scintillation Counter 
(LSC). Regular spec-checks were performed throughout the analysis to ensure the 
recovery of the samples remained above 95 %. 
E. fetida were extracted by liquid extraction using the same solvents as for the soil 
extractions. Prior to extraction, E. fetida were defrosted, solvent (5 mL) was then 
added to the defrosted samples and the worm/solvent mix was homogenised for 5 
minutes using a LabGen Series 7 homogeniser. The suspension was transferred from 
the beaker to a glass test tube and the beaker was then rinsed with an additional 3 mL 
of solvent which was combined with the suspension to give a total extract volume of 
8 mL. The extracts were centrifuged at 415 g for 30 minutes (CHRIST Rotational 
Vacuum-Concentrator RVC 2-33 CD) and a 1 mL sample of the resulting 
supernatant was then added to 10 mL of EcoScint A.  
Method validation studies showed that average recoveries ranged from 82.8 
(diclofenac) to 100.6 (carbamazepine) % for the soil methods and from 86.3 
(fluoxetine) to 100.9 (carbamazepine and diclofenac) % for the earthworm extraction 
methods. 
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2.3.3.2 Liquid scintillation counting 
Radioactivity in soil pore water and soil and worm extracts were determined using 
Liquid Scintillation Counting (LSC) using a Beckman LS 6500 LSC counter 
(Beckman Coulter Inc., Fullerton, USA). Samples were counted three times for 5 
min. Counts were corrected for background activity by using blank controls. 
Counting efficiency and colour quenching were corrected using the external standard 
ratio method. Measured radioactivity of the pharmaceuticals in the earthworm 
extracts were corrected to account for soil-associated pharmaceuticals present in the 
gut. 
2.3.4 Potential metabolism in Eisenia fetida 
To ascertain whether the radioactivity measured in the earthworm samples was that 
of the parent compound or metabolite/transformation products additional studies 
were performed using cold compounds. Studies were performed at 20 times the soil 
concentration in the original studies to ensure that compounds were able to be 
detected in the worm matrices. Due to analytical limitations, studies to ascertain 
whether any metabolism had occurred in the earthworms were unable to be 
performed with orlistat. 
E. fetida were exposed to unlabelled carbamazepine, diclofenac and fluoxetine for 21 
days (six replicates per compound) under similar conditions to the main uptake 
studies (section 2.3.3), after which they were allowed to purge their guts for 24 hours 
and subsequently frozen (-20
o
C) ready for analysis. E. fetida were then injected with 
a stable isotope (carbamazepine d-10, diclofenac d-4 and fluoxetine d-5) and 
extracted using methods previously outlined in this study (section 2.3.3.1). The 
supernatant from these extractions was taken to dryness under a nitrogen stream and 
reconstituted in 200 µL of methanol:water (50:50 v:v). This was further centrifuged 
at 12000 RPM to sediment any loose particles. Resulting extracts were transferred to 
HPLC vials for analysis. Calibration (six concentrations, three replicates) and quality 
control (Q.C.) samples (three concentrations, six replicates at intermediary 
concentrations between the calibration range) were also prepared in worm matrix for 
each of the respective compounds (Appendix 4 and Appendix 5). 
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2.3.4.1 LC-MS/MS analysis 
Extracts were analysed for the pharmaceuticals by LC-MS/MS using a Dionex 
Ultimate 3000 and Applied Biosystems API 3000. HPLC separation was performed 
with a Symmetry C18 3.5 m, 4.6x75 mm column and Symmetry C18 3.5 mm, 
2.1x10mm guard column (Waters) with a mobile phase flow rate of 1 mL/min. The 
mobile phase composition was aqueous 1 % formic acid (v:v) (mobile phase A) and 
1 % formic acid (v:v) in acetonitrile (mobile phase B) using a gradient program over 
5 min for carbamazepine and fluoxetine and 7.5 min for diclofenac. For 
carbamazepine and fluoxetine the gradient was  0.0-2.5 min 43 % B, 2.5-2.6 min 43-
95 % B, 2.6-3.6 min 95 % B, 3.6-3.7 min 95-43 % B, 3.7-5.0 min 43 % B. For 
diclofenac the relative flow of mobile phase B was 0.0-1.5 min 43 % B, 1.5-4.0 min 
43-80 % B, 4.0-4.2 min 80-95 % B, 4.2-5.5 min 95 % B, 5.5-5.7 min 95-43 % B, 
5.7-7.5 min 43 % B. MS/MS analysis was undertaken using atmospheric pressure 
electrospray ionisation (ESI) in positive ionisation modes, using the turbo ion-spray 
interface. Spray voltage was 5000 V and source collision induced dissociation was in 
positive ESI, with the ESI capillary line maintained at 550C and collision gas (N2) 
pressure set at 6 (additional information on LC-MS/MS methods can be found in 
Appendix 4). 
Qualitative and quantitative analysis of compounds was based on retention time, 
multiple reaction monitoring (MRM) of two product ions and the ratios between the 
product ions. Limits of detection (LOD) were not assessed because sensitivity was 
not an issue with the amount of analyte. Lower limit of quantification (LLOQs) were 
375 ng/mL, 12.5 ng/mL and 150 ng/mL for carbamazepine, diclofenac and 
fluoxetine respectively. 
When LC-MS/MS analysis was unable to detect parent compound in the earthworm 
samples, extracts were subsequently analysed by LC-FTMS (solariX 9.4T, Bruker) 
to look for known metabolites and transformation products of the parent compound 
(Appendix 2). 
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2.3.5 Modelling 
2.3.5.1 Earthworm kinetic modelling 
A first order one-compartment model was used to estimate the uptake and depuration 
rates for each test compound from pore water.  The toxicokinetic model, as described 
in Equation 1, was fitted to measured internal worm concentration data and based on 
principles outlined by Ashauer et al., (2010; 2006). The parameters were estimated 
using the software OpenModel (v 1.2; University of Nottingham, 2008; 
http://www.nottingham.ac.uk/environmental-modelling/OpenModel.htm). The 
model was parameterized using residual sum of squares with the Levenberg-
Marquardt algorithm followed by Monte-Carlo Markov-Chain (MCMC) with the 
results from the Marquardt fit as input values. Confidence intervals were 
characterized by the 95 % percentile of the simulated variables. Pore water derived 
bioconcentration factors were calculated by setting the water concentration to 1 and 
by running the model until equilibrium was reached. Bioconcentration factors and 
their confidence intervals could then be read directly from the internal 
concentrations. The method is described in full in Ashauer et al., (2010; 2006).  
 
dCorganism/dt = kin * Cpw (t) – kout * Corganism (t)  
    
Equation 1
 
Where t is time (hours), kin is the uptake rate constant (L/kg d
-1
), Cpw is the 
concentration in the pore water (nmol/L), kout is the depuration rate constant (d
-1
) and 
Corganism is the concentration in the organism (nmol/kg). 
It is a valid assumption that a large percentage of the uptake into earthworms occurs 
dermally via the pore water based on previous work which has suggested this 
(Belfroid et al., 1995; Jager et al., 2003; Vijver et al., 2003) and hence omission of 
potential direct uptake from soil is justified.  
Chapter 2                                                   Uptake and Depuration of Pharmaceuticals in Earthworms 
65 
2.3.5.2 Modelling dissipation of study compounds in soil 
A simple first-order degradation kinetic model was fitted to the results of the soil 
analysis during the uptake phase. Model parameters were optimized according to 
recommendations by FOCUS (FOCUS, 2006) using the least squares method with 
Microsoft® Excel Add-Inn Solver. Half-lives (DT50, the time for a 50 percent 
decline in the concentration of pharmaceutical) were then calculated using a true 
replicates FOCUS (FOCUS, 2006) spread sheet. 
2.3.5.3 Comparison of data to predictive models 
Models exist to predict environmental exposure scenarios such as those outlined in 
the Technical Guidance Document (TGD) on Risk Assessment (Part 2) (Equation 2). 
Pore water concentrations obtained in this study were compared to estimated 
concentrations (PECpw), calculated using sorption coefficients (Kd) for the selected 
pharmaceuticals (Table 2.2) based on equations outlined in the TGD (Equation 2). 
BCFs obtained in this study were compared to estimated BCFs using models 
outlined in Belfroid et al., (1993) and Jager, (1998) to evaluate the current models 
used in risk assessment. 
 
PECpw = (PECsoil*RHOsoil)/(Kd*1000)    Equation 2 
 
Where PECpw (mg/L) is the predicted environmental concentration in the pore water, 
PECsoil (mg/kg) is the concentration in the test soil, RHOsoil is the bulk density of the 
soil (kg/m
-3
) and Kd is the soil sorption distribution coefficient for each 
pharmaceutical in the test soil (L/kg). 
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2.3.6 Statistical analysis 
Statistical analysis of the data was performed using SigmaPlot (v. 12). For each 
compound, data on burrowing times and percentage weight gain from the toxicity 
study were first tested for normality using a Shapiro-Wilk test and then for equal 
variance. If these passed then a one-way ANOVA was performed to assess the 
differences in the values among the treatment groups. Where normality failed, 
analysis of variance was performed using a Kruskal Wallis analysis on ranks. 
Differences between the measured and predicted pore water concentrations were first 
tested for normality using a Shapiro–Wilk test, as normality failed for each 
pharmaceutical the difference between measured and predicted values was then 
evaluated by a Mann–Whitney U Rank test. The relative accuracy of the estimated 
results was estimated by calculating proportional deviation from the measured to the 
estimated value.  
2.4 Results and discussion  
2.4.1 Sorption of study pharmaceuticals to test soil 
Sorption coefficients (Kd) for the study pharmaceuticals increased in the order of 
carbamazepine < diclofenac < fluoxetine < orlistat (Table 2.2). Whilst the sorption of 
a pharmaceutical can vary considerably depending upon the soil type (Tolls, 2001) 
the values for carbamazepine, diclofenac and fluoxetine all fall within the ranges 
previously reported in scientific literature (Barron et al., 2009; Drillia et al., 2005; 
Kwon and Armbrust, 2008; Xu et al., 2009c). The results suggest that orlistat has a 
particularly strong sorption capacity to the soil. This may be due its particularly 
hydrophobic nature and the presence of a large clay fraction in the soil which has a 
high sorption capacity due to its small size and large surface area (McGechan and 
Lewis, 2002). 
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Table 2.2 Sorption of test pharmaceuticals to study soil (mean value provided ± standard deviation, n = 6). 
Pharmaceutical Distribution coefficient (Kd) 
(L/kg)
a
 
Carbamazepine 4.83 ± 0.68 
Diclofenac 28.65 ± 3.27 
Fluoxetine 608.42 ± 87.57 
Orlistat 1493.98 ± 92.01 
a Kd values were determined experimentally following OECD 106. 
2.4.2 Toxicity of study pharmaceuticals to Eisenia fetida  
No mortality was observed in any of the toxicity experiments. There were no 
significant differences in the burrowing times of E. fetida for each of the 
pharmaceutical treatments (x 10 and x 100) in comparison to the blank and solvent 
controls (F<0.709, d.f. = 3, p > 0.05). More than 90 % of earthworms burrowed 
beneath the soil within 10 minutes of being placed on the surface. Over the test 
period, the masses of E. fetida increased, however there was no significant difference 
in the growth rate of E. fetida exposed to pharmaceutical treated soils or to control 
soils (for carbamazepine and fluoxetine [F<2.323, d.f. = 3, p>0.05]) (for diclofenac 
and orlistat [H<4.610, d.f. = 3, p>0.05]). No unusual earthworm behaviour (e.g. 
coming to the soil surface, stiffening or curling into a ball) or physiological 
differences (e.g. surface lesions) were noted for any of pharmaceutical exposed 
worms. It was therefore concluded that as no visible effect on the earthworm 
behaviour was seen at 100 x the proposed test concentrations, uptake and depuration 
would unlikely be affected by toxic effects of the study compounds.  
There is relatively little research on pharmaceutical toxicity to earthworms, previous 
studies have observed no E. fetida mortality after exposure to tetracyclines at 
environmentally relevant concentrations (Qi et al., 2005) similar to the results from 
this study. However, exposure to chlorotetracycline and tetracycline has induced 
changes in biochemical markers including serious DNA damage to coelomocytes 
and enzyme activities in earthworms (Dong et al., 2012). As pharmaceutical toxicity 
was not evaluated on a biochemical scale in this study further research could 
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investigate if similar effects are observed with human pharmaceuticals comparable to 
what has been observed with tetracyclines. 
2.4.3 Uptake and depuration of pharmaceuticals in Eisenia fetida 
2.4.3.1 Main trends in soil and pore water data from uptake phase  
For all of the pharmaceuticals, throughout the exposure phase, there was a decrease 
in radioactivity in the soil followed by an increase in uptake by E. fetida. Only small 
amounts of radioactivity were unable to be recovered from the test soil in the worm 
free exposure (> 94 % recovery) for carbamazepine, fluoxetine and orlistat. Thus E. 
fetida were consistently exposed to similar concentrations of the pharmaceuticals 
throughout the exposure phase. For diclofenac < 65 % of the radioactivity could be 
recovered using a combination of solvent extraction and soil combustion after 21 
days (see discussion below). 
The amount of radioactivity measured in the carbamazepine study decreased slightly 
in the pore water over the period of uptake phase which can probably be explained 
by the decrease in radioactivity extracted from the soil over 21 days (Figure 2.3). 
Only in the fluoxetine study was an increase in radioactivity measured in the pore 
water over the uptake phase (Figure 2.4). By the end of the uptake phase, in the pore 
water, only 50 % of the original radioactivity was measured in the orlistat study 
possibly due to the strong sorption of orlistat to the soil or uptake into E. fetida. In 
terms of concentration, carbamazepine had the highest concentration in the pore 
water which can explain the initial rapid uptake in the earthworms whilst the slow 
uptake of orlistat could potentially be explained by the lowest concentration in the 
pore water suggesting that this compound was not bioavailable. 
2.4.3.2 Pharmaceutical degradation 
Apart from in the diclofenac study, the dissipation of radioactivity from the test soil 
was modelled using single first order kinetics (Appendix 3). The soil data fit well 
according to single first order kinetics with Chi square values all below the accepted 
level (Table 2.3). The half-lives (DT50) in the carbamazepine and fluoxetine studies 
would suggest these are the most stable compounds which is in agreement to 
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previous work where little to no degradation of carbamazepine and fluoxetine was 
observed with half-lives > 60 days (Monteiro and Boxall, 2010, 2009; Redshaw et 
al., 2008a). Previous research has shown that, depending on soil type, the half-life 
for diclofenac can range from 3.07 up to 20.44 days (Xu et al., 2009c). Regression 
has shown that diclofenac degradation rate constants are negatively correlated with 
soil clay content (Xu et al., 2009c). The test soil being of a particularly clayey nature 
may explain the larger DT50 values in this study (Table 2.3) due to less diclofenac 
degradation in comparison to previous work. Orlistat had a half-life of 48 days 
(11497 hours) which is the lowest of all the pharmaceuticals 
2.4.3.3 Uptake and depuration of pharmaceuticals in Eisenia fetida 
E. fetida were seen to take up all of the study compounds (Figure 2.3) but the degree 
and pattern of uptake into the worm was different for all of the compounds. 
Measured radioactivity in the carbamazepine study increased over the first 160 hours 
(~ 7 d) of exposure after which time it declined, possibly due to the observed 
dissipation of the radioactivity in the soil and soil pore water (Figure 2.3). Similarly, 
in the fluoxetine study measurements of radioactivity in the E. fetida tissue increased 
over the first 160 hours (~ 7 d) of the exposure phase and then appeared to reach a 
steady state (Figure 2.3). For diclofenac and orlistat, measurements of radioactivity 
continuously increased and did not appear to have reached a steady state by the end 
of the uptake phase (Figure 2.3). 
  
Table 2.3 Summary of key results from uptake and depuration experiment, including pH range of soil throughout each exposure (± standard deviation), the time taken for 50 and 90 % 
degradation of the pharmaceuticals in soil according to FOCUS modelling and the modelled E. fetida uptake and depuration rates including the pore water based BCF (BCF provided with 95 % 
confidence intervals in brackets, n = 3). Diclofenac soil concentrations could not be modelled. 
Pharmaceutical  pH  Kinetics χ2 DT50 (d) DT90 (d) k
in
  
(uptake rate)  
(L/kg d
-1
)  
k
out
  
(depuration 
rate) (d
-1
)  
BCF  
(pore water) 
Carbamazepine  6.3 ± 0.2 First order 2.0 68 226 0.24 0.14 2.21 (1.3 – 3.5) 
Diclofenac  6.2 ± 0.1 N/A N/A N/A N/A 0.036 0.0021  21.5 (13.9 – 30.6) 
Fluoxetine  6.3 ± 0.2 First order 5.1 66 220 1.11 0.047 30.8 (25.4 – 35.8) 
Orlistat  6.2 ± 0.2 First order 6.4 48 159 0.071 0.0016  51.5 (40.0 – 65.3) 
7
0
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As soon as the depuration phase began, E. fetida immediately eliminated all of the 
pharmaceuticals from the earthworm tissue as measurement of radioactivity in the 
samples decreased. For carbamazepine and fluoxetine this was fairly rapid with 
complete elimination by day 3 and 7 of the depuration phase respectfully. 
Elimination in the diclofenac study was also fairly rapid at the start, it was not 
completely eliminated from the earthworm by 21 days with < 20 % of the 
radioactivity remaining in the tissue. Orlistat was eliminated the slowest from E. 
fetida with modelled depuration rates of 0.0016 d
-1
. By the end of the depuration 
phase > 60 % of the radioactivity taken up in the orlistat study remained in the 
earthworm. 
The first order, one compartment model, based on pore water measurements, was 
successfully fitted to the uptake and depuration data for all four study compounds 
(Figure 2.3 A-D). Uptake rates and depuration rates are provided in Table 2.3. The 
pore water-based BCFs obtained from the model increased in the order of 
carbamazepine < diclofenac < fluoxetine < orlistat. The relatively large BCF of 
51.53 for orlistat can be attributed to the minimal elimination of this compound from 
the earthworm in the depuration phase whilst for carbamazepine the fast elimination 
of 0.14 d
-1 
is accountable for the smaller BCF of 2.21. The BCFs increase in a 
similar order to the increase in log Kow values for the respective compounds perhaps 
inferring that the degree of hydrophobicity plays a key role in the uptake of 
pharmaceuticals from soils. 
In comparison to aquatic BCFs for pharmaceuticals published in scientific literature, 
earthworms seem to have lower BCF values. For fluoxetine and diclofenac aquatic 
BCFs have been reported at values much larger than calculated for the earthworms 
(Brown et al., 2007; Lahti et al., 2011; Paterson and Metcalfe, 2008; Schwaiger et 
al., 2004; Zhang et al., 2010) with BCFs reported up to 185 900 for fluoxetine in the 
fresh water shrimp (Gammarus pulex) (Meredith-Williams et al., 2012) which is 
over 6000 times greater than the BCF generated for earthworms. Aquatic BCFs for 
carbamazepine are similar to the BCF of 2.21 obtained in this study (Lahti et al., 
2011; Meredith-Williams et al., 2012; Zhang et al., 2010) with results from 
Vernouillet et al., (2010) showing that algae (Psuedokirchneriella subcapita) has a 
BCF of 2.2 which is remarkably similar. 
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A) 
 
 
B) 
 
C) 
 
D) 
 
Figure 2.3 Uptake and depuration curves for Eisenia fetida exposed to A) carbamazepine, B) diclofenac, C) 
fluoxetine, and D) orlistat. Mean (n = 3  SE) measured concentrations in the worm are represented by the circles 
and the data lines represent the first order model fit. Mean Concentrations (n = 3  SE) in the soil and soil pore 
water are represented by the open and closed triangles respectively. 
 
Biological attributes such as species size, number of segments, feeding habits and 
reproduction may play a key role in uptake and bioconcentration of pharmaceuticals. 
Previous work has suggested that an increase in organism size corresponds to a 
decrease in BCF (Hendriks et al., 2001), and whilst this is true for p, p’ – DDE as 
bioaccumulation in the smaller E. fetida was < 6 times higher than in Lumbricus 
terrestris (Peters et al., 2007), pharmaceutical uptake into different earthworm 
species has not yet been evaluated to explore this concept further. In comparison to 
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fish species which are larger than E. fetida this relationship does not follow as has 
previously been shown fish BCFs for pharmaceuticals tend to be higher than BCFs 
observed in this study. Mercury accumulation in earthworms has demonstrated that 
species length and age is important in chemicals assimilating in tissues with 
decreased mercury contents following increased growth and development (Zhang et 
al., 2009). In the aquatic environment a positive relationship between lipid content 
and bioconcentration of chemicals has also been suggested (Barron, 1990; Hendriks 
et al., 2001; Schlechtriem et al., 2012). This would suggest differences in 
accumulation of pharmaceuticals in earthworms as lipid contents can range between 
1 – 20 % (Dynes, 2003).  
2.4.3.4 Mass balance results 
A mass balance was performed to account for the radioactivity present in the 
experiment, using measurements in E. fetida, soil and pore water samples. At the end 
of the exposure phase > 89 % of the compound was recovered for carbamazepine, 
fluoxetine and orlistat. While soil data demonstrated dissipation of orlistat in the 
exposure phase, the soil combustion data confirms this is not due to mineralisation 
but instead due to the formation of bound residues. However for diclofenac, whilst 
combustion data showed some recovery of non extractable residues by the end of the 
uptake phase only 52 % of the initially applied compound could be recovered, 
suggesting perhaps a loss of 
14
C - carbon dioxide released via mineralisation. 
Formations of non-extractable residues in soils have been investigated since 1980’s 
(Calderbank, 1989)  however very little work has explored pharmaceutical bound 
residues in soil (Kreuzig and Höltge, 2005; Kreuzig et al., 2003). Specifically, the 
persistent nature of 
14
C sulfadiazine was shown in work by Kreuzig and Höltge 
(Kreuzig and Höltge, 2005) where only 1 % of the radiotracer was mineralized 
to 
14
C-carbon dioxide and 82 % was transferred to non-extractable residues after 102 
days. A pharmaceutical which may be irreversibly sorbed to soil may remain bio-
available for uptake by soil organisms. Uptake of bound residues into earthworms 
was observed with pesticides however tissue to soil ratios were 2−10 times higher in 
soils with freshly spiked pesticides compared to soils containing previously non-
extractable residues for the same compounds (Gevao et al., 2001). 
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2.4.4 Metabolism 
A number of studies have reported the detection of metabolites and transformation 
products of the pharmaceutical parent compound in aquatic organisms (Lahti et al., 
2011; Paterson and Metcalfe, 2008). Little information is known about 
biotransformtion of pharmaceuticals in terrestrial organisms. 
Both carbamazepine and fluoxetine were detected in the worm tissue at 
concentrations slightly greater than expected and thus we can assume that what was 
measured in the radiolabelled studies was the parent compound. Diclofenac was not 
detected (Table 2.4). A literature search was then performed to identify known 
diclofenac metabolites and transformation products (Appendix 2). Diclofenac worm 
extracts were subsequently analysed using LC-FTMS (solariX 9.4T, Bruker) to look 
for known diclofenac metabolites and transformation products collated from 
literature sources. However no valid matches were made. The measured radioactivity 
in the diclofenac study and subsequent BCFs therefore refer to diclofenac parent 
compound and any potential transformation products. 
Table 2.4 Analyte detection in earthworm samples (n =6). 
Compound Soil spike 
(mg/kg - 
nominal) 
BSAF Expected 
(ng/g) 
Average 
measured (ng/g) 
(± standard 
deviation) 
Carbamazepine 0.78 0.33 260 491.16 (± 18.52) 
Diclofenac 0.8 0.57 456 < LOQ 
Fluoxetine 1.6 0.29 466 802.98 (± 97.77) 
 
2.4.5 Evaluation of existing predictive models 
2.4.5.1 Pore water concentrations 
Pore water concentrations of pharmaceuticals throughout the uptake and depuration 
phase were estimated (Equation 2) and compared to the measured values obtained in 
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the study. For fluoxetine and orlistat, which had the highest Kd values, pore water 
concentrations were significantly under estimated (U = 699, P = 0.012; U = 654, P = 
0.004 respectfully) in comparison to the measured data (Figure 2.4 C, D). For 
carbamazepine and diclofenac, which were less strongly sorbed to the soil, the 
estimated pore water concentrations were closer to the measured data but slightly 
overestimated with carbamazepine statistically different (U = 761, P = 0.043) whilst 
there was no significant difference for diclofenac (U = 755, P = 0.076). As there was 
a statistically significant difference between the measured and estimated data for a 
large proportion of the pharmaceuticals this infers that parameters other than the soil 
distribution coefficient (Kd) are important in estimating pore water concentrations. 
Alternatively, the results may also imply that batch sorption tests are not an 
appropriate way to calculate sorption coefficients (Kd) as it does not accurately 
stimulate the micro-environments of real soils. The inaccuracies of the Kd calculation 
may therefore be limiting the prediction of pore water concentrations. Nevertheless, 
the results show that the predicted environmental concentration in pore water for 
modelling purposes outlined the TGD may not be appropriate for pharmaceuticals. 
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C) 
 
D) 
 
Figure 2.4 Comparison between measured pore water concentrations obtained from the uptake and depuration 
experiment and estimated pore water concentrations based on Kd values calculated for each pharmaceutical for 
A) carbamazepine, B) diclofenac, C) fluoxetine, D) orlistat. The closed and open diamonds represent measured 
concentrations and estimated concentrations respectfully. 
 
2.4.5.2 Bioconcentration factors 
The QSARs generally overestimated the pore water BCFs, particularly for orlistat 
where the measured BCF was up to 6000 times higher than the estimated value 
(Figure 2.5). There are a number of possible explanations for the lower than 
predicted BCF for orlistat. This may be because of the molecular weight cut off 
which is generally seen for compounds with a high log Kow. According to REACH 
guidelines at log Kow values between 4 and 5, log BCF increases linearly with log 
Kow, however at very high log Kow (< 6) a decreasing relationship between these two 
parameters is observed and reduced uptake due to molecular size may be 
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attributable. The QSARs do not represent true earthworm uptake, orlistat uptake into 
E. fetida may also be inhibited perhaps through irreversibly bound fractions and non-
available residues in the pore water. Whilst previous work suggests that uptake 
across the gut wall is important for compounds with a log Kow greater than 5 the 
particularly large log Kow for orlistat may actually mean that the compound is so 
strongly bound to the soil that it is unable to desorb and enter the earthworm. 
Combustion results from this study and additional research (Ryan, 2013) has 
demonstrated appreciable degradation (DT50 2.4 – 23.2 d), mineralisation and 
significant irreversibly bound residues (27.16 % [21 d]) of orlistat which supports 
the idea that the total applied orlistat concentration is not available for uptake. It 
should be noted however that both of the QSARs were not developed specifically to 
predict pharmaceutical uptake, and therefore may have limited use. The QSAR by 
Belfroid (1993) had a limited log Kow window (4.2 – 5.7 which was later 
extrapolated to 2 -7) and was developed for specifically for neutral compounds. 
 
Figure 2.5 Comparison between earthworm BCFs obtained from the model in this study (white), predictions 
from the QSAR described in Belfroid et al., 1993 (grey) and predictions from the QSAR in the TGD based on 
Jager, 1998 (black) for carbamazepine (CBZ), diclofenac (DCF), fluoxetine (FLX) and orlistat (ORL). 
 
These results suggest that there may be other descriptors or parameters which may 
be important in predicting the uptake of pharmaceuticals into earthworms, but most 
importantly the discrepancies between the estimated BCFs and those from the 
measured data highlight that the current QSARs are not applicable and new 
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estimation methods for predicting pharmaceutical uptake into earthworms are needed 
for future risk assessment. Approaches which consider the ionised state of the 
molecule are integral in obtaining realistic BCFs and might improve predictions of 
earthworm BCFs for pharmaceuticals. For chemicals in the neutral form, uptake is 
predicted to be higher while the bioavailability of ionised molecules will be 
dependent on the pH of the surrounding medium. Models which explore ionisation 
include the work by Lo and Hayton, (1981) and Erickson et al., (2006) and the cell 
model (Trapp, 2004). Specifically the cell model uses Fick’s first law of diffusion for 
the neutral molecules and Nernst-Planck equation for the ionisable fraction of 
molecules to predict the movement, by diffusion, of molecules in a living cell. This 
model includes principles of the ion trap effect and assumes only the freely dissolved 
molecules in the cell can undergo diffusion and when the end point of diffusion (net 
flux is zero) has been reached this is known as equilibrium. The equilibrium 
concentration ratio between the inside and outside of the cell can currently be used to 
predict fish BCFs and with further research could be adapted to predict accurate 
earthworm BCFs. 
2.5 Conclusions 
The work presented here demonstrates that pharmaceuticals present in soils at 
environmentally relevant concentrations can be taken up by the earthworm Eisenia 
fetida. A relatively simple one compartment first order model can fit the uptake into 
E. fetida based on the assumption that uptake into the worm occurs via the pore 
water. Carbamazepine and fluoxetine do not appear to be metabolised in the current 
studies and therefore for the remaining thesis, uptake of radioactivity of these 
compounds is assumed to be parent compound. For diclofenac metabolism does 
seem to occur, however this could not be characterised as a specific transformation 
product. Therefore the radioactivity measured in the diclofenac study will refer to 
that of the parent compound and potential transformation products. Current QSAR 
estimation techniques to predict bioconcentration factors in earthworms, for the large 
part, overestimate BCFs. The results suggest that the uptake of highly hydrophobic 
compounds such as orlistat does not scale according to log Kow, implying a cut off 
point for a linear relationship between Kow and BCF above which increasing log Kow 
value does not appear to correlate with elevated bioconcentration. Even the higher 
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BCFs noted in this study are nonetheless quite low in absolute terms of plant and 
animal uptake.  
Additional research is needed to establish the influence that soil parameters (e.g. pH, 
organic matter content) and species traits have on the uptake of pharmaceuticals into 
soil invertebrates. However studies described in this chapter are highly labour 
intensive. To explore the effects of environmental and species traits on uptake would 
be challenging using the methods. Therefore, in the next chapter, the use of a 
minimised approach is explored. 
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Chapter 3 Applicability of the Minimised Design Approach 
for Assessing Bioconcentration in Invertebrates 
3.1 Introduction 
Concern about bioconcentration, bioaccumulation and biomagnification of synthetic 
chemicals in biota has led to the establishment of bioconcentration tests, guidelines 
and assessment criteria (OECD 305 (OECD, 2012)). A bioconcentration factor 
(BCF) is a useful metric for the scientific evaluation of the risks of chemicals 
(pesticides, biocides, veterinary medicines, pharmaceuticals and industrial 
chemicals) in the environment (e.g. REACH). BCFs are typically compared to a 
threshold to determine whether there is a risk of bioaccumulation or not.  
Bioconcentration studies generally consist of an uptake phase where test organisms 
are exposed to a chemical followed by a depuration (or elimination) phase where 
organisms are transferred to clean exposure medium free from chemical 
contamination, the concentration of the chemical in the organism at different time 
points in both phases is monitored (Figure 3.1). An example of such an approach can 
be found in Chapter 2. 
 
 
 
 
 
 
 
Figure 3.1 Schematic of an uptake and depuration experiment and comparison of sampling points between 
traditional designs (black lines) and minimised design (red line). Where k1 and k2 are the uptake and depuration 
rates respectively and Ct1 and Ct2 are the concentrations in organism measured at the end of uptake and end of 
depuration respectively. 
 
 
 
Uptake Elimination 
Ct1 Ct2 
 Organism 
Exposure medium 
containing chemical Clean exposure medium 
Time 
Organism 
sampling points 
k1 k2 
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Experimentally determined BCFs can be derived using a ratio of measured internal 
concentration and exposure medium concentration when steady state concentrations 
have been reached in the test organism. When steady state has not been achieved, 
measured data can be modelled to determine uptake and depuration rate constants 
and subsequently BCFs (sometimes termed kinetic BCFs) can be calculated from 
these. A full explanation of tokicokinetic modelling and BCF calculation can be 
found in Chapter 2 (section 2.3.5). 
Generally, bioconcentration studies following OECD guidelines require a substantial 
amount of laboratory effort due to the degree of replication that is needed and the 
sampling frequency during the uptake and depuration phases. For example, terrestrial 
invertebrate bioconcentration guidelines, such as those used in Chapter 2 suggest that 
earthworms should be sampled in triplicate a minimum of six times during both the 
uptake and depuration phases (OECD, 2010). For aquatic invertebrates the total 
number of species used in published uptake and depuration study ranges between 33 
- 98 (Ashauer et al., 2010; Karlsson, 2013; Meredith-Williams et al., 2012; Rubach 
et al., 2010) while original fish bioconcentration tests suggest a minimum of four 
fish to be sampled at least five times during uptake and four times during depuration 
(OECD, 1996). The rigour of the current guidelines means that large numbers of 
animals are required and that labour and analytical resources are costly. The 
magnitude of the tests may also be inhibiting our understanding of the factors and 
processes affecting uptake of chemicals in the environment as it almost physically 
impossible to perform large multi-factor uptake studies into chemical uptake using 
existing guidelines. 
Recognising the labour intensity of BCF studies for fish, Springer and colleagues 
(2008) proposed a new minimised test design for the OECD 305 (OECD, 1996) and 
U.S. EPA (850.1730) test guidelines for fish. This design aimed to estimate BCF 
using the kinetic definition (BCFminimised) (uptake rate constant/depuration rate 
constant) which meant that steady state tissue concentrations did not need to be 
achieved. However both uptake and depuration must follow first order kinetics. The 
proposed design requires that test organisms are collected and analysed only once at 
the end of the uptake phase/beginning of depuration (Ct1) and once at the end of the 
depuration period (Ct2). Water samples are also required on a regular basis 
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throughout the uptake period (Cw/Cpw) to calculate an average exposure medium 
concentration. Using simple algebraic expressions (Equation 3 and Equation 4) 
uptake and depuration rate constants and BCFs can then be estimated. 
k2 = (ln Ct1 – ln Ct2)/td     
   
Equation 3 
Where t1 and t2 are the beginning and end of the depuration period, respectively. The 
uptake rate constant (k1) is then calculated based on the depuration rate constant (k2) 
generated from Equation 3. 
k1 = k2 * Ct1/Cw/pw (1- e-
k
2
t
u)  
     
Equation 4 
Where k2 is depuration rate constant, the mean concentration of the test substance in 
the medium during exposure phase is Cw or Cpw and tu and td the length of uptake and 
depuration periods. Lastly a kinetic BCF from minimised design (BCFminimised) can 
be calculated by dividing the uptake rate by the depuration rate (Equation 5). See 
Table 3.1 for a full explanation of parameters used. 
BCFminimised = k1/k2    
     
Equation 5 
 
Springer et al., (2008) showed that this design uses significantly fewer animals and 
resources, yet still provides useful BCF estimates. Since this publication a new 
approach has been adopted for the fish BCF test guideline (OECD 305,(2012)) 
which utilises fewer fish for both cost and animal welfare reasons. Some of the key 
changes include only using one test concentration (when the BCF is independent of 
the test concentration) and, if specific criteria are met then a minimised aqueous 
exposure test design could be used. This minimised aqueous exposure design is 
similar to that proposed by Springer et al., (2008) in that it allows for reduced fish 
sampling in the uptake and depuration phases and reduced exposure medium 
sampling. These changes in the guidelines indicate that regulatory agencies are 
recognising there is a need to change experimental designs to reduce organism 
usage. 
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Table 3.1 Parameters and definitions for minimised design equations. 
Parameter Definition Units 
k1 Uptake rate L/kg d
-1
 
k2 Depuration rate d
-1
 
Ct1 Concentration in organism at end of uptake mg/kg 
Ct2 Concentration in organism at end of depuration mg/kg 
Cw or Cpw Mean concentration of exposure medium during uptake phase mg/L 
td Length of depuration phase d 
tu Length of uptake phase d 
BCF Bioconcentration factor L/kg 
 
While the minimised approach has been shown to be valid for fish, to date no-one 
has explored its wider applicability to other taxonomic groups. Therefore, this study 
was performed to assess the applicability of the minimised design for estimating 
BCFs in terrestrial and aquatic invertebrates. The study used existing datasets, 
published by a number of authors, on the uptake of a wide variety of pesticides and 
pharmaceutical compounds into different aquatic and terrestrial invertebrates to 
evaluate whether the minimised approach could generate reasonable estimates for 
rate constants and BCFs. The results were used to develop general guidance on the 
application of the approach. 
3.2 Materials and Methods 
3.2.1 Collation of uptake and depuration data 
Datasets from a number of BCF studies were collated. The studies included different 
periods of uptake and depuration and different chemical classes. A summary of data 
collated is provided in Table 3.2. Studies were chosen specifically to provide a range 
of invertebrate species whilst also including a range of compounds with differing 
physico-chemical properties and modes of toxic action and different test matrices 
(Table 3.2, Appendix 6). For example, the log Kow values of the chemicals in the 
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data set ranged from -0.81 to 8.19 and the dataset covered neutral compounds, weak 
acids and weak bases. Raw data from these previous studies was obtained, including 
measured internal concentrations and measured exposure medium concentrations for 
the duration of the experiments. 
All of the studies used a one compartment first-order toxicokinetic model to simulate 
the internal concentrations in the organisms using the measured concentrations of the 
test chemicals in the exposure medium as the driving variable. The aquatic studies 
consisted of a water only exposure and therefore the exposure medium was Cw. For 
terrestrial species, uptake was assumed to come from the pore water (Cpw). First 
order toxicokinetic model equations are described further in Chapter 2 (2.3.5). The 
estimated BCFtraditional (based on the full uptake and depuration studies) for the 
chemicals used in the studies ranged from 0.132 to 700 900 (Appendix 6). 
3.2.2 Estimation of rate constants and BCFs using the minimised 
approach 
Measured internal concentrations of chemicals in organisms from the last day of 
uptake and last day of depuration, for each study, were taken from the datasets along 
with measured data on concentrations of the study compound in the test media 
during the uptake phase (water or pore water). These data were then used in 
Equation 3 and Equation 4 to re-estimate the uptake and depuration constants and 
then BCFminimised values. BCFminimised values were subsequently compared to those 
previously published in the literature sources (BCFtraditional) to assess the applicability 
of the minimised design to estimate BCFs in a range of invertebrate species. 
It should be noted in the Springer approach (2008), 28 d was used for tu and td was 
14 d. If the original study consisted of different time periods then measurements 
were rescaled and interpolated from reported measurement to provide the 28 d and 
14 d measurements respectively. For the purposes of recalculating BCFs, in this 
study, the length of the uptake and depuration phases remained as they were in the 
original experiment (Table 3.2). This is an important difference, because it allowed 
us to test if the minimised design method is also applicable when much shorter 
experiments are used. 
  
 
Table 3.2 Summary of data collated on published BCFs (more detaile d table can be found in Appendix 6). 
 
 
  
Test species Chemicals tested Number of 
studies 
log Kow range
a Uptake period (tu) 
(days) 
Depuration period 
(td) (days) 
BCF range 
Gammarus pulex Beta-blocker, anti-cancer, anti-epileptic, 
sedative, anti-depressant, insecticide, fungicide, 
herbicide, biocide, algaecide 
25 (-0.81) - 5.31 < 2 < 6  1.64 - 185 900 
Anax imperator      Insecticide 1 4.96 2 5 100 
Asellus aquaticus      Insecticide 1 4.96 2 5 3242 
Chaoborus obscuripes      Insecticide 1 4.96 2 5 2428 
Cloeon dipterum      Insecticide 1 4.96 2 5 1782 
Daphnia magna      Insecticide 1 4.96 2 5 541 
Molanna angustata Insecticide 1 4.96 2 5 5331 
Neocaridina 
denticulata      
Insecticide 1 4.96 2 5 1291 
Notonecta maculata Insecticide 1 4.96 2 5 407 
paraponyx stratiotata Insecticide 1 4.96 2 5 1601 
Plea minutissima      Insecticide 1 4.96 2 5 654 
Procambarus sp. Insecticide 2 4.96 2 5 280 - 1295 
8
5
 
  
 
Table 3.2 Continued 
Test species Chemicals tested Number 
of studies 
log Kow range
a Uptake period (tu) 
(days) 
Depuration 
period (td) (days) 
BCF range 
Ranatra 
linearis 
Insecticide 1 4.96 2 5 392 
Culex pipens Insecticide 1 4.96 2 5 13930 
Sialis lutaria Insecticide 1 4.96 2 5 9625 
Planorbarius 
corneus 
Beta-blocker 1 3.05 3 3 57.3 
Notonecta 
glauca 
Beta-blocker, anti-cancer, anti-epileptic, sedative, 
anti-depressant 
6 (-0.81) - 4.65 2 2 0.13 - 1.60 
Lumbriculus 
variegatus 
Anti-epileptic, NSAIDb, anti-depressant, stimulant, 
antimicrobial, antibiotic 
17 (-0.02) - 5.42 2 2 1 - 700 900 
Eisenia fetida Anti-epileptic, NSAID
b, anti-depressant, weight 
loss aid 
4 2.25 - 8.19 21 21 1.14 – 63.03 
a 
Log Kow as reported in publications (specific log Kow for chlorpyrifos not provided therefore Bowman and Sans (1983) reference used).  
b 
NSAID – Non-steroidal anti-inflammatory drug. 
 
8
6
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3.2.3 Statistical analysis 
The (log) BCFtraditional and the (log) BCFminimised were plotted against each other in a 
correlation plot (Figure 3.2) and linear regression was used to test if the slope and 
intercept were significantly different from 0. As both X (log BCFminimised) and Y (log 
BCFtraditional) were subject to error, linear regression was fit as a Deming (or Model 
II) regression. The null hypothesis (Ho) was that the slope is equal to zero whilst the 
alternative hypothesis (Ha) was that the slope is significantly different to zero. It also 
tested to see if the slope was significantly different from 1 (i.e. if confidence interval 
of slope includes 1), because a slope of 1 indicates perfect correlation between the 
two methods. Separate correlations were also made between the uptake (k1traditional/ 
k1minimised) and depuration rate (k2traditional/ k2minimised) constants as well as individual 
data sets used in the analysis using Deming regression. 
3.3 Discussion and Results 
3.3.1 Uptake and elimination rates 
For both the uptake rate constants and the elimination rate constants, regressions 
between the minimised approach and original data do not correlate particularly well 
and deviated from the 1:1 line (Figure 3.2). In both the uptake and depuration rate 
correlations the regression line was significantly non zero (p < 0. 0001) however the 
slope was closer to 1 in the uptake rate figure (95 % confidence interval: 1.053 – 
1.383; Figure 3.2) than the depuration rate figure (95 % confidence interval: 1.662 – 
2.881;Figure 3.2). Therefore there was a better regression between uptake rate 
correlation (k1) than depuration rate correlation (k2). 
Greater deviation around the regression and 1:1 line was most evident for the lower 
values of uptake and depuration rates in comparison to the larger values. There was 
less error around the larger rate constants. Interestingly the uptake rate data points 
for Karlsson, 2013 data set were always below the 1:1 line but in a linear fashion in 
comparison to the remaining data which were more scattered. The k1traditional appear 
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to be consistently underestimated by the constant amount however this does not 
occur in the k2 figure. 
In comparison, a greater proportion of the data points were above the 1:1 line for the 
Ashauer et al., data set (2007, 2006; 2010), this is particularly evident with the 
depuration rates. A lack of relationship between depuration rates is important as it 
can influence the time to reach steady state calculations. In this analysis, G. pulex 
exposure to 4-nitrobenzyl-chloride resulted in depuration rates of 3.16 d
-1 
 and 
0.0432 d
-1 
for the original and minimised calculations respectively which 
corresponds to either 3 or 0.41 days to reach steady state within the organism. The 
minimised approach may therefore not generate data applicable for use in 
toxicokinetic-toxicodynamic modelling. 
3.3.2 Bioconcentration factors 
BCFs were unable to be estimated using the minimised approach when the 
concentration in the organism at the end of depuration phase was greater than 
internal concentration measured at the end of the uptake phase. This occurred in a 
few studies, particularly where the BCFtraditional was very high e.g. triclosan (Table 
3.2) (Appendix 7). In total 60 BCF values could be used from the BCFtraditional and 
compared to BCFminimised estimates. 
Deming regression analysis demonstrated a statistically significant correlation 
between BCF values obtained using the traditional and minimised approaches 
(Figure 3.2). The slope of the regression line was significantly non zero (p = < 
0.0001) and the hypothesis that the slope is equal to 1 was not rejected (slope: 0.99, 
95 % confidence interval: 0.91 – 1.07) therefore suggesting there is a significant 
linear relationship between the two variables (Figure 3.2). The intercept of the 
regression was also close to zero (intercept: -0.32, 95 % confidence interval: -0.77 – 
0.13). Thus the BCFminimised estimates are in agreement with the BCFtraditional values 
and there were no systematic and no proportional differences between the two 
methods. Specifically, 98 % (96 %; 65 %) of the minimised design BCF values fall 
within a factor of 10 (factor 5; factor 2) of the BCFtraditional values (Figure 3.2). As 
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previously discussed, there was a weak correlation between the uptake and 
elimination rate constants generated by the minimised design and the original data. 
However this is interesting as it appears the respective inaccuracies of the k1minimised 
and k2minimised appear to compensate each other to calculate accurate BCFminimised 
values. 
A)                                                                 B)                   
 
C) 
 
Figure 3.2 (A) Regression between uptake rate (k1) from minimised design and k1 provided in literature. (B) 
Regression between depuration rate (k2) from minimised design and k2 provided in literature. (C) Relationship 
between log BCFminimised estimates from the minimised design and log BCFtraditional obtained from the literature. 
Data include Ashauer et al., 2006 (  ); Ashauer et al., 2007 (  ); Ashauer et al., 2010 (  ); Rubach et al., 2010 (  ); 
Meredith – Williams et al., 2012 (  ); Karlsson et al., 2013 (  ) and Chapter 2 (this thesis) (  ). Deming regression 
line (black dash), with equation and 1:1 line (solid) with factor of 10 (grey dash) also provided. 
A 
A B 
C 
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Estimates of BCFminimised may not be accurate if the uptake and elimination kinetics 
differ greatly from first order. Some datasets used in this analysis exhibited small but 
systematic deviations from first order toxico-kinetics. However the significant 
correlation between the BCFtraditional and BCFminimised suggests that the BCFminimised 
results are robust against slight deviations from first order toxicokinetics. Any 
deviation from the 1:1 line can probably be explained by the depuration rate 
constants from the minimised design, specifically the weak correlation between 
depuration rates (k2minimised and k2traditional) as discussed previously (Figure 3.2).  
Only 37 % of studies included in this analysis had reached steady state in the 
exposure phase duration. Apart from a few cases when the study length was much 
shorter than required to reach steady state (< 10 % steady state), there was no 
relationship between the ratio of rate constants (k1minimised/k1traditional) and the 
percentage of steady state reached in each phase (Figure 3.3). As the percent steady 
state reached increased, the ratio remained variable around 1 and when 100 % steady 
state had been achieved the greatest divergence around k1minimised/k1traditional was 
noted. Thus the minimised design yields similar rate constants to the traditional 
design when the duration of the experiment allows for at least 10 % of steady state to 
be reached in the exposure and depuration phases. 
 
Figure 3.3 Relationship between uptake rate and percentage of steady state reached in uptake (   ) and depuration 
phase (     ) for each experiment. 
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In a number of experiments the concentration of the chemical in the exposure media 
decreased (< 72 % of initial concentration), a result perhaps of dissipation from the 
test beaker or uptake into the organism. Whilst in the depuration phase, the chemical 
sometimes reappeared in the exposure water. The minimised approach appears to be 
robust enough to deal with changes in exposure medium concentration as the degree 
to which the exposure medium concentration changes did not affect the BCF 
calculation. There were no significant relationships between correlations of 
BCFminimised/BCFtraditional and percent change in exposure medium concentration, with 
reported r
2
 0.071 and r
2
 0.276 for percent disappearing and reappearing respectively 
(Figure 3.4). 
 
Figure 3.4 Regression between change in exposure medium concentration (% decline in exposure phase (      ) 
and % reappearing (    ) in depuration phase) and BCF ratio. Regression lines provided by dashed lines for % 
decline (narrow dash) and % reappearing (wide dash).  
 
Therefore it appears that there are no systematic errors in BCF calculation if changes 
in exposure medium concentration are observed, uptake is not entirely first order or 
if steady state has not been achieved in the test. This is important because it 
demonstrates the robustness of the design. When steady state does not need to be 
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reached this means that experiments can be shorter in terms of time scale which is 
advantageous with respect to time and effort costs. 
3.3.2.1 Minimised further? 
Further analysis explored whether the minimised design could be further reduced. 
Instead of taking an average of several measurements of exposure concentrations 
during the exposure phase, which can be up to eight sampling points for one study, 
an average was calculated by only using exposure medium concentrations from the 
start and end of the exposure phase. Using an average of these two sampling points 
yielded comparable BCFminimised values to those when a full average was used (Figure 
3.5). Deming regression demonstrates that there were no systematic and no 
proportional differences between the two approaches (slope: confidence interval: 
0.7986 – 1.036, Y-intercept confidence interval: -0.4562 – 0.8761). These results 
may offer an even smaller design to calculate accurate BCFs using considerably 
fewer materials. 
 
Figure 3.5 Regression between BCF values calculated using exposure medium concentration measured over a 
period of exposure and only the beginning and end of exposure. Regression (dash) and 1:1 (solid) lines also 
provided. 
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3.3.2.2 Study specific analysis 
The BCFtraditional were generally very small for pharmaceutical exposure in Notonecta 
glauca (0.13 – 1.60) (Meredith - Williams et al., 2012). The minimised design 
generated BCFs which were correspondingly very similar (0.17 - 2.11). However > 
80 % of N. glauca BCFs were overestimated. This fits with the overall trend as the 
minimised design generally over estimates BCF values in comparison to the original 
published BCFs as more data points lie above the 1:1 line (Figure 3.2). At the other 
end of the scale, some of the largest published BCFs were obtained in the fluoxetine 
exposures with Gammarus pulex and Lumbriculus variegatus (< 218 500) (Table 
3.2). Conversely, the corresponding BCFminimised for these were consistently under 
estimated by up to two orders of magnitude (Figure 3.2). In Figure 3.2, the data point 
for fluoxetine from the Meredith-Williams et al., (2012) study is a clear outlier. This 
is a result of very minimal fluoxetine elimination observed  in G. pulex and resulted 
in a BCFtraditional of 185 000 which is several orders of magnitude larger than those 
previously calculated in aquatic exposures for this compound (Nakamura et al., 
2008). Following the minimised design, the corresponding BCF for this fluoxetine 
exposure was 1560.55. 
Data from Ashauer et al., 2010 fitted very well to the 1:1 line, the slope of the 
regression line was also significantly different from zero (p = < 0.0001) and thus 
showed a significant relationship between the two methods for calculating BCF 
(Appendix 9). A wide range of chemicals were evaluated in this dataset with 
differing physico-chemical properties and BCF values which demonstrates that this 
is a fairly robust way to estimate BCFs with limited laboratory effort. When data for 
G. pulex from a number of publications were collected and analysed separately from 
the whole data set, Deming regression showed a significant relationship between the 
two methods with a slope of 1.082 (95 % confidence interval: 0.85 – 1.32), intercept 
of -0.88 (95 % confidence interval: -2.29 – 0.54) and slope significantly different 
from zero (p = < 0.0001) (Figure 3.6). A majority of data points lie below the 1:1 
and whilst statistics show the minimised approach can accurately estimate BCFs this 
would infer that the approach generally overestimates BCFs for G. pulex. 
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Figure 3.6 Relationship between log BCF (minimised) estimates from the minimised design and log BCF 
(original) obtained from the literature for G. pulex only. Deming regression line (dash), with equation and 1:1 
line also provided (solid). 
 
For earthworm data, correlations between BCFs presented in the original paper and 
those calculated by the minimised design results produced a slope of 0.77 (95 % 
confidence interval: 0.43 – 1.11) and intercept of 1.39 (95 % confidence interval: -
12.23 – 15.01). Combined with a slope not significantly different to zero (p = 
0.0105) there appears to be a good relationship between the two methods. This is 
interesting because the Springer approach was originally designed for aquatic BCF 
calculation but results presented here demonstrate that it is also probably suitable for 
terrestrial BCF calculations. Using the minimised design would reduce earthworm 
use by approximately 70 %; there would also be considerable savings in terms of 
time and cost of materials. There is a substantial lack of earthworm studies with 
regards to studying the uptake kinetics of organic chemicals, pharmaceuticals in 
particular and the minimised design may be an attractive option to resolve this. 
Variation in data points around the 1:1 line and regression line for the Rubach et al., 
(2010) data can be attributable to the fact that species differences are important in the 
uptake of chemicals (Rubach et al., 2010). Specifically differences in BCFs amongst 
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15 species of freshwater arthropods as well as between juvenile and adult species (G. 
pulex and Procambarus sp.) were observed in the original data set (Appendix 6). 
Even though all experiments consisted of a chlorpyrifos exposure only, this research 
demonstrates that various species at different life stages can accumulate and 
eliminate chemicals in differing amounts and thus generate a range of BCF values. 
Variation in BCF values for L.variegatus is also evident in the Karlsson et al., (2013) 
data set due to changing exposure medium pH affecting ionisable chemical uptake. 
The minimised approach seems to account well for both these factors affecting 
chemical uptake as the variation in the BCF values is within the general noise of the 
whole data set. In view of the complete data set it is evident that the variation around 
the 1:1 line increases as the BCF value increases (Figure 3.2). It appears that larger 
BCFs are subject to greater error. 
Additional research has explored the use of the minimised design to estimate fish 
BCFs specifically for pharmaceutical exposures (Constantine, 2011). The results also 
yielded comparable, accurate BCFs with a reported r
2 
of 0.99 and a slope of 1.02. 
This was shown to be a robust design as 55 pharmaceuticals were compared with 
BCFs ranging from 0.6 to 12 000. 
3.3.3 Wider implications 
As the minimised design yields very good proxies for BCFs (Figure 3.2), but poor 
estimates of the true uptake and elimination rate constants the minimised design may 
therefore offer an acceptable approach to calculate BCF values for regulatory 
purposes where risk assessments require BCFs to be reported within a range (Figure 
3.7). 
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Figure 3.7 Schematic depicting potential applications of minimised design 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For scientific purposes, as a result of reduced laboratory effort, the minimised design 
may allow for several studies to be carried out at once enabling many different 
parameters to be evaluated. Factors such as species differences (Meredith-Williams 
et al., 2012; Rubach et al., 2010) and effect of changing exposure medium properties 
(Díez-Ortiz et al., 2010; Karlsson, 2013) published in recent research, require us to 
evaluate the uptake and bioconcentration of organic chemicals in greater depth. 
Combined with an increasing number of chemicals which are being discharged in the 
environment further research into the uptake of pharmaceuticals in particular into 
invertebrates are needed. As results would be cheaper and faster to generate the 
minimised design may reveal patterns amongst the numerous chemicals and the 
thousands of species exposed under a plethora of environmental conditions. Specific 
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exposure scenarios may therefore be highlighted which may need to be evaluated 
further, through toxicokinetic – toxicodynamic studies for example (Figure 3.7). 
3.4 Conclusions 
A comparison of BCFs generated from full study designs (BCFtraditional) and those 
estimated using the principles of the minimised design (BCF minimised) would infer 
that the minimised design is a viable alternative approach to use. For a single 
experiment, test organism usage would be reduced by > 70 % as well as a reduction 
in experimental material and labour efforts required. Whilst the agreement between 
uptake and depuration rates generated by the two approaches is somewhat variable 
the minimised design is advantageous with respect to calculating overall BCFs. The 
approach is robust as steady state does not need to be achieved in the test system and 
BCFs are not affected by changes in exposure medium concentration. The approach 
therefore can provide a method to calculate reasonably good BCF estimates which 
may be used to determine if additional studies are required for example to explore if 
BCFs are concentration dependent. Care should however be taken when using the 
minimised design to calculate BCF values when compounds don’t depurate from the 
organism and for rate constant determination, particularly when estimating 
depuration rates. It is important to note the lack of relationship between traditional 
and minimised rate constants. The use of toxicokinetic – toxicodynamic modelling 
may be more appropriate if rate constants are to be analysed as well as BCFs.  
One of the most significant findings is that the minimised design appears to work 
well across a range of species (including both terrestrial and aquatic), chemicals and 
different exposure mediums offering a suitable alternative for BCF calculation in 
variety of environmental chemical exposure scenarios. Further analysis could 
explore the use of the minimised design concept for calculating additional BCFs, 
specifically for earthworm exposures as only a small number were collected and 
evaluated in the current work. 
In the next Chapters, the minimised approach was therefore employed to explore the 
effects of environmental parameters and species type on the uptake of 
pharmaceuticals into earthworms. 
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Chapter 4 How Soil Properties Affect the Uptake of 
Pharmaceuticals into Earthworms 
4.1 Introduction 
Research presented in Chapter 2 and a small number of recent publications have 
demonstrated that pharmaceuticals can be taken up from soils into invertebrates such 
as earthworms (Kinney et al., 2012, 2008). Specifically, Chapter 2 investigated the 
uptake and depuration kinetics of four pharmaceuticals into the earthworm E. fetida. 
Pore water based bioconcentration factors (BCFs) increased in the order of 
carbamazepine < diclofenac < fluoxetine < orlistat and ranged between 2.2 – 51.5. 
The results demonstrated that physico-chemical properties are important in the 
uptake of pharmaceuticals and that earthworm BCF’s could not be predicted solely 
based on hydrophobicity of the chemical (log Kow). 
It is well known that the same pharmaceutical can behave very differently in 
different soil types (Drillia et al., 2005; Monteiro and Boxall, 2009; Oppel et al., 
2004). For example, distribution coefficients for pharmaceuticals between soil 
particles and soil pore waters are known to vary by several orders of magnitude 
(Krogh et al., 2008; Monteiro, 2009; Tolls, 2001). As diffusion across the skin from 
the pore water has been shown to be the primary exposure pathway for chemicals in 
the soil environment (Vijver et al., 2003), it is therefore likely that uptake of 
pharmaceuticals could also vary significantly across soils.  
As most pharmaceuticals are ionisable, the uptake of pharmaceuticals into organisms 
can also vary depending on the pH of the environment (Karlsson, 2013; Nakamura et 
al., 2008). Different uptake from soils with different pH values could therefore be 
expected. Knowledge of the relationships between soil properties and pharmaceutical 
uptake is however very limited. There is therefore a real need to begin to generate 
data on the uptake of pharmaceuticals from soils with different characteristics in 
order to identify the key drivers affecting uptake and ultimately to develop uptake 
modelling approaches for use in environmental risk assessment. 
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The study described in this chapter was therefore peformed to explore the effects of 
soil properties on pharmaceutical uptake and depuration in the earthworm Eisenia 
fetida, and help elucidate the relationships between soil properties and uptake. The 
study focused on four pharmaceuticals, from a variety of therapeutic uses and 
covering a range of physico-chemical properties. To help explain any potential 
differences in uptake and depuration, parallel studies were performed to assess the 
fate and distribution of the study pharmaceuticals in test soils.  
4.2 Materials and Methods 
4.2.1 Pharmaceutical compounds and reagents 
All studies were performed using 
14
C labelled compounds. Labelled fluoxetine 
[methyl-
14
C] and carbamazepine [carbonyl-
14
C] were obtained from American 
Radiolabelled Chemicals (Missouri, USA), diclofenac [U – 14C] was obtained from 
Perkin Elmer (Boston, USA) and orlistat [tridecanyl-2-
14
C] was provided by 
GlaxoSmithKline (GSK, UK). Physico-chemical properties and specific activities for 
the pharmaceuticals can be found in Table 1.3. Acetonitrile (99.9 %), methanol (99.9 
%) and ethyl acetate (99.9 %) were obtained from Fisher Scientific (Loughborough, 
UK).  
4.2.2 Test soils 
Five standard test soils were obtained from LUFA Speyer, Germany (Figure 4.1). 
The soils, 2.1, 2.3, 2.4, 5M and 6S, included clayey loam, silty sand and loamy sand 
varieties and were chosen to provide a range of soil characteristics including varying 
soil pH, organic carbon content, cation exchange capacity and particle size 
distributions (Table 4.1). Soils were air dried and sieved to 2 mm prior to testing.  
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Figure 4.1 Test beakers containing five different test soils (2.1, 2.3, 2.4, 5M and 6S) for earthworm exposures 
prior to addition of earthworms. 
 
Table 4.1 Soil properties for the standard test LUFA Speyer soils. Mean values of different batch analyses are 
provided ± standard deviation (SD). 
 
Standard soil 
type 
2.1 2.3 2.4 5M 6S 
Organic 
carbon in % 
C 
0.65 ± 
0.10 
0.94 ± 
0.10 
2.26 ± 0.25 1.00 ± 0.2 1.64 ± 0.12 
Nitrogen in 
% N 
0.05 ± 
0.01 
0.08 ±0.02 0.2 ±0.04 0.11 ± 
0.02 
0.2 ± 0.02 
pH value 
(0.01 M 
CaCl2) 
5.1 ±0.3 6.8 ±0.2 7.2 ± 0.2 7.3 ± 0.1 7.1 ± 0.1 
Cation 
exchange 
capacity 
(meq/100g) 
4.3 ± 0.5 10.9 ±1.1 31.4 ± 4.6 16.6 ± 2.8 27.2 ± 1.4 
Soil type Silty sand Silty sand Clayey 
loam 
Loamy 
sand 
Clayey 
loam 
Water 
holding 
capacity 
(g/100g) 
31.1 ± 2.1 37.3 ± 1.8 44.1 ± 1.2 39.5 ± 2.9 40.5 ± 2.1 
Particle size (mm) distribution according to USDA (%) 
< 0.002 2.8 ± 1.1 8.5 ± 1.7 25.9 ± 2.1 11.1 ± 1.2 40.5 ± 2.1 
0.002 – 0.05 10.2 ± 1.8 28.4 ± 4.5 40.5 ± 1.0 29.7 ± 2.8 35.0 ± 2.9 
0.05 – 2.0 87.0 ± 1.5 63.1 ± 5.0 33.6 ± 1.8 59.2 ± 3.2 24.5 ± 3.5 
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4.2.3  Test organism  
E. fetida were obtained from Blades Biological Ltd (Kent, UK) and cultured in a 
medium of peat and cow manure (50:50), kept moist with deionised water at room 
temperature (20 ± 3 
o
C). The organisms were fed twice weekly with homogenised 
mashed potato powder. E. fetida were obtained from a single species culture and 
cultures were maintained for at least four generations before being used in the uptake 
studies. The lipid content of E. fetida, determined using the method of Folch et al., 
(1957), was 5.11 ± 0.29 % (wet weight) (Chapter 2). 
4.2.4 Fate studies 
Triplicate beakers of each test soil (2.1, 2.3, 2.4, 5M and 6S) (35 ± 1 g) were 
prepared to sample at eight time points (0 and 6 h, 1, 3, 7, 10, 14 and 21 d) where 
pore water and soil samples would be analysed to allow for determination of the 
distribution of chemicals in the soil matrices over time. To each of the five soils, 
labelled pharmaceuticals were added using 125 – 165 l of a carrier solvent to give 
concentrations of 26, 25, 28 and 44 g kg-1 of carbamazepine, diclofenac, fluoxetine 
and orlistat respectively. For carbamazepine and fluoxetine, ethanol was used as the 
carrier solvent; for diclofenac, methanol was used and orlistat was applied in 
acetonitrile. After spiking, each test beaker was left for 2 h and then mixed to create 
an even distribution of the pharmaceutical within the sample. Following spiking and 
mixing, the carrier solvents were allowed to evaporate for 48 hours. Blank and 
solvent controls were also prepared free from test chemical. Following preparation, 
the moisture content of all soils was adjusted to 40 – 60 % of the MWHC by addition 
of deionised water. All beakers were incubated in a growth chamber at 20 ± 2 
o
C, 
using a 16:8 light/dark cycle [600 lx], and at 60 % humidity. 
At each sampling point, soil was sampled for pH analysis and determination of 
pharmaceutical residues and pore water was extracted from the respective beakers 
using the method outlined in Chapter 2. Briefly, syringe’s containing 25 ± 5 g of test 
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soil were centrifuged for 40 minutes at 3000 rpm after which the pore water was 
collected from the bottom of the tube and transferred to a 2 mL Eppendorf tube. The 
Eppendorf tubes were then further centrifuged at 12000 rcf for four minutes to 
sediment any loose particles. A 1 mL sample of pore water was then added to 10 mL 
of EcoScint A scintillation cocktail for analysis. The pH of all soil and pore water 
(with the exception of carbamazepine) samples was measured using a Hanna pH 
electrode (HI-1093B) (Figure 4.2).  
 
 
 
 
 
Figure 4.2 Pore water extractions of test soils after centrifugation (A) and pH analysis of pore water samples (B). 
 
4.2.5 Uptake and depuration studies  
The uptake and depuration studies followed the ‘minimised’ approach described in 
Chapter 3. Earthworms were exposed in glass jars containing 50 ± 1 g of each test 
soil. For each test, soil beakers were prepared and spiked with the four 
pharmaceuticals at similar concentrations and following similar methods to those in 
the fate studies. Adult E. fetida (200 - 500 mg) were then added to each test beaker 
after having been acclimatised under experimental conditions for 48 h in non-treated 
test soil. After addition, the time it took for each earthworm to completely burrow 
into the soil was noted. For each soil type, blank and solvent controls were prepared. 
Earthworm beakers were incubated in the growth chamber and moisture adjustments 
were performed as reported in the fate study. For each pharmaceutical treatment in 
each soil type, six replicates were sampled at the end of the uptake period (21 d) and 
six at the end of the depuration phase (42 d). E. fetida were then removed from the 
A B 
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vessels, and transferred to moist filter paper for 24 h to allow them to purge their 
guts. The worms were then frozen until analysis.  
4.2.6 Preparation of samples for analysis 
Soil and earthworms were extracted using methods similar to those outlined in 
Chapter 2. Briefly, soil samples were extracted by liquid extraction. For the 
carbamazepine study, 5  0.5 g of soil was extracted twice for 45 minutes on a side 
to side shaker (250 oscillations min
-1
) with 2 x 10 mL of methanol. A similar method 
was used in the fluoxetine and orlistat studies except that a mixture of acetonitrile 
and water (7:3 v/v) and acetonitrile only were used as solvents, respectively. For the 
diclofenac study, 5 g samples of soil were extracted three times for 45 minutes with 
3 x 10 mL ethyl acetate. Samples (1 mL) of extracts were then added to 10 mL of 
EcoScint A for analysis of the radioactivity present.  
As previous work has shown that orlistat and diclofenac form irreversibly bound 
residues with soil (Chapter 2); combustion analysis of these soil samples was also 
performed using a Perkin Elmer 307 Sample Oxidiser according to similar methods 
outlined in 2.3.3.1. 
E. fetida samples were defrosted and the internal pH of each worm was measured 
using a Thermo Scientific Orion pH microelectrode. Each worm was dissected 
across the segments in the direction from the anterior to the posterior. The pH probe 
was then inserted directly into the earthworm tissue taking care to avoid internal 
organs and the digestive tract. E. fetida were then extracted by liquid extraction 
using the same solvents as for the soil extractions. For each worm, 5 mL of solvent 
was added and the worm/solvent mix was homogenised for 5 minutes using a 
LabGen Series 7 homogeniser. The suspension was transferred to a glass test tube 
and the beaker was then rinsed with an additional 3 ml of solvent which was 
combined with the original suspension to give a total volume of 8 mL. This was 
centrifuged at 415 g for 30 minutes (CHRIST Rotational Vacuum-Concentrator 
RVC 2-33 CD) and a 1 mL sample of the supernatant was then added to 10 mL of 
EcoScint A for analysis of the radioactivity present.  
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Method validation studies showed that average recoveries ranged from 72.43 to 
94.72 % for the pharmaceuticals in the five different soil types (detailed recovery 
information provided in Appendix 10). Recoveries ranged from 86.3 (fluoxetine) to 
100.9 (carbamazepine and diclofenac) % for the earthworm extraction methods. 
4.2.7 Liquid scintillation counting 
Radioactivity in the soil pore water and soil and worm extracts were determined 
using Liquid Scintillation Counting (LSC) using a Beckman LS 6500 LSC counter 
(Beckman Coulter Inc., Fullerton, USA). Samples were counted three times for 5 
min. Counts were corrected for background activity by using blank controls. 
Counting efficiency and colour quenching were corrected for using the external 
standard ratio method. 
4.2.8 Calculating BCF - kinetic modelling 
Measured radioactivity of the corresponding pharmaceuticals in the earthworm 
extracts were corrected to account for soil-associated pharmaceuticals present in the 
gut after gut purging (see section 2.3.3 for more detail). Based on minimised design 
principles outlined in Chapter 3, earthworm tissue concentrations were then used to 
calculate uptake and depuration rates for the study compounds in each soil type 
using Equation 3 and Equation 4. The uptake and depuration rates were then used to 
estimate pore water based kinetic bioconcentration factors (BCFs) (Equation 5). For 
a full explanation of BCF calculations see section 3.2.2. 
4.2.9 Calculating soil BSAF 
Soil based bioaccumulation factors (BSAF) were estimated from the pore water 
based BCFs for all pharmaceuticals using soil water partition coefficients (Kd) 
calculated from fate studies (Equation 6). The Kd value used for each compound was 
an average Kd calculated across the different sampling points in the uptake phase. 
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Equation 6 
Regression analysis was then performed to compare BSAF values and soil properties 
and BCF values and pore water properties. 
4.2.10 Statistical analysis 
Statistical analysis of the data was performed on SigmaPlot (v .12). A two-way 
analysis of variance (ANOVA) with a significance level of 0.05 was performed, 
keeping study type (blank/treatment) as repeated and time as a variable factor. 
Endpoints tested included the differences in soil and pore water pH across time, and 
in comparison to control samples, after which additional pair-wise comparisons of 
the data were performed according to the Holm-Sidak method. Further two-way 
ANOVAs were performed to check differences in soil and pore water pH 
measurements made in the same soil type but under different pharmaceutical 
treatments over time. A one-way ANOVA was employed to assess differences in 
internal pH values of the worms in comparison to the controls and between uptake 
and depuration measurements. A three–way ANOVA was used to check for changes 
in internal pH for worms exposed in the same soil but under different pharmaceutical 
treatments at both the end of the uptake and depuration phases. Additionally, for 
each pharmaceutical, data on the burrowing times of E. fetida were tested against the 
control treatment burrowing times using a one-way ANOVA to assess the 
differences in the values among the treatment groups. Prior to all tests, normal 
distribution and equal variance were tested by performing a Shapiro–Wilk and 
Levene–Mediane test, respectively. If the normality test failed then the one-way 
ANOVA was instead performed on ranks. 
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4.3 Results 
4.3.1 Fate studies 
Measurements of radioactivity in the soil and pore water changed over time and 
these changes appear to be dependent on pharmaceutical compound and in a number 
of cases, on soil type (Figure 4.3). By 21 d radioactivity was detected in all treatment 
beakers in all soil types. In most soil types, measured radioactivity tended to 
decrease after 1d, however in soil 6S in the fluoxetine study, measured radioactivity 
increased from 0.017 to 0.021 mg/kg over the period of the uptake phase. 
Carbamazepine was fairly persistent in all soil types whilst initial results showed 
rapid dissipation of diclofenac and orlistat from the test beakers. However, 
combustion analysis confirmed the formation of nonextractable (bound) residues 
(NER’s) in both the diclofenac and orlistat studies. NER fractions increased from 
0.005 to 0.028 mg/kg and 0.012 to 0.032 mg/kg for orlistat and diclofenac 
respectively (Appendix 11). 
Pore water concentrations of the pharmaceuticals differed to a greater extent, 
depending on soil type, in comparison to the soil concentrations (Figure 4.3). Soil 
2.1 generally had the highest pore water concentrations for all pharmaceuticals while 
soil 2.4 generally had the lowest concentrations. From 10 d onwards pore water 
concentrations tended to decrease in all soil types especially for diclofenac, 
fluoxetine and orlistat. This was most evident in soil 2.1 for all pharmaceuticals.  
The soil – water distribution (Kd) appears to be chemical specific and were affected 
by soil properties as there was a range of Kd values for each pharmaceutical in the 
five different soil types; namely carbamazepine (1.34 – 4.45 L/kg), diclofenac (5.63 
– 18.37 L/kg), fluoxetine (55.48 – 71.44 L/kg) and orlistat (28.99 – 110.01 L/kg). 
Over the initial 10 d of the uptake phase, orlistat became less strongly bound to the 
soil as the amount recovered in the solvent extraction increased whilst the 
combustion analysis concentrations decreased. Interestingly, following this change, 
orlistat pore water concentrations began to decrease which coincided with a 
significant decrease in the pH of these pore water samples from all five soil types. 
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Additional changes in both soil and pore water pH over time, and in comparison to 
the controls were noted as a result of the presence of the pharmaceuticals 
(diclofenac, fluoxetine and orlistat) in the soil matrix (Figure 4.4). Whilst these 
changes appeared to be influenced by soil type it is important to note these changes 
were not statistically significant for all soil types and were not consistent over time. 
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Figure 4.3 Dissipation of activity for soils treated withcarbamazepine (I), diclofenac (II), fluoxetine (III) and 
orlistat (IV) in soil (A) and pore water (B) throughout 21 day in five different soil types (2.1    , 2.3    , 2.4    ,   
5M     and 6S    ). Average C(t)/C(0) ratio provided with ± standard deviation (n = 3), where C(t) is concentration 
at time of sampling and C(0) is concentration at 0 d.  
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Figure 4.4 pH measurements made during the uptake phase in pore water (A) and soil samples (B) from the five 
soils (2.1, 2.3, 2.4, 5M and 6S) for the diclofenac (black diamonds), fluoxetine (white diamonds) and orlistat 
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(grey diamonds) studies. Mean pH values provided ± standard deviation (n = 3). Statistical analysis results from 
Holm-Sidak pair wise comparison provided (corresponding star colour to pharmaceutical treatment) (p < 0.05). 
4.3.2 Earthworm uptake  
Uptake into E. fetida from the four treatments, carbamazepine, diclofenac, fluoxetine 
and orlistat was seen from the five soils. Fluoxetine had the greatest uptake rate (k1) 
in all soils (1.138 – 2.351 L/kg d-1) apart from soil 5M where orlistat had a higher 
uptake rate (1.477 L/kg d
-1
), whilst carbamazepine had the fastest depuration rate 
(k2) in all five soils (0.16 – 0.243 d-1) (Table 4.2). This is comparable to previous 
work in a single soil type (Chapter 2; 2.4.3.3) where fluoxetine had the fastest uptake 
rate and carbamazepine had the fastest depuration rate in E. fetida. Highest pore 
water-based BCFs were observed for orlistat (< 115.92) and the smallest BCFs for 
carbamazepine. Differences in BCFs were observed for the different soil types, 
especially in the diclofenac (7.02 – 69.57) and orlistat studies (30.51 – 115.92), 
whereas smaller variability of the BCFs was noted for fluoxetine (16.78 – 20.42) and 
carbamazepine (1.05 - 1.61) (Table 4.2). 
Calculating soil pore water distribution coefficients (Kd) allowed the conversion of 
the pore water BCFs to soil based bioaccumulation factors (BSAFs) based on soil Kd 
values (Table 4.2). BSAFs were generally low (< 2), especially for carbamazepine 
and fluoxetine. Similarly to the BCF, the diclofenac exposure resulted in the largest 
range of BSAFs, up to 12.36 in soil 5M. Only very weak or no correlations we found 
between uptake and soil properties including properties such as organic carbon 
content, cation exchange capacity, soil concentrations and soil pH. Similarly 
individual pore water properties were unable to adequately explain uptake as weak 
relationships were observed between BCFs and pore water properties.  
  
 
Table 4.2 Results from minimised design experiments in five soil types showing measured E. fetida concentration at the end of 21 d uptake phase (Ct1) and 21 d depuration phase (Ct2) and mean 
concentration of pharmaceutical in the pore water during the uptake phase (Cpw). Calculated uptake (k1) and depuration rates (k2) are presented along with pore water based BCF values derived 
using the minimised design approach. Soil/water adsorption coefficients (Kd) are also provided with soil BSAF estimates based on Kd values. 
   
 
Ct1 mg/kg 
(internal)  
Ct2 mg/kg 
(internal) 
Mean Cpw 
(mg/L) in 
uptake 
phase 
k2 (dep. 
rate) (d
-1
) 
k1 (uptake rate)   
(L/kg d
-1
) 
Pore 
water 
BCF  
Soil Kd 
(average 
21 d) 
Soil BSAF 
(based on Kd) 
Carbamazepine   
LUFA 2.1 0.0243 0.0005 0.0191 0.187 0.243 1.30 1.34 0.97 
LUFA 2.3 0.0089 0.0001 0.0059 0.243 0.372 1.53 3.87 0.40 
LUFA 2.4 0.0082 0.0001 0.0052 0.215 0.345 1.61 4.45 0.36 
LUFA 5M 0.0110 0.0002 0.0107 0.200 0.210 1.05 2.20 0.48 
LUFA 6S 0.0112 0.0004 0.0075 0.160 0.249 1.56 3.44 0.45 
Diclofenac   
LUFA 2.1 0.0567 0.0320 0.0046 0.027 0.777 28.56 6.88 4.15 
LUFA 2.3 0.0047 0.0043 0.0043 0.004 0.054 15.04 7.25 2.07 
LUFA 2.4 0.0043 0.0037 0.0013 0.008 0.175 21.50 18.37 1.01 
LUFA 5M 0.0047 0.0047 0.0052 0.001 0.043 69.57 5.63 12.36 
LUFA 6S 0.0093 0.0058 0.0035 0.023 0.159 7.02 6.37 1.10 
Fluoxetine   
LUFA 2.1 0.0105 0.0009 0.0006 0.115 2.351 20.42 55.48 0.37 
LUFA 2.3 0.0077 0.0013 0.0005 0.084 1.651 19.74 64.85 0.32 
LUFA 2.4 0.0038 0.0009 0.0003 0.068 1.138 16.78 71.44 0.19 
LUFA 5M 0.0059 0.0017 0.0004 0.059 1.128 19.18 64.06 0.29 
LUFA 6S 0.0049 0.0005 0.0003 0.108 1.829 16.89 58.17 0.29 
1
1
1
 
  
 
Table 4.2 continued 
 
 Ct1 mg/kg 
(internal)  
Ct2 mg/kg 
(internal) 
Mean Cpw 
(mg/L) in 
uptake 
phase 
k2 (dep. 
rate) (d
-1
) 
k1 (uptake rate)   
(L/kg d
-1
) 
Pore 
water 
BCF  
Soil Kd 
(average 
21 d) 
Soil BSAF 
(based on Kd) 
Orlistat   
LUFA 2.1 0.0284 0.0139 0.0018 0.034 1.039 30.51 28.99 1.05 
LUFA 2.3 0.0138 0.0114 0.0007 0.009 1.051 115.92 75.10 1.54 
LUFA 2.4 0.0086 0.0063 0.0004 0.015 1.092 74.40 110.01 0.74 
LUFA 5M 0.0138 0.0065 0.0006 0.036 1.477 40.82 84.59 0.48 
LUFA 6S 0.0092 0.0079 0.0010 0.007 0.485 68.36 51.30 1.33 
1
1
2
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There was a statistically significant difference in internal E. fetida pH after exposure 
to pharmaceuticals in comparison to control earthworms; however this was not true 
for all soil types except in the fluoxetine study (Figure 4.5). Significant differences 
were also observed between measurements made on the uptake and depuration 
samples. Interestingly, not only does the internal pH change between different soil 
types it was also significantly different between different pharmaceutical treatments 
in a single soil type at the end of the uptake phase (except soil 2.3 and 5M (p = < 
0.001 – 0.003)) and the end of the depuration phase (except soil 2.1 and 2.3 (p = 
<0.001).  
 
 
Figure 4.5 Average internal pH measurements (n = 6, ± standard deviation) of E. fetida exposed to 
pharmaceuticals (I = carbamazepine, II = diclofenac, III = fluoxetine, IIII = orlistat) in five different soil types. 
Grey bar shows measurement in uptake phase and white bar shows measurements made in depuration phase with 
error bars providing ± standard deviation. Where (a) there is statistically significant (p < 0.05) difference of in 
comparison to blank controls and (b) is a statistically significant (p < 0.05) difference between the uptake and 
depuration phases. 
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4.4 Discussion 
4.4.1 Pharmaceutical fate in soils 
In agreement with previous research and results from Chapter 2 carbamazepine was 
fairly persistent in all soil types (Kinney et al., 2006; Monteiro and Boxall, 2009; 
Williams et al., 2006). Conversely a decline in radioactivity was measured in the 
diclofenac study, reasons for this include volatilisation or a small proportion of the 
chemicals may have dissipated from the test system; a result perhaps of 
mineralisation (Figure 4.3). The Kd values reported in Table 4.2 fall within the 
ranges found in previous research for carbamazepine (0.49 – 37 L/kg,(Drillia et al., 
2005)) and diclofenac (1.21 – 17.72 L/kg, (Xu et al., 2009c)) however lower than 
previously observed for fluoxetine (992 – 2546 L/kg, (Kwon and Armbrust, 2008)). 
For orlistat the Kd values are considerably lower than recorded in our own batch 
sorption experiments at 1494 L/kg (reported in Chapter 2). 
Other than research primarily on veterinary antibiotics (Heise et al., 2006; Schmidt 
et al., 2008) this is some of the first work to demonstrate that human 
pharmaceuticals can form irreversibly bound residues with soil and the degree of 
NER can be influenced by soil type (Appendix 11). Previous work has shown non 
extractable pesticide residues remain bioavailable for uptake by earthworms and thus 
NERs may be contributing to some of the uptake observed in this study (Gevao et 
al., 2001). To the best of our knowledge, this is also some of the first research which 
demonstrates that soil and pore water pH can change after addition of chemicals to 
the soil environment. Both pharmaceutical physico-chemical properties and soil type 
appear to influence the degree of pH change, as changes in comparison to the 
controls and over time was not consistent across all five soil types (Figure 4.4). 
Further analysis should explore this with a wider range of chemicals and soil types.  
Interestingly, the pore water pH measurements were not as you would expect from 
the corresponding soil pH for the range of soils evaluated. Pore water pH was 
consistently higher than soil pH and higher than pore water pH measurements made 
from floodplain sites contaminated with metals in a previous study which ranged 
between 7.51 – 7.88 (Vijver et al., 2007). In the fluoxetine study, changes in pore 
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water pH would result in a range between 36 to 64 % of the ionised fraction of 
fluoxetine. The observed changes in pH of soil and pore water samples would have 
minimal effect on the ionised percentage of diclofenac as it would remain 
extensively ionised (> 99 %) in the pH range of soils (Appendix 12). Similar results 
were observed in the fluoxetine study as soil pH changes would have had little 
change on the extent of ionisation of the parent compound (Appendix 13).  
The environment comprises of a wide range of ionisable chemicals and different soil 
types and these initial results may have considerable impact on environmental 
modelling scenarios, which currently do not account for changes in pH. Changes in 
soil and pore water pH may have significant effects on the fate of chemicals in the 
terrestrial environment through processes such as sorption, leaching and degradation 
and should be considered in a modelling framework (Franco et al., 2009; Kah and 
Brown, 2006). 
4.4.2 Relationships between soil and pore water properties with 
earthworm uptake 
4.4.2.1 Soil based BSAF 
Regression analysis between various soil properties and BSAF values failed to 
highlight key factors which may be responsible for pharmaceutical uptake into worm 
(Figure 4.6). Previously clay and organic matter content have been shown to 
influence bioavailability of organic pollutants in soils (Chung and Alexander, 1998; 
Weber and Weed, 1968; White et al., 1997; White, 1976). Research has shown 
greater earthworm uptake of phenanthrene in soils with higher clay content (White et 
al., 1997) however this was not observed with soil BSAF values calculated in this 
study. 
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Figure 4.6 Regression plots between soil based BSAFs calculated in this study (carbamazepine – diamond, 
diclofenac – triangle, fluoxetine – square and orlistat – cross) and selected soil properties including soil pH, soil 
distribution coefficient (Kd), organic carbon content and cation exchange capacity. 
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This study used soils with an environmentally realistic pH range (6.6 - 8.2) (Figure 
4.6). Therefore, this may account for the lack of clear effect of soil pH on the uptake 
of pharmaceuticals into earthworms as the pH range was fairly small. Where 
differences in BSAFtotal were observed in the diclofenac study (Table 4.2) and 
significant differences in soil pH between the five soil types were measured (Figure 
4.4); diclofenac was always extensively ionised (> 99 %) and no relationship 
between BSAFtotal and soil pH were found. Additional studies could explore  
pharmaceutical exposure in soils with a wider pH range as research has shown 
E.fetida can survive in soils between pH 4.3 – 7.5 (Sims and Gerard, 1985). 
As clear relationships with soil properties and earthworm BSAFs were unable to be 
found, it would suggest earthworm uptake is a complex interaction of a variety of 
factors and processes and does not exclusively rely on a single soil parameter. In 
addition, previous research has shown the ingestion of soil particles plays a minor 
role in the accumulation of chemicals (log Kow < 6) into earthworm tissues (Jager et 
al., 2003; Vijver et al., 2003) and thus may contribute to the lack of clear 
relationships between soil based BSAFs and soil properties for carbamazepine, 
diclofenac and fluoxetine.  
Instead, for a large proportion of chemicals uptake via diffusion across the 
earthworm skin dominates (Jager et al., 2003; Vijver et al., 2003). Therefore, 
understanding pore water properties may be a more appropriate approach to evaluate 
uptake. For this reason considering the sorption of pharmaceuticals is important as 
this will determine how much of the chemical is in the pore water and not sorbed to 
the soil surface. 
 
4.4.2.2 Pore water based BCFs 
Only weak relationships were found between pore water properties such as pH and 
pore water based BCFs. Unlike studies in the aquatic environment which found clear 
relationships between pH of the exposure medium and BCFs for ionisable chemicals 
(Karlsson, 2013; Nakamura et al., 2008), the results presented in this chapter 
demonstrated that, like soil pH; pore water pH cannot account solely for the 
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differences in the accumulation of ionisable pharmaceuticals into earthworms 
(Figure 4.7).  
 
Figure 4.7 Regression plot between porewater pH and pore water based bioconcentration factors obtained in this 
study (diclofenac – triangle, fluoxetine – square and orlistat – cross). 
 
Regarding earthworm exposures specifically cadmium uptake from pore water was 
found to be pH dependent (Oste et al., 2001). In the current study, only a slight 
relationship was observed in the diclofenac exposure as the BCF increased with 
decreasing pore water pH. Even though the pore water pH was significantly different 
across soil types, diclofenac was always extensively ionised (>99 %) and therefore 
changes in pore water pH and the subsequent fraction of ionised:netural species is 
not expected to be solely responsible for controlling pharmaceutical uptake 
(Appendix 12, Appendix 13). 
Highest internal concentrations were observed in exposures which had the highest 
pore water concentration of the respective pharmaceutical and therefore would 
suggest the bioavailability of chemicals in pore water is a limiting factor in 
earthworm uptake. For all pharmaceuticals, this was in soil 2.1, whilst soil 2.4 
generally had the lowest pore water concentrations (Figure 4.3). However high 
internal concentrations at the end of the exposure does not necessarily translate into 
highest BCFs as other factors are at play such as depuration rates each of which are 
specific to an exposure scenario. 
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As pore water concentrations are clearly important, changing the soil moisture 
content has been suggested to enhance the sorption of some pesticides to soils, with a 
decreased moisture content potentially leading to partitioning of chemicals from bio-
available fractions in the pore water to less accessible sites (Shelton and Parkin, 
1991; Shelton et al., 1995). However as the moisture content was monitored daily 
and kept at around 60 % of the MWHC for each soil type this is an unlikely 
explanation as to the observed differences in uptake in this study. 
Clearly many factors and processes in both the pore water and soil are governing the 
fate and subsequent uptake of pharmaceuticals into earthworms as current attempts 
to single out principal factors are yet to be successful. However considering uptake 
as a combination of both soil and pore water parameters may offer a better 
explanation. Different properties can interact to influence the bioavailable fraction 
such as explored in the work by Davis (1971) and White (1997). Regression analysis 
between BCF, organic carbon content and pore water concentration from the current 
study was performed to evaluate this concept further (Figure 4.8). Whilst it is 
important to note that not all regressions were significant, in general, fluoxetine and 
diclofenac results showed increased earthworm BCF in soils which had decreasing 
soil organic matter content (SOM). This could be explained by the presence of SOM 
decreasing the proportion of the chemical in pore water which in turn reduces 
potential for uptake. The results presented tend to agree that decreasing SOM leads 
to higher pore water concentrations of the pharmaceuticals (Figure 4.8). For 
fluoxetine a significant relationship in all regressions was noted, however for 
diclofenac this was only when a marked decrease in pore water concentration 
correlated to an increase in organic carbon content of the test soils. Relationships 
also showed an increase in organic carbon (OC) corresponded to a decrease in BCFs 
for the various soils and thus fits with previous research findings that the SOM is 
regulating the available fraction of pharmaceuticals in the pore water. This was most 
evident in the fluoxetine results and to a lesser extent in the diclofenac results, with 
weak correlations especially between BCF and OC (Figure 4.8).  
 
  
 
Figure 4.8 Correlations between organic carbon content, pore water concentration and bioconcentration factor for carbamazepine, diclofenac, fluoxetine and orlistat, linear regression line 
provided with corresponding R2 (* indicates significant relationship and p value provided for such regressions).  
 
 
1
2
0
 
p = 0.024 
p = 0.004 
p = 0.047 
p = 0.045 
Chapter 4                                                                                                                            Soil Properties 
121 
 
For the neutral pharmaceuticals, orlistat and carbamazepine, no significant 
correlations were observed, but in general, an increase in organic carbon content still 
follows a decrease in pore water concentration. However, in contrast a decrease in 
pore water concentration generally showed an increase in BCF (although not 
significant) (Figure 4.8). As numerous complex interactions exist between SOM, 
pore water concentrations and BCFs and no significant relationships were observed, 
apart from for fluoxetine, further experiments should be carried out using a wider 
variety of soil types to allow for appropriate exploration and conclusions to be 
drawn. 
In conclusion as one single soil type did not generate the largest BCFs for all 
pharmaceuticals and this would suggest that earthworm uptake is both a factor of soil 
type (including soil and pore water parameters) and pharmaceutical physico-
chemical properties. However, it is clear that for some pharmaceuticals the influence 
of soil type on the uptake and accumulation of pharmaceuticals is more significant 
(i.e. diclofenac) than for others (i.e. carbamazepine) with greater divergence in BCFs 
values reported. Exposure in the terrestrial system is a dynamic process and the 
availability of chemicals to organisms is highly changeable. 
4.5 Conclusions 
Earthworms differ in their ability to access chemicals in different soils types, 
whether they are sequestered or bio-available. The elimination of chemicals can also 
be influenced by differences in soil properties.  
The complex nature of numerous interactions between pharmaceutical chemical 
properties and soil properties ensures that it is incredibly difficult to disseminate the 
key factors influencing pharmaceutical uptake in earthworms. Whilst different soil 
types may affect the uptake and accumulation of some chemicals, BCF and BSAF 
results presented in this study suggest that others are less influenced by soil 
chemistry. Further work could explore the influence of dissolved organic carbon 
(DOC) in the pore water which may increase the bioavailability of chemicals. 
Unfortunately this was not measured in the current study and additional experiments 
to explore this are necessary.  
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Information on how soil properties can affect chemical uptake are important in terms 
of both risk assessment and modelling. Currently used, generalised models are 
unlikely to accurately represent the potential uptake and risk associated with soil-
borne contaminants and, as our research shows, numerous factors are involved in 
determining uptake. For modelling, a better understanding of biological factors 
influencing the uptake of chemicals residing in soils is important to accurately 
estimate the bioaccumulation potential. Additional work needs to explore the effect 
of changing pH in the earthworm tissue, soil and pore water samples on the uptake of 
ionisable chemicals and the subsequent implications of this for exposure modelling 
scenarios. Specifically, changes in earthworm tissue pH may result in wider 
implications such as the ion trap phenomena observed in plant cells (Trapp, 2004) 
being induced in earthworms, or negative effects on earthworm internal 
environments. However, as it is not clear which factors specifically lead to pH 
change further studies are needed to quantify and qualify these complicated 
processes. 
This study represents the first attempt to evaluate the complex interplay between 
pharmaceutical chemical properties and soil chemical properties and how these 
govern potential exposure scenarios for a critical terrestrial organism. While there 
are many confounding complexities and unanswered questions this work represents a 
first important step in understand the terrestrial fate of pharmaceuticals, a critical 
component in understanding environmental risk. 
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Chapter 5 Does Uptake of Pharmaceuticals Vary Across 
Earthworm Species? 
5.1 Introduction 
In Chapter 2 and Chapter 4, the uptake of a range of pharmaceuticals, with different 
physico-chemical properties, into the epigenic earthworm, Eisenia fetida was 
explored. E. fetida is the preferred standard reference earthworm species in many 
international regulatory guidelines for risk assessment such as the Organisation of 
Economic and Cooperative Development acute earthworm toxicity test (OECD 207 
(OECD, 1984)). Results showed that pharmaceuticals were accumulated by E. fetida 
and pore water based bioconcentration factors ranged from 2.25 (carbamazepine) to 
51.53 (orlistat) (Chapter 2). 
However, a number of different earthworm species co-exist within the soil 
environment. These species vary in their behaviour, physiological properties and in 
their preference of particular soil characteristics e.g. texture or pH (Edwards and 
Bohlen, 1996). Data for non-pharmaceutical contaminants (DDE and metals) 
indicates that chemical uptake and toxicity can vary across species (Kelsey and 
White, 2005; Langdon et al., 2005; Morgan and Morris, 1982; Spurgeon and Hopkin, 
1996). These differences in uptake are thought to be due to diﬀerences in processing 
of soil organic matter, ecological strategy, and lipid content across the earthworm 
species studied (Kelsey et al., 2005). It is possible that the uptake of pharmaceuticals 
into other species could be very different from E. fetida. In order to fully understand 
the risks of pharmaceuticals in terrestrial systems it would be valuable to develop 
knowledge of the differences, if any, in uptake across different species. 
This study therefore explored the uptake of four commonly used human 
pharmaceuticals into the earthworm, Lumbricus terrestris and compared the findings 
to previous results for the uptake of the chemicals into E. fetida from Chapter 2 in 
order to evaluate whether earthworm species traits are important in determining 
pharmaceutical uptake. Recently, Lumbricus terrestris have been suggested to be a 
more suitable earthworm test species for risk assessment as they reside in the soil 
environment unlike E. fetida which are more commonly found in manure/compost 
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matrices (Dean-Ross, 1983; Sims and Gerard, 1985). The test chemicals included the 
anti-epileptic drug carbamazepine, the anti-inflammatory diclofenac, the anti-
depressant fluoxetine and orlistat which can be used as weight loss aid. Detailed 
physico-chemical properties of each pharmaceutical and study species can be found 
in Table 1.3 and Table 5.1 respectfully. 
Table 5.1 Characteristics of Eisenia fetida and Lumbricus terrestris. 
(a) (Edwards and Lofty, 1972) 
(*) (Reginald William Sims and Gerard, 1985) 
(‡) (Edwards, 2004)  
(^) (Svendsen et al., 2002)   
(#) (Butt, 1991) 
  
 Eisenia fetida Lumbricus terrestris 
Ecological grouping Epigeic Anecic 
Time to maturity (days) 28 – 30
‡
 112 at 15 
o
C
^
 
Colour Brown and buff bands
‡
 Head darker, tail lighter
‡
 
Optimal temperature (
o
C) 25 (0 – 35)
 ‡
 ~ 10
a
 
Length (mm) 60 – 120* 90 – 350* 
Diameter (mm) 3 – 6* 6 – 10* 
Number of segments (mm) 80 – 120* 140 – 155* 
Mode of reproduction Obligatory amphimictic  Obligatory amphimictic 
Cocoon incubation time 18 - 26
‡
 90 at 15
 o
C
#
  
Where in soil profile? Leaf litter/surface* Deep burrows* 
Soil pH preference 4.3 – 7.5* 6.2 – 10.0* 
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5.2 Materials and Methods 
5.2.1 Pharmaceutical compounds and reagents 
The test chemicals were 
14
C labelled compounds to allow for lower limits of 
detection in the samples and thus the soil could be spiked with environmentally 
relevant concentrations in the uptake studies. Labelled fluoxetine and carbamazepine 
were obtained from American Radiolabelled Chemicals (Missouri, USA), diclofenac 
was obtained from Perkin Elmer (Boston, USA) and orlistat was kindly provided by 
GlaxoSmithKline (GSK, UK). Solvents including acetonitrile (99.9 %), methanol 
(99.9 %) and ethyl acetate (99.9 %) were HPLC grade and obtained from Fisher 
Scientific (Loughborough, UK).  
5.2.2 Test soil 
The test soil was a clay loam variety (soil 280) obtained from LandLook (Midlands, 
U.K.) and had been used in earlier earthworm uptake studies with E. fetida (Chapter 
2; section 2.2.2). Prior to the uptake studies, the field fresh soil was air dried then 
sieved to 2 mm to ensure homogeneity within the soil matrix. Soil 280 had an 
organic matter content of 3 %, a pH of 6.3 and a total organic carbon concentration 
of 1.89 %. 
5.2.3 Test organism  
L. terrestris were obtained from Blades Biological Ltd (Kent, UK). L. terrestris were 
cultured in a plastic box containing 8 kg of soil 280 and kept in a growth chamber 
under experimental conditions (see below) prior to use in the uptake studies. They 
were fed twice weekly with birch leaves and pre-treated horse manure which was 
dried at 105
o
C and then rewetted, both of which were applied to the top of the 
culture medium. The mean lipid content of L. terrestris has been reported in 
literature as 1.23 ± 0.20 % based on fresh weight (Albro et al., 1992). 
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5.2.4 Experimental design 
The L. terrestris uptake experiments followed the minimised design approach 
described in Chapter 3. Specifically; earthworms were exposed to each 
pharmaceutical, individually for a 21 d uptake phase. Exposures consisted of a 500 
mL amber glass jar containing 350 ± 5 g test soil 280, and one L. terrestris 
earthworm (3 - 6 g). The soil had been previously spiked with one of the four 
chemicals (0.8 – 1.5 mL), mixed by placing on an end over end shaker for 24 h and 
then the lids were removed to allow solvent to evaporate off for 72 h. The resulting 
soil concentrations were 36, 9.9, 7.2 and 15.8 µg/kg for carbamazepine, diclofenac, 
fluoxetine and orlistat respectively. Earthworms were also added to blank control 
and solvent control beakers which were kept under test conditions.  
The moisture content of the soils was monitored throughout the study and if 
necessary adjusted with deionised water to maintain the soil at 40 – 60 % of the 
maximum water holding capacity (MWHC). Earthworm beakers were incubated 
under controlled conditions to a constant dark cycle at 13 ± 2 
o
C and 60 % humidity 
and fed twice weekly (see culturing conditions). After 21 d, for each pharmaceutical 
treatment, six L. terrestris were removed from the spiked soil and left on moist filter 
paper for 30 h to purge their guts. The remaining earthworms were transferred to 
clean soil (350 ± 5 g) for a further 21 d for the depuration phase. After which the 
remaining six earthworms were removed from each treatment and allowed to void 
their gut contents (30 hours). All L. terrestris were then immediately frozen (-20
o
C) 
until analysis. 
Soil samples were taken at the beginning and end of the uptake phase and frozen 
until analysis. Pore water was extracted from the soil in exposure beakers at the 
beginning and end of the uptake phase via centrifugation. Duplicate samples (25 g) 
of soil were taken from each beaker and the pore water extracted using the method 
outlined in section 2.3.3.1 then immediately analysed. Measurements of soil and 
pore water pH were also made on all samples using a Hanna pH electrode (HI-
1093B) at time of sampling.  
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5.2.5 Sample analysis 
Prior to worm analysis, each L. terrestris was defrosted and dissected along the 
earthworm through the cuticle and epidermis to reveal muscle tissue. A micro pH 
probe (Thermo Scientific Orion pH microelectrode) was inserted into the muscle 
tissue to record the internal pH.  Worms were then extracted using an approach 
based on that used for E. fetida as described in section 2.3.3.1. The extraction 
solvents were methanol, ethyl acetate, acetonitrile:water (7:3) and acetonitrile for 
carbamazepine, diclofenac, fluoxetine and orlistat respectively and 25 mL of solvent 
was used per earthworm and each extraction took approximately 20 minutes. 
Suspended earthworm-solvent mixtures were centrifuged at 2000 rpm and a 1 mL 
sample of the resulting supernatant was taken and added to 10 mL EcoScint A 
scintillation cocktail ready for counting the radioactivity on a Liquid Scintillation 
Counter (LSC).  
Soil was extracted using liquid extraction according to methods outlined in Chapter 
2. Results from previous experiment confirmed the formation of irreversibly bound 
residues between diclofenac and soil 280 so combustion analysis of these soils was 
also performed to determine if there was radioactivity remaining in the soil 
according to methods reported in 2.3.3.1. Recoveries for all four pharmaceuticals in 
test soil 280 have been determined in previous validation studies (2.3.3.1). Briefly, 
method validation studies showed that average recoveries ranged from 82.8 
(diclofenac) to 100.6 (carbamazepine) %. 
5.2.5.1 Liquid scintillation counting 
Measured radioactivity in pore water, soil and worm extracts were determined using 
LSC on a Beckman LS 6500 LSC counter (Beckman Coulter Inc., Fullerton, USA). 
Each sample was counted three times for 5 minutes. Counts were corrected for 
background activity by using blank controls. Counting efficiency and colour 
quenching were corrected using the external standard ratio method.  
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5.2.6 Kinetic model fitting 
Measured radioactivity in the earthworm extracts allowed for calculation of L. 
terrestris tissue concentrations at the end of the uptake phase (Ct1) and end of 
depuration phase (Ct2). Along with measured pore water concentrations, tissue 
concentrations were input into Equation 3 and Equation 4 to calculate uptake (k1) and 
depuration rates (k2) for L. terrestris in each exposure (refer to Chapter 3 for a full 
explanation of minimised design calculations). The uptake and depuration rates were 
then used to estimate pore water based kinetic bioconcentration factors (BCFs) 
(Equation 5).  
For comparison, data from the previous full uptake and depuration E. fetida 
experiments (Chapter 2) was resampled according to if the experiment had been 
carried out using the minimised design principles to generate equivalent minimised 
design pore water based BCFs to L. terrestris. Measured data used in the calculations 
was originally obtained from full uptake and depuration studies according to OECD 
317 (OECD, 2010) outlined in Chapter 2. 
5.2.7 Statistical Analysis 
Statistical analysis of the data was performed on SigmaPlot (v .12). Prior to all tests, 
normal distribution and equal variance were tested by performing a Shapiro–Wilk 
and Levene–Mediane test, respectively. Firstly, measurements of soil and pore water 
pH made at 0 h and 21 d were compared to see if the average of each measurement 
was independent using a paired t-test. For the diclofenac exposure a one-way 
ANOVA was employed to assess differences in internal pH values of the worms in 
comparison to the control blanks and to see if there was a difference between 
measured pH values during the uptake period in comparison the depuration phase. 
For the remaining test chemicals as the normality test failed the one-way ANOVA 
was instead performed on ranks.  
 
Chapter 5                                                                                                                             Species Traits 
129 
 
5.3 Results 
For all pharmaceuticals there was a decrease in concentrations of radioactivity in the 
soil and soil pore which can be attributed to uptake into L. terrestris, formation of 
non-extractable residues (Chapter 2) or possibly small amounts of mineralisation 
(Al-Rajab et al., 2010). pH measurements indicated that over 21 d the presence of 
diclofenac increased the pore water pH (t (11) = -3.624, p =0.004) and decreased the 
soil pH (t (11) = 2.656, p = 0.022). The presence of orlistat decreased both the pore 
water (t (11) = 3.6534, p = 0.004) and soil pH (t (5) = 6.006, p = 0.002) over the 
uptake period. No pH differences were noted in the carbamazepine study, increases 
in soil pH from 0 h to 21 d (t (11) = -10.452, p = < 0.001) were found to be 
significant in the fluoxetine exposure (Figure 5.1, Figure 5.2). 
 
Figure 5.1 Measured soil pH in different study treatments during at start of study (grey bars) and end of uptake 
phase (21 d) (dashed bars). Average pH measurements provided with ± standard deviation (n = 6). Significant 
differences in measurements between 0 h and 21 d denoted by ‘a.’ 
 
Figure 5.2 Measured pore water pH in different study treatments during at start of study (grey bars) and end of 
uptake phase (21 d) (dashed bars). Average pH measurements provided with ± standard deviation (n = 6). 
Significant differences in measurements between 0 h and 21 d denoted by ‘a.’ 
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5.3.1 Lumbricus terrestris uptake  
All four pharmaceuticals were taken up by L. terrestris over 21 d. After 21 d, 1.96 ± 
0.65, 1.17 ± 0.57, 2.11 ± 1.04 and 0.72 ± 0.18 % of applied radioactivity was taken 
up by L. terrestris in the carbamazepine, diclofenac, fluoxetine and orlistat studies 
respectively. Similar average internal concentrations (Ct1) were observed after 21 d 
for diclofenac and orlistat and these two pharmaceuticals also had the greatest 
amount of chemical remaining within the tissue once the depuration phase had 
ended. The highest uptake rate (k1) was observed in the fluoxetine study with a mean 
of 11.685 L/kg d
-1
 whist the slowest accumulation was observed in the diclofenac 
exposure (0.468 L/kg d
-1
). The diclofenac exposure also had, on average, the slowest 
depuration rate (k2) at 0.05 d
-1
 with approximately 90 % of the accumulated 
radioactivity remaining in the L. terrestris after the depuration period (0.00387 
mg/kg). Comparatively, carbamazepine was eliminated fastest from the earthworm at 
0.132 d
-1 
which resulted in a tissue concentration at the end of the depuration phase 
of 0.00162 mg/kg (Table 5.2).  
Pore water based bioaccumulation factors (BCFs) increased in the order of 
diclofenac < fluoxetine < orlistat < carbamazepine for L. terrestris after exposure to 
the pharmaceuticals in soil 280 and ranged from 6.69 – 83.79 (Table 5.2). Internal 
pH differences were noted in the carbamazepine (Q = 2.715, p = < 0.05) and 
diclofenac (t = 3.488, p = 0.007) treatments at the end of the depuration phase in 
comparison to the controls and for fluoxetine at the end of the uptake phase (Q = 
2.788 p = < 0.05). Meanwhile, orlistat was the only compound to have significant 
differences in L. terrestris internal pH measurements between the uptake and 
depuration phases (Q = 3.327, p = < 0.05) (Figure 5.3). 
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Figure 5.3 Internal pH measurements of L .terrestris exposed to four pharmaceuticals (carbamazepine, 
diclofenac, fluoxetine, orlistat) in test soil 280. Grey bar shows measurement in uptake phase and white bar 
shows measurements made in depuration phase with error bars providing ± SD (n = 6). Where (a) there is 
statistically significant (p < 0.05) difference of in comparison to blank controls and (b) is a statistically significant 
(p < 0.05) difference between the uptake and depuration phases. 
 
  
 
Table 5.2 Results from L. terrestris study minimised design experiments together with previously calculated  E. fetida BCFs showing average measured earthworm tissue concentrations (± 
standard deviation, n = 6) at the end of 21 d uptake phase (Ct1) and 21 d depuration phase (Ct2) and mean concentration of pharmaceutical in the pore water during the uptake phase (Cpw) (± 
standard deviation, n = 6). Calculated uptake (k1) and depuration rates (k2) are also presented along with BCF values derived using the minimised design approach. 
 Ct1 mg/kg (internal)  Ct2 mg/kg (internal) Mean Cpw (mg/L) in 
uptake phase 
k2 (dep. rate) 
(d
-1
) 
k1 (uptake rate) 
(L/kg d
-1
) 
Minimised test 
design BCF 
Lumbricus terrestris (this study) 
Carbamazepine 0.0261 ± 0.0086 0.00162 ± 0.00005 0.00416  ±  0.0012  0.132 0.884 6.69 
Diclofenac 0.0043  ± 0.0002 0.0038  ± 0.0011 0.00050  ± 0.00008 0.005 0.437 83.79 
Fluoxetine 0.0059  ± 0.0009 0.0010  ± 0.00004 0.00011  ± 0.00007 0.086 5.744 66.90 
Orlistat 0.0044  ± 0.0011 0.0022 ± 0.0006 0.00027  ± 0.00014 0.033 1.085 33.21 
Eisenia fetida (Chapter 2) 
Carbamazepine 0.0097  ± 0.0018 0.0001  ± 0.00001 0.00864  ± 0.001 0.209 0.238 1.14 
Diclofenac 0.0214 ± 0.0036 0.0056 ± 0.0007 0.00126  ± 0.0004 0.064 1.476 23.03 
Fluoxetine 0.0233 ± 0.0018 0.0028 ± 0.0021 0.00060 ± 0.0001 0.102 4.456 43.76 
Orlistat 0.0162 ± 0.0026 0.0095 ± 0.0011 0.00062 ± 0.0001 0.025 1.601 63.03 
1
3
2
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5.3.2 Comparison between Lumbricus terrestris and Eisenia fetida 
The uptake rates (k1) were considerably faster in the L. terrestris study in 
comparison to E. fetida for carbamazepine, diclofenac and fluoxetine however the 
depuration rates were comparable and fitted within the ranges found in previous E. 
fetida studies (Table 5.2). Nevertheless, in both earthworm species, fluoxetine was 
evidently taken up the fastest while carbamazepine was eliminated the quickest. The 
carbamazepine treatment had the highest average pore water concentration (0.0031 
mg/L) and also the highest L. terrestris internal concentration (0.0261 mg/kg) after 
21 days exposure which was also similar to the findings of the E. fetida study 
(Chapter 2). 
For the smaller earthworm E. fetida, pore water based BCFs calculated based on the 
minimised design were 1.14 (carbamazepine), 23.03 (diclofenac), 43.76 (fluoxetine) 
and 63.03 (orlistat) (Table 5.2). In comparison, BCFs were larger in the L. terrestris 
studies for carbamazepine, diclofenac and fluoxetine. Specifically, the pore water 
based BCFs were 83, 73 and 35 % larger in L. terrestris than E. fetida. Conversely, 
for orlistat BCFs were almost two times larger in E. fetida (63.03) than L. terrestris 
(33.21) (Table 5.2, Figure 5.4). 
 
Figure 5.4 Comparison of Lumbricus terrestris (grey) and Eisenia fetida (white) bioconcentration factors (BCFs) 
and for the study compounds. 
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5.4 Discussion 
There is increasing recognition of the importance of species traits in determining the 
uptake of chemicals, including pharmaceuticals, in the aquatic environment 
(Meredith-Williams et al., 2012; Rubach et al., 2012, 2010) traits such as respiration, 
locomotion and behaviour explaining observed differences in uptake. However, very 
little research has investigated the effect of species differences on the uptake of soil-
borne organic contaminants. This study was therefore performed to explore the 
difference in uptake of pharmaceuticals from soil by two different earthworm 
species. 
The larger BCFs in L. terrestris for three of the test compounds (carbamazepine, 
diclofenac and fluoxetine) in comparison to E. fetida present contradictory results to 
previous research findings which observed ten times higher BCFs for E. fetida than 
L. terrestris after exposure to the persistent DDT metabolite, p,p’-DDE (Kelsey et 
al., 2005). Comparatively, in agreement to the work by Kelsey et al., (2005), the 
BCF for orlistat was approximately 50 % smaller in the current L. terrestris study 
than the E. fetida pore water based BCF. 
The differences in BCF’s between L. terrestris and E. fetida may be due to 
differences in earthworm ecological strategy. E. fetida are epigeic species which 
primarily live at or near the soil surface and consume course particulate organic 
matter and surface litter whilst anecic species, such as L. terrestris live in deep 
burrows and come to surface to feed on surface litter (Bouché, 1983). Therefore as 
the soil in these experiments was mixed thoroughly, the deep burrowing action of L. 
terrestris would ensure they have the opportunity to explore the soil to a greater 
extent with more potential opportunities for chemical uptake in comparison to E. 
fetida which prefer to reside near the soil surface.  
The uptake of chemicals has been postulated to be related to hydrophobicity and the 
lipid content of the organism. For carbamazepine, diclofenac and fluoxetine the 
results do not follow this trend as L. terrestris have a lower lipid content suggesting 
less accumulation which is reverse of what the results demonstrate. Differences in 
lipid content can however offer an explanation for the BCFs in the orlistat exposure 
because E. fetida have a higher lipid content (as reported in Chapter 2). Combined 
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with the fact orlistat is a particularly hydrophobic neutral compound with a large log 
Kow value of 8.97 this would infer orlistat has a higher propensity for uptake into 
lipids and thus may account for the larger E. fetida BCF. 
Furthermore, additional explanations for the larger E. fetida pore water based BCF in 
the orlistat study include size/volume ration principles. As the size of an object 
increases the surface area to volume ratio decreases therefore as L. terrestris are a 
larger species of earthworm this would infer that the smaller, E. fetida, have a greater 
potential for the diffusion of chemicals through their tissues.  
Previous research elucidating the uptake of chemicals into earthworms demonstrated 
that a majority of uptake from the soil environment occurs via diffusion across the 
earthworm skin from pore water for a large proportion of chemicals (log Kow < 6). 
However as the hydrophobicity of the chemicals increased uptake via the gut route 
became increasingly important (Jager et al., 2003). A combination of large surface 
area to volume ratio ensuring minimal uptake via diffusion and the hydrophobic 
nature of orlistat restricting uptake to primarily across the gut wall may explain the 
smaller pore water based BCFs in L. terrestris in comparison to E. fetida.  
Whilst this may explain the orlistat uptake, other mechanisms or processes must 
exist for carbamazepine, diclofenac and fluoxetine which ensure greater 
accumulation and higher BCFs in L. terrestris. These pharmaceuticals are also more 
hydrophilic than orlistat and therefore diffusion across the earthworm skin is the 
dominant route of exposure therefore the larger volume of tissue in the L. terrestris 
could facilitate a higher capacity for uptake, shown by faster uptake rates (k1), or 
greater storage ability of the chemicals in the tissue, as shown by the larger tissue 
concentrations (Ct1) at the end of the uptake phase (Table 5.2). Little is known about 
the metabolism of pharmaceuticals in earthworms but this may also be a factor 
influencing uptake in different earthworm species. Previous work presented in 
Chapter 2 demonstrates that diclofenac is metabolised in E. fetida studies however 
additional studies are required to see if similar transformation products are formed in 
L. terrestris exposures. Potential metabolism, together with gut load and retention 
time for ingested soil particles which may alter the bioavailability of the 
pharmaceuticals (Hartenstein et al., 1981; Hartenstein and Amico, 1983). 
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These research findings demonstrate that species traits are important in determining 
uptake and BCF calculations. In terms of the wider environment, birds feeding on L. 
terrestris would generally be more at risk than if they were to ingest a similar 
number of the smaller, E. fetida, and thus the potential food chain effects as a result 
of bioaccumulation would also be greater. However for risk assessment purposes it 
may not be necessary to take into account species differences as all BCFs for the 
four pharmaceuticals were within an order of magnitude of each other. Nevertheless, 
it is important to recognise that only two species were evaluated in this study and 
therefore to draw more general conclusions it may be necessary to look at a wider 
range of earthworm species for example with differing burrowing habits, soil 
property preferences and sizes. 
All test chemicals were thoroughly mixed in the soil to create an even distribution of 
the pharmaceuticals. This heterogeneity is not representative of the natural soil 
environment where pharmaceuticals will most likely be applied to the top layers of 
the soil profile after application of sludge and manure. Earthworms which prefer to 
reside at or near the soil surface would therefore have a greater exposure to 
chemicals than the deep burrowing species which come to the surface less often. 
Hydrophilic pharmaceuticals which have a greater potential for movement with 
percolating water flows may be more widely distributed in the soil profile than 
highly sorptive pharmaceuticals and therefore differences in pharmaceutical physico-
chemical properties can also affect earthworm uptake in the natural environment. 
Recent research has demonstrated that the veterinary antibiotic, sulfadiazine 
accumulated in greater concentrations in the soil boundary layer between channel 
compartment and bulk soil. Over time, the shells of microaggregates also had a 
larger sulfadiazine concentration than the core (Reichel and Thiele-Bruhn, 2013). 
Pharmaceuticals accumulating in earthworm channels may present a greater risk to 
burrowing earthworm species where there is the potential for greater uptake of 
chemicals. Additional studies are required to determine whether this needs to be 
addressed with regards to risk assessment. 
The observed changes in pore water, soil and internal pH (Figure 5.1, Figure 5.2, 
Figure 5.3) would also indicate that the presence of chemicals can alter the chemistry 
of the soil. This is important in terms of modelling exposure scenarios and risk 
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assessment exercises as soil properties such as pH are currently assumed to remain 
constant and changing these properties may alter chemical bioavailability. 
5.5 Conclusions 
After isolated exposure of test organisms (Lumbricus terrestris) to carbamazepine, 
diclofenac, fluoxetine and orlistat for 21 days uptake phase followed by 21 days 
depuration period the range of pore water based BCFs for these compounds were 
6.69 to 83.79. These findings demonstrate bioaccumulation by L. terrestris appear to 
be highly compound speciﬁc. As a result of comparison to previous research on the 
uptake of pharmaceuticals into a smaller earthworm (E. fetida), the bioaccumulation 
of pharmaceuticals into earthworms also appear to be species specific, with the 
larger worm (L. terrestris) showing a greater capacity for the uptake of 
carbamazepine, diclofenac and fluoxetine and thus larger pore water based BCFs. In 
terms of risk assessment these results highlight that may be necessary to look at 
species differences when determining the effect of pharmaceutical residues in the 
soil environment. Further research is required to evaluate the effect of species traits 
on pharmaceutical uptake using a wider variety of test organisms before conclusions 
can be drawn as to whether a single species should not be used as a model to 
represent all organisms in the risk assessment of chemicals. 
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Chapter 6 Fate and Uptake of Pharmaceuticals in Soil – 
Plant Systems 
6.1 Introduction 
Due to the detection of pharmaceuticals in soils (Butler et al., 2012; Dalkmann et al., 
2012; Durán-Alvarez et al., 2009; Golet et al., 2003; Kinney et al., 2006; Redshaw 
et al., 2008a; Vazquez-Roig et al., 2010), as described in Chapter 1, concerns have 
been raised over the potential for these substances to be taken up into human food 
items and to pose a risk to human health (Boxall et al., 2006; Wu et al., 2010). A 
number of studies have demonstrated the uptake of pharmaceuticals from both 
human and veterinary use, into plants (Boxall et al., 2006; Dolliver et al., 2007; 
Herklotz et al., 2010; Holling et al., 2012; Kong et al., 2007; Redshaw et al., 2008b; 
Shenker et al., 2011; Wu et al., 2010, 2012). Studies have explored the uptake and 
translocation of a variety of pharmaceuticals with a particular focus on the anti-
depressant drug, fluoxetine and antibacterial chemicals including sulfamethazine, 
sulfamethoxazole and trimethoprim into numerous plant species  including root and 
shoot crops such as soybean, lettuce and carrot. 
A number of studies have explored plant uptake from a hydroponic culture medium 
such as the work by Herklotz et al., (2010) and Redshaw et al.,(2008b). Specifically, 
uptake of fluoxetine was seen in the stems (5 % mean uptake of applied burden; 
0.49 μg/g (wet weight)) and leaves (3 % mean uptake; 0.26 μg/g wet weight), 
however there was no evidence of uptake into the curd (Redshaw et al., 2008b). 
Fluoxetine also remained undetected in plant roots whereas soil uptake studies have 
generally noted a concentration of the compound in the roots albeit smaller than the 
amount detected in the main plant (Winker et al., 2010). 
Studies have also revealed variations in plant uptake between different species 
exposed to pharmaceuticals (Boxall et al., 2006; Herklotz et al., 2010; Wu et al., 
2012). Recent studies have also investigated the uptake into plants with the addition 
of sewage sludge to test systems and uptake via the application of reclaimed waste 
water effluent to simulate realistic environmental exposures in the field (Holling et 
al., 2012; Shenker et al., 2011; Wu et al., 2012, 2010). Results indicate that plant 
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uptake is higher in the biosolid amended soils, probably a result of higher exposure 
concentrations however pharmaceuticals introduced by irrigation water appear to be 
more available for translocation (Wu et al., 2010).  
Many of the previous plant uptake studies have been done at unrealistic exposure 
concentrations. Studies typically have looked at uptake only with no attempt being 
made to understand the temporal fate of the pharmaceutical in soil matrices. Without 
understanding the dynamics of the distribution and fate of the pharmaceuticals in the 
soil, it is difficult to establish relationships between the properties of pharmaceuticals 
and uptake. This study was therefore initiated to explore the fate, distribution and 
uptake of a range of pharmaceuticals in soil-plant systems. The study was performed 
on two crop species with five pharmaceuticals and an antimicrobial personal care 
product covering a diverse range of physico-chemical properties (Table 6.1). 
6.2 Materials and methods 
Analytical grade carbamazepine (> 98 %), diclofenac (> 98 %), fluoxetine (> 98 %), 
propranolol (> 99 %), sulfamethazine (> 99 %), and triclosan (> 97 %) were 
obtained from Sigma-Aldrich (Sydney, Australia). Deuterated forms of selected 
study compounds (carbamazepine-D10 (99.8 %), diclofenac-D4 (98.5 %), 
fluoxetine-D5 (99.4 %), propranolol-D7 (99.6 %), and triclosan-D3 (98.6 %) were 
purchased from TLC Pharmachem (Canada) for use as internal standards in the the 
chemical analyses. 
Tepko soil (obtained from near Tepko township in South Australia) was used for 
both the plant uptake and fate studies (pH 6.25, EC 0.09 dS/cm, OC 1 %, CEC 5.2 
cmol(+)/kg, clay 8 %). Prior to testing, the soil was air dried then sieved to 2 mm to 
ensure homogeneity. 
Ryegrass seeds (Lolium perenne, Guard variety) were obtained from Seed Services 
(SARDI, South Australian Research and Development Institute) and radish 
(Raphanus sativus, Cherry belle variety) from Mr Fothergills (Sydney, Australia). 
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Table 6.1 Selected properties of test chemicals (full description of physico-chemical properties are Table 1.3) 
Test chemical pKa Log 
Kow
a
 
Log 
Dow
b
 
Carbamazepine N/A 2.5 N/A 
Diclofenac 4.0 4.5 2.30 
Fluoxetine 10.1 4.1 0.19 
Propranolol 9.5 3.5 0.19 
Sulfamethazine 7.4 0.9 0.87 
Triclosan 8.1 4.8 4.80 
a 
Unionised form of the drugs 
b
 Log Dow at pH 6.25 
 
6.2.1 Fate study 
Duplicate pots of soil were prepared (200 ± 5 g) and spiked with aliquots of 1 g/L (in 
acetone) solution of each study pharmaceutical to give a nominal concentration of 10 
mg/kg. Following spiking, soil was mixed by hand to ensure a homogeneous 
distribution of the test chemicals; pots were then left for 2 h in a fume cupboard to 
evaporate off any solvent. Blank control pots were also prepared. Pots were then 
kept in controlled conditions (14 h light (23
o
C) 10 h dark (15
o
C)) until time of 
sampling. Moisture content adjustments were made on a daily basis, by addition of 
deionised water, to ensure levels remained at 60 % of the soil maximum water 
holding capacity (MWHC). Sampling points were 0 h, 1, 3, 7, 14, 40 d. At each 
sampling point, duplicate pots were removed and the soil pore water was extracted. 
Extractions were done by taking 2 x 25 g portions of soil from each pot and placing 
these on top of a glass wool insert in in 2 x 25 mL disposable plastic syringes. 
Syringes were placed in plastic centrifuge tubes and centrifuged at 3500 rpm for 45 
minutes. The resulting pore water, collected in the centrifuge tubes for each single 
sample, was pooled and centrifuged again at 15000 rpm for an additional 30 minutes 
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and then transferred to vials ready for analysis. Samples of whole soils were also 
taken and stored at -20C for later analysis. 
6.2.2 Uptake of pharmaceuticals into plants 
Plastic pots containing 500 ± 5 g and 200 ± 5 g were prepared for use in uptake 
studies with radish and ryegrass respectively. Pots were prepared in triplicate for 
each pharmaceutical and plant type and spiked as per the fate study to give a final 
soil concentration of 1 mg/kg. Solvent and blank controls were also prepared in 
triplicate. Soils were then left for 48 hours to equilibrate before a total of 6 and 16 
seeds were initially added to each pot for radish and ryegrass respectively which 
were then lightly covered in test soil. 
Plants were left to grow for 6 weeks in a growth chamber under the same conditions 
as the pots in the fate study (Figure 6.1). Pots were arranged in a randomised order 
(specific positions were determined based up on a random number generator in 
Microsoft Excel). A similar watering regime to that used in the fate study was 
adopted to maintain moisture levels at 60 % of the MWHC. As the experiment 
progressed, the growth of the plant was taken into account for the watering strategy. 
Germination counts were made at 11 days. After 12 days of growth, when 
approximately 80 – 90 % of plants had germinated the radish plants were thinned to 
leave behind three seedlings.  This was to ensure maximum germination potential in 
order to gather enough biomass for the chemical analysis. After 50 % emergence, 
plants were fed Ruakura nutrient solution, where 5 mL was applied per 250 g soil 
twice weekly (for three weeks) instead of the DI water. After 3 weeks, addition of 
nutrient solution continued with one 5 mL application of nutrient solution per 250 g 
of soil per week (for nutrient solution preparation see Appendix 14).  
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Figure 6.1 Radish and ryegrass plants before harvest. 
 
At harvest, loose soil was removed from around the radish plant to allow for the 
intact removal of the whole radish (Figure 6.2). The radish plant was thoroughly 
rinsed in deionised water to remove any soil residues, patted dry with paper towel, 
weighed, divided up into root and above ground biomass and these were then re-
weighed separately. For the ryegrass, after measuring the maximum height of the 
plants from each treatment, the above ground plant material was cut away, rinsed in 
DI water, patted dry and then weighed. All plant samples were cut into smaller 
pieces then freeze dried and stored at - 20
o
C until extraction for residue analysis. Soil 
was also taken from the plant pots, at the end of the uptake study, for analysis. 
 
Figure 6.2 Radish plants after harvest. 
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6.2.3 Pharmaceutical analysis 
6.2.3.1 Extraction from soil and plant material 
Pharmaceutical compounds were extracted from soils and plants using validated 
methods chosen for their high percentage recoveries (Appendix 17). Prior to plant 
and soil extractions 1 mg/g of deuterated stable isotope standards were added to their 
respective samples (100 ug/L stock solution). Since stable isotopes were unavailable 
for sulfamethazine, control plants and control soil samples were spiked with a known 
amount of sulfamethazine to determine recoveries. For the soil extraction, 5 mL of 
methanol was added to 1g soil (wet weight) and 1 g of sand. After addition of the 
solvent the test tubes were vortexed for 1 minute and then ultrasonicated for 15 
minutes. Lastly the tubes were centrifuged for 30 minutes at 1500 rpm and the 
supernatant was removed. The extraction process was repeated with a further 
addition of 5 mL methanol and then 5 mL acetone. The supernatants from the three 
extractions were combined and then evaporated to dryness before being reconstituted 
in 1mL methanol, sonicated for 5 minutes and then transferred into LC-MS/MS vials 
for analysis. 
For the plant extractions, sand (1 g) was added to 1 ± 0.1 g of plant material for each 
of the samples and 5 mL of extraction solvent (70:30 acetonitrile:Milli-Q water 
solution) was then added to the test tube. After addition of the solvent the test tubes 
were vortexed for 1 minute and then ultrasonicated for 15 minutes. The samples 
were then centrifuged for 30 minutes at 1500 rpm and the supernatant was removed 
and the process repeated for two further extractions. The combined extracts (15 mL) 
were diluted with Milli-Q to make a maximum solvent concentration of 10 % and the 
extract was then applied to an Oasis HLB (Waters Corporation) 6 mL 200 mg solid 
phase extraction (SPE) cartridge that had been preconditioned with Milli-Q water 
and methanol. The cartridges were left to dry under vacuum, washed with 10 % 
methanol in Milli-Q water and eluted with 2 x methanol (3 mL) and 1 x 
dichloromethane (3 mL). The eluates were combined and evaporated to dryness 
under a nitrogen stream and reconstituted in 1 mL methanol. Lastly the test tubes 
were sonicated for 5 minutes ready for the extract to be transferred into LC-MS/MS 
vials. 
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6.2.3.2 LC-MS/MS analysis 
Cleaned-up, extracts were analysed for the pharmaceuticals by LC-MS/MS using a 
ThermoFinnigan TSQ Quantum Discovery Max (Thermo Electron Corporation). 
HPLC separation was performed with a Kinetex C18 100 x 2.1 mm (2.6 µm particle 
size) column (Phenomenex, USA) with a mobile phase flow rate of 0.3 mL/min. The 
mobile phase composition was 0.1 % formic acid and acetonitrile using a gradient 
program over 12 min. The relative flow of 0.1 % formic acid was 95 % for 2 min, 20 
% after 3 min, 2 % at 4 min and held for 3 min until 7 min before returning to 95 % 
by 9.5 min. MS/MS analysis was undertaken using atmospheric pressure 
electrospray ionisation (ESI) in both positive and negative ionisation modes. Spray 
voltage was 5000 V and source collision induced dissociation was -12 V in positive 
ESI and -4000 V and 10 V for negative ESI, with the ESI capillary line maintained at 
350C and collision gas (Ar) pressure set at 1.5 mTorr. Qualitative and quantitative 
analysis of compounds was based on retention time, multiple reaction monitoring 
(MRM) of two product ions and the ratios between the product ions (More details of 
the analytical method pertaining to each compound are in Appendix 15). 
Lower limits of quantification (LOQs) were determined by repeat injections (n=6) of 
the lowest detectable concentrations of the compounds. The LOQ was defined as 
three multiplied by three times the standard deviation (3) of the responses. The 
LOQs relating to the soil and plant matrices were based on the respective recoveries 
within each matrix (Appendix 16). 
6.2.4 Data analysis 
6.2.4.1 Soil degradation 
Concentrations of pharmaceuticals in soil and pore water were plotted against time 
of sampling. Where there was a significant difference in concentration to that 
measured at 0 d, three kinetic models were used to fit the data: a simple first order 
degradation kinetic (SFO; Equation 7) model, a first order multi-compartment model 
(FOMC; Equation 8) (Gustafson and Holden, 1990) and a bi-exponential first order 
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model (BFO; Equation 9) (FOCUS, 2006). Model parameters were optimized 
according to recommendations by FOCUS (FOCUS, 2006) using the least squares 
method with Microsoft® Excel Add-Inn Solver. 
Ct = C0*e-
kt
     
     
Equation 7 
Ct = C0 (1+βt)
-α
    
     
Equation 8 
Ct = Ct1+Ct2 = C01*e 
(-k1t) 
+ C02e*
(-k2t) 
     
Equation 9 
 
Where Ct is the concentration of pharmaceutical remaining in soil (μg/g) after t 
(days), C0 is the initial concentration of pharmaceutical (μg/g), k the rate of 
degradation (day
-1), β is the location parameter, α is a shape parameter determined by 
coefficient of variation k values. For Equation 9, Ct1 + Ct2 is the total amount of 
pharmaceutical applied at time, t = 0 (in two compartments), C01 and C02 are the 
amount of chemical applied to compartment 1 and 2 respectively and k1 and k2 are 
independent decay rate constants for compartments 1 and 2 respectively. Models 
used specific to each pharmaceutical, parameters and measurements to assess the 
goodness of fit for the optimised parameters are outlined in Appendix 18. For SFO 
and FOMC model fits the time it took for a 50 or 90 % decline in the concentration 
of the pharmaceutical (DT50, DT90) could then be calculated from the model fits 
(Appendix 18; Table 6.2). For BFO models no analytical solution exists to calculate 
degradation end points. 
6.2.4.2 Uptake factors 
Measured concentrations for each of the pharmaceuticals taken up by the radish and 
ryegrass were used to calculate soil and pore water-based uptake factors (UFs). UFs 
were derived using concentrations in the soil, pore water and plant material 
(Equation 10, Equation 11, Equation 12). 
 
s
p
soil
C
C
UF       
Equation 10 
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d
soil
 waterpore
K
UF
UF     
     
Equation 11 
pw
s
d
C
C
K      
     
Equation 12 
Where UFsoil is the soil-based UF, UFpore water is the soil pore water-based UF, Cp is the 
concentration in plant material, Cs is the concentration in soil, Cpw is the 
concentration in the pore water and Kd is the average soil sorption coefficient for 
each pharmaceutical calculated across seven sampling points in the fate study (Table 
6.2). 
6.2.5 Statistical analysis 
Statistical analysis of the data was performed using SigmaPlot (v .11). A one-way 
ANOVA (significance level 0.05) was employed to assess differences in plant 
biomass (dry weight) between plants grown under treated soil and controls. 
Additionally, a one-way ANOVA was employed to assess any differences in 
concentration of the pharmaceuticals in the soil and pore water over 40 d exposures, 
with additional comparisons between sampling points assessed by Holm-Sidak pair-
wise comparison. Prior to all tests, normal distribution and equal variance were 
tested by performing a Shapiro–Wilk and Levene–Mediane test, respectively. 
6.3 Results and Discussion  
6.3.1 Fate study 
Over 40 d average Kd values ranged from 0.99 to 121.88 L/kg and increased in the 
order of sulfamethazine < carbamazepine < fluoxetine < diclofenac < propranolol < 
triclosan (Table 6.2). Some of the study compounds persisted in the soil throughout 
the 40 d uptake period whilst others were readily dissipated (Figure 6.3; Table 6.2). 
There was no significant difference between measured concentrations at 0 d and 40 d 
for carbamazepine (p = 0.026), fluoxetine (p = 0.162) and propranolol (p = 0.757). 
Triclosan dissipated from the soil after 14 d (p = 0.004).   
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Figure 6.3 Average measured soil (closed points) and pore water (open points) concentrations during fate study 
(40 d) for test pharmaceuticals; carbamazepine (A), diclofenac (B), fluoxetine (C), propranolol (D), 
sulfamethazine (E) and triclosan (F). Best model fit provided by dashed line for soil and a solid line for pore 
water where necessary and error bars represent standard error of mean (n = 3). 
 
Concentrations of diclofenac (p = 0.032) and sulfamethazine (p = 0.013) 
significantly decreased after 1 d and were undetectable after 3 d. The dissipation of 
these three compounds was fast (0.06 – 1.4 d-1; Table 6.2); compounds followed 
single first order kinetics and corresponding DT50 values were 0.5 d, 0.99 d and 
11.55 d for diclofenac, sulfamethazine and triclosan respectively. The persistent 
nature of carbamazepine is consistent with previous findings in this thesis (Chapter 
2) and previous research (Kinney et al., 2006; Monteiro and Boxall, 2009; Williams 
et al., 2006). The observed degradation of triclosan is also consistent with previous 
research which has suggested a half-life of 18 days (Ying et al., 2007). Results 
A B 
C D 
E F 
Chapter 6                                                   Fate and Uptake of Pharmaceuticals in Soil – Plant Systems 
148 
 
presented in this study show that in less than 40 days; only 10 % of the applied 
triclosan remained in the soil (Table 6.2) which has been previously reported to 
transform to methyl triclosan (Butler et al., 2012; Waria et al., 2011). Previous fate 
studies have also shown that diclofenac is not persistent and readily biodegradable 
from soils as a result of chemical mineralisation (Al-Rajab et al., 2010; Dalkmann et 
al., 2012) The half-life observed in this study (0.5 d) is therefore comparable to 
previous findings of < 5 d(Al-Rajab et al., 2010) and considerably faster than 
observations by Xu et al., (2009c) who reported DT50’s ranging from 3.1 d (loamy 
sand) to 20.4 d (silty loam) (Table 6.2). 
Even though diclofenac and sulfamethazine were not detectable in whole soil 
extracts after 3 d, detectable concentrations of these chemicals in the pore water were 
seen for the full duration of the fate study (Figure 6.3). By 40 d, concentrations of all 
test chemicals remaining in the pore water decreased in the order carbamazepine > 
fluoxetine > sulfamethazine > propranolol > triclosan > diclofenac (Figure 6.3).With 
the exception of sulfamethazine on 0 d, carbamazepine concentrations were 
consistently the highest in the pore water (1321– 3129 µg/L) over 40 d (Figure 6.3). 
Sulfamethazine concentrations were initially high (2932 – 6502 µg/L) however after 
1 d, concentrations dropped to 832 – 2683 µg/L after which they decreased at a 
slower rate. Unlike soil dissipation, pore water dissipation did not follow first order 
kinetics. The models that described pore water dissipation better included first order 
multi-compartment model (FOMC; Equation 8) (Gustafson and Holden, 1990) and a 
bi-exponential first order model (BFO; Equation 9) (Table 6.2). Pore water 
concentrations decreased significantly in the diclofenac (p = 0.016) and 
sulfamethazine studies  (p = < 0.001) resulting in DT50’s < 20 d (Table 6.2) in 
comparison to DT50’s for the remaining compounds of > 40 d. Whilst triclosan 
dissipated rapidly from the soil, pore water concentrations were not significantly 
different at any of the sampling points over 40 d (p = 0.266). 
 
  
 
Table 6.2 Summary statistics from soil and pore water dissipation modelling (more detailed table including model fit provided in Appendix 18). 
 
* No significant difference between 0 d and 40 d measured concentrations therefore data was not modelled to determine degradation rates. 
  Pore water Soil 
Pharmaceutical Model DT50 (d) DT90 (d) Rate 
constants 
 r
2
 Model DT50 (d) DT90 (d) Rate 
constants 
r
2
 
Carbamazepine * > 40  > 40   * > 40  > 40   
Diclofenac FOMC 19.65 2.57E+0
3 
α = 0.79, β 
= 0.34 
0.88 SFO 0.50 1.64 (1.4) 0.99 
Fluoxetine * > 40  > 40   * > 40  > 40   
Propranolol * > 40  > 40   * > 40 > 40   
Sulfamethazine BFO   C01 = 91, 
C02 = 9, k1 
=0.85, k2 = 
0.017 
0.99 SFO 0.99 3.29 (0.7) 0.99 
Triclosan * > 40 > 40   SFO 11.55 38.38 (0.06) 0.97 
1
4
9
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6.3.2 Plant uptake 
Plants contain ion channels and enzymes which could also be potentially targeted by 
pharmaceuticals and may initiate a response such as inhibition in the transport of 
essential elements required for plant growth for example (Williams and Cook, 2007). 
Previous research has highlighted the potential for pharmaceuticals to induce toxic 
effects on plants (Kong et al., 2007). Dose response relationships with plants grown 
under triclosan treatment have been noted starting at 0.44 mg/L in hydroponic 
studies (Herklotz et al., 2010) and low observed effect concentrations (LOECs) seen 
at 0.74 mg/kg after plant growth in quartz sand (Reiss et al., 2009). In this study, 
however, no observed effect on plant growth was noted for any of the treatments in 
comparison to the controls (p = 0.08 – 0.966) for both radish and ryegrass, probably 
due to the more realistic exposure concentrations that were used (Figure 6.5). This is 
in support of previous research where concentrations of carbamazepine in root tissue 
ranging between 202 µg/kg - 426 µg/kg yielded no observed effect on ryegrass aerial 
plant growth (Winker et al., 2010) (Figure 6.4). 
 
Figure 6.4 Percentage growth of control for ryegrass as a result of pharmaceutical treatment (fluoxetine [FLX], 
diclofenac [DCF], carbamazepine [CBZ], triclosan [TCS], sulfamethazine [SMZ], propranolol [PRL]). Average 
value provided with error bars representing standard deviation, based on dry weight of plant material (n = 6).
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Figure 6.5 Percentage growth of control for radish leaf (A) and bulb (B) as a result of pharmaceutical treatment 
(fluoxetine [FLX], diclofenac [DCF], carbamazepine [CBZ], triclosan [TCS], sulfamethazine [SMZ], propranolol 
[PRL]). Average value provided with error bars representing standard deviation, based on dry weight of plant 
material (n = 6). 
 
Five of the six test chemicals were taken up in detectable quantities into radish and 
ryegrass (Table 6.3; Figure 6.6). The degree of uptake varied across pharmaceuticals 
and plant species. With the exception of propranolol, greater uptake into radish was 
seen, after combining the concentrations in the bulb and leafy parts, compared to 
ryegrass. For both radish and ryegrass, carbamazepine was taken up the greatest 
extent with measured concentrations up to 52 µg/g in the radish leaf. Whilst 
sulfamethazine was taken up by both plants, concentrations were consistently below 
the LOQ. Therefore both radish leaf and radish bulb accumulated chemicals in the 
order of carbamazepine > triclosan > diclofenac > propranolol > fluoxetine > 
sulfamethazine whereas chemicals accumulated in the ryegrass in the order of 
carbamazepine > propranolol > triclosan > fluoxetine > diclofenac > sulfamethazine 
(Figure 6.6). 
A 
B 
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In the propranolol exposure, there was very high uptake into the ryegrass but this 
was not mirrored in the radish leaf where concentrations were some 16 times less 
(Figure 6.6). This was also true for triclosan, although to a lesser extent. For the 
remaining pharmaceuticals, concentrations in the radish leaf and ryegrass were 
generally similar. 
Greater fluoxetine uptake into the roots was observed in this study (170 ng/g) in 
comparison to previous research where fluoxetine root concentrations were < 22.2 ± 
5.3 ng/g (Wu et al., 2010). The previous study involved fluoxetine application via 
biosolids and the effect of soil properties on uptake also must be considered. The 
amended soil concentration in the Wu et al., (2010) study was lower (0.07 mg/kg) 
than the current study whereas in an earlier study Redshaw and colleagues saw 
fluoxetine uptake by Brassicaceae tissue cultures from a hydroponic set-up 
comparable to the results from our study at 0.26 - 0.49 µg/g (Redshaw et al., 2008b). 
  
 
Table 6.3 Average soil concentrations measured at the end of the experiment from soils collected from the plant pots, soil – water partition distribution coefficients (Kd) values  calculated 
during fate study, measured plant concentrations (± standard deviation, n = 6), and calculated  uptake factors (UF) for ryegrass, radish bulb and leaf.  
 Radish soil 
(µg /g) 
Ryegrass 
soil (µg/g) 
Soil Kd 
(average 
21 d) 
Ryegrass 
conc. 
(µg/g) 
Radish 
leaf 
conc. 
(µg/g) 
Radish 
bulb 
conc. 
(µg/g) 
Ryegrass 
UFsoil 
Radish 
leaf UFsoil 
Radish 
bulb UFsoil 
Ryegrass 
UFpore 
water 
Radish 
leaf 
UFpore 
water 
Radish 
bulb 
UFpore 
water 
Carbamazepine 0.71 ± 0.1 0.46 ± 0.2 7.85 ± 
1.5 
30.23 ± 
2.8 
43.02 ± 
9.3 
5.88 ± 
0.4 
65.26 60.59 8.28 
8.31 7.71 1.05 
Diclofenac 0.07 ± 0.04 0.05 ± 0.02 12.40 ± 
8.3 
0.33 ± 
0.1 
0.79 ± 
0.3 
0.37 ± 
0.02 
6.82 11.53 5.39 
0.55 0.93 0.43 
Fluoxetine 0.47 ± 0.08 0.55 ± 0.03 8.39 ± 
4.2 
0.04 ± 
0.01 
0.04 ± 
0.02 
0.17 ± 
0.15 
0.08 0.10 0.36 
0.01 0.011 0.043 
Propranolol 0.16 ± 0.04 0.21 ± 0.04 79.44 ± 
29.8 
2.37 ± 
0.7 
0.14 ± 
0.1 
0.19 ± 
0.1 
11.04 0.91 1.20 
0.14 0.011 0.015 
Sulfamethazine < LOQ 0.01 ± 0.001 0.99 ± 
0.5 
< LOQ < LOQ < LOQ < LOQ < LOQ < LOQ 
< LOQ < LOQ < LOQ 
Triclosan 9.31 ± 0.85 0.05 ± 0.01 121.88 ± 
33.9 
2.00 ± 
0.5 
0.91 ± 
0.2 
1.13 ± 
0.64 
37.59 0.10 0.12 
0.31 0.0008 0.001 
1
5
3
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6.3.3 Uptake factors 
The greatest UFsoil values for the ryegrass, radish leaf and radish bulb were obtained 
in the carbamazepine treatments, with values of 65.26, 60.59 and 8.28, respectively 
(Table 6.3). Relatively small UFsoil values were found for fluoxetine (0.08 – 0.36) 
which can probably be accounted for by the high soil concentration remaining at the 
end of the experiment and the observed low uptake (Figure 6.3). Work by 
Karnjanapiboonwong et al., (2011) found greater triclosan UFs between the soil and 
the root in the pinto bean (Phaseolus vulgaris), which ranged between 9 -12, in 
comparison to UFsoil (0.12) and UFpore water (0.001) values generated in this study for 
the radish root. However in the ryegrass exposure the triclosan UFsoil is considerably 
larger in the present study at 37.6. 
Calculated UFpore water range between 0.01 – 8.31, 0.0008 – 7.71 and 0.001 – 1.05 for 
the ryegrass, radish leaf and radish bulb respectively (Table 6.3). Similar to UFsoil 
carbamazepine exposure resulted in the highest UFpore water in the ryegrass, radish leaf 
and radish bulb. Triclosan had the lowest UFpore water in the radish leaf (0.0008) and 
bulb (0.001) whereas fluoxetine had the lowest UFpore water in ryegrass (0.01). 
6.3.4 Potential factors influencing the uptake of pharmaceuticals 
Plant uptake is thought to be heavily dependent on the physico-chemical 
characteristics of the chemical, including the Henry’s Law constant, water solubility 
and octanol-water partition coefficient (Bacci et al., 1990; Briggs et al., 1983; Duarte 
Davidson and Jones, 1996; Trapp et al., 1990). Physico-chemical properties are 
important because they can describe whether a chemical is neutral or ionisable at 
environmentally relevant pH values. A clear distinction has been made between the 
plant uptake of neutral chemicals and chemicals which are ionised (electrically 
charged) and separate models exist to predict uptake of chemicals in both these 
forms (Trapp, 2004). However it is important to note the total concentration in a 
plant cell comprises neutral, ionic and complexed forms of  a compound (Trapp, 
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2004). In this study, carbamazepine was the only neutral chemical whereas the 
remaining pharmaceuticals were ionisable. 
For neutral chemicals, hydrophobicity (usually expressed as log Kow) has been 
postulated to be the most important property involved in the uptake of chemicals into 
a plant from the soil medium (Hellström, 2004) as the degree of uptake appears to be 
proportional to the octanol-water partition coefficient (Briggs et al., 1982; Paterson 
et al., 1994). Briggs et al., proposed that plant uptake of neutral chemicals can be 
represented by a Gaussian curve distribution where maximum translocation of 
chemicals can be seen at a log Kow, ~1.78 in comparison to particularly hydrophobic 
(high log Kow) and hydrophilic (low log Kow) chemicals which are taken up to a 
lesser extent.  
The high pore water concentrations in the carbamazepine exposure may have played 
a crucial role in the large amount of uptake observed. However the consistently high 
carbamazepine uptake into leafy parts of the plants (< 52 µg/g) can more likely be 
attributable to the log Kow of around 2 for this compound which is in the range of 
Kow values for which maximum translocation of neutral compounds is expected 
(Briggs et al., 1982). Greater carbamazepine concentrations were noted in the leaf 
material in comparison to the roots (Figure 6.6; Table 6.3) which is in agreement 
with previous research findings (Shenker et al., 2011; Winker et al., 2010; Wu et al., 
2010, 2012). It appears that the uptake of carbamazepine is passive and not restricted 
by root membranes. Carbamazepine has relatively low hydrophobicity and is mainly 
transported by mass flow from the roots and thus concentrates in the mature and 
older leaves (Shenker et al., 2011). 
Even though triclosan is slightly ionised at the test soil pH of 6.19 (1.2 %), most of 
the compound will be in the non-ionised form. The unionised molecule has a log Kow 
of 4.80 so the low observed uptake for triclosan can be also explained by the 
Gaussian distribution relating uptake to hydrophobicity (Briggs et al., 1982). Small 
radish UFpore water (0.0008 – 0.001) and UFsoil (0.10 – 0.12) values for triclosan uptake 
demonstrate that particularly hydrophobic chemicals are not taken up to a great 
extent in the plant material. 
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Figure 6.6 Total uptake of carbamazepine, diclofenac, fluoxetine, propranolol and triclosan into ryegrass (dark 
grey), radish leaf (grey) and radish bulb (white) after plants were grown from seed in pharmaceutically spiked 
soil for 40 days. Average concentrations provided with error bars representing the standard error (n = 6). 
Sulfamethazine uptake was below LOQ.  
 
Similar to triclosan, only a small proportion of sulfamethazine (5.8 %) would be in 
the ionised form at the pH of the study soil. Based on the Gaussian distribution 
(Briggs et al., 1982), the neutral form of sulfamethazine (log Kow of 0.9) would not 
be expected to enter the root system - it is therefore not surprising that concentrations 
of sulfamethazine were below the LOQ and that UFs could not be calculated. The 
complete dissipation from the soil by 3 d may have also contributed to the 
unquantifiable sulfamethazine uptake (Figure 6.3). 
Diclofenac, fluoxetine and propranolol are expected to be extensively ionised in the 
test soil (> 99 %). Previous research demonstrates that plant uptake of the 
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dissociated species of an ionisable compound is lower compared to the unionised 
species (Briggs, 1981; Trapp, 2000). As demonstrated in Figure 6.6 there were up to 
600 times less uptake of diclofenac, fluoxetine and propranolol in the ryegrass in 
comparison to the neutral pharmaceutical, carbamazepine. Specifically for 
diclofenac, the large ionisation combined with the results from the fate study which 
show extensive dissipation from both the soil and pore water, and low measured 
concentrations can probably explain the minimal uptake of diclofenac into the radish 
and ryegrass. 
Previous research findings demonstrate that some pharmaceuticals have a tendency 
to accumulate in the roots with the roots acting as a sink for hydrophobic neutral 
compounds (Herklotz et al., 2010; Wu et al., 2010). In general, organic chemicals 
with log Kow > 4 are expected to have high potential for root retention and low 
translocation capacity (Duarte Davidson and Jones, 1996). Even though diclofenac 
and fluoxetine have log Kow > 4 (Table 6.1), this is in their unionised form. As both 
diclofenac and fluoxetine are extensively ionised at test soil pH log Kow is not 
applicable and thus cannot explain plant uptake. However log Dow (pH corrected log 
Kow) could be a better descriptor for ionised chemicals as our results show a general 
increase in log Dow corresponds to an increase in UFpore water and UFsoil. For example 
fluoxetine and propranolol have low log Dow values (Table 6.1) and smaller UFpore 
water (< 0.14) than diclofenac (UFporewater < 0.93) at log Dow 2.3. 
Similar to other studies, our results found differences in uptake between the two crop 
species (Boxall et al., 2006; Wu et al., 2012). Differences may be resultant of factors 
such as degree of root growth, transpiration rates and the size and shape of the leaf 
material. Differences in plant lipid contents may also be important as this can affect 
the affect the sorption of hydrophobic chemicals (Bromilow and Chamberlain, 1995; 
Orita, 2012). The reported lipid content of perennial ryegrass ranges between 2 – 4 
% (Mir et al., 2006). Whereas radish bulbs only contain trace amounts of lipid which 
may explain the lower observed uptake of carbamazepine, diclofenac and 
propranolol in the radish (Figure 6.6). 
Based on the results presented, the factors which affect the uptake of 
pharmaceuticals into plants include physico-chemical properties of the 
pharmaceuticals, species type including lipid content and distribution between above 
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and below ground plant. Additional research has also demonstrated that soil 
properties can also affect plant uptake (Chiou et al., 2001; Harris and Sans, 1967; 
Topp et al., 1986) and therefore to conclude, the uptake of chemicals into plants is a 
complex process governed by a combination of soil, plant and chemical factors. 
However on the whole, the uptake behaviour observed in this study makes sense 
based on the knowledge from previous research. 
6.4 Conclusions 
Radish and ryegrass can take up a variety of pharmaceuticals and personal care 
products from spiked soil. Using a combination of fate study and plant uptake data it 
is clear that relationships between plant uptake and the available fraction of the 
chemical are key. Whilst a chemical may have a log Kow which fits within the 
Gaussian distribution correlating with a high propensity for uptake, this clearly is not 
the only property influencing uptake into plants. The ionisable state of the chemical 
together with its potential for degradation may result in diminishing concentrations 
in the soil matrix. The fraction available for uptake may therefore be very small and, 
correspondingly, the measured concentrations in the plant material will also be 
minimal. Interestingly, fate studies data show that whilst a chemical may dissipate 
from the soil it can still remain in the pore water. This may hold wider implications 
for risk assessment and screening techniques as chemicals present in the pore water 
may still be bioavaible for uptake into a organism. 
The results presented in this Chapter demonstrate that, in some circumstances, 
uptake and distribution of pharmaceuticals in a plant can be related to 
hydrophobicity and ionisation of the molecule, (Kow), and generally followed a 
Gaussian distribution, although this is not always the case. The results presented here 
would suggest that there are different drivers responsible for the uptake between 
different plant species. It is instructive to note that pharmaceuticals are 
predominantly ionisable organic chemicals, and in contrast to neutral organics, this is 
a characteristic that is likely to affect their partitioning behaviour in terms of 
bioavailability, plant uptake and molecular interaction with soil matrices of variable 
pH. It therefore may be important to question previous assumptions on plant uptake 
and specific models may be required to accurately predict plant uptake which 
Chapter 6                                                   Fate and Uptake of Pharmaceuticals in Soil – Plant Systems 
159 
 
account for species differences, distribution of chemicals in the plant, chemical 
properties and the fate of the pharmaceutical in different soil matrices. 
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Chapter 7 Discussion 
7.1 General discussion and recommendations 
In recent decades a great deal of work has been undertaken concerning the fate and 
effects of pharmaceuticals in the environment. Whilst the aquatic environment has 
been comprehensively explored with regards to the presence, fate, uptake and effects 
of pharmaceuticals, the terrestrial environment has not yet been studied to the same 
extent. A large proportion of research in the soil compartment has focused on the 
development of extraction techniques combined with the improvement of 
appropriate analytical methods to determine the concentrations of pharmaceuticals in 
soil matrices. Several studies have also investigated the fate of pharmaceuticals in 
soils through sorption, leaching and degradation experiments. While research has 
also looked at the uptake pharmaceuticals, particularly of veterinary origin into crop 
species, fewer studies exist concerning the uptake of pharmaceuticals into soil 
dwelling organisms such as earthworms. As the detection of pharmaceuticals in the 
soil environment has been documented, the presence of pharmaceuticals may pose a 
risk to soil inhabiting species and thus studies exploring the factors and processes 
affecting uptake from soils is warrented.  
Studying the uptake of pharmaceuticals in the soil environment is important because 
uptake into soil dwelling species particularly at the base of the food web has the 
potential for bioaccumulation through the food chain and far wider reaching effects 
to be seen. One such example of the wider implications of pharmaceutical residues in 
the environment was the rapid decline in vulture populations in the Indian sub-
continent (Oaks et al., 2004). Experimental evidence indicates that the casual factor 
of this decline is the consumption of meat by these scavenging birds from cattle 
carcasses containing high levels of the non-steroidal anti-inflammatory drug 
diclofenac (Green et al., 2007, 2006; Oaks et al., 2004). Uptake into vegetable crops 
also presents a potential human risk via the consumption of contaminated crops. The 
present studies were therefore initiated to explore the factors and processes which 
affect the uptake of pharmaceuticals into terrestrial species. The studies presented in 
this thesis primarily focussed on the uptake of pharmaceuticals into earthworms. 
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However additional studies were also performed to assess uptake into plants. 
Laboratory studies evaluated the relationship between uptake; and soil parameters 
(e.g. organic matter, soil pH); pharmaceutical physico-chemical properties (e.g. pKa, 
log Kow); and species traits. A summary of data generated from the experiments 
detailed in this thesis can be found in Table 7.1. 
Initial studies demonstrated that the pharmaceuticals, carbamazepine, diclofenac, 
fluoxetine and orlistat are taken up by earthworms, Eisenia fetida (Chapter 2). Pore 
water based bioconcentration factors ranged between 2.2 and 51.5 and increased in 
the order of carbamazepine < diclofenac < fluoxetine < orlistat. BCFs obtained in 
this study for earthworms were comparable to BCFs calculated in the aquatic 
environment for carbamazepine however considerably lower than previous research 
on aquatic invertebrates for fluoxetine (Meredith-Williams et al., 2012). Kinetic 
modelling demonstrated that pharmaceuticals were accumulated and eliminated to 
different extents in E. fetida depending on the pharmaceutical compound. Both 
carbamazepine and fluoxetine were taken up and eliminated the quickest and had 
reached near steady state in the organism after 21 days. Diclofenac and orlistat were 
accumulated at a much slower rate in the earthworm tissue and were not completely 
eliminated during the depuration phase. 
The next steps in the research were to look at additional factors affecting the uptake 
of pharmaceuticals in the terrestrial environment. However the studies carried out in 
Chapter 2 were highly labour intensive and to explore many factors using these 
methods would be challenging. Therefore, the use of a minimised approach was 
explored in Chapter 3. Research successfully demonstrated that the minimised 
design approach, previously introduced by Springer et al., (2008), is viable 
alternative approach to calculate BCFs in aquatic and terrestrial invertebrates without 
having to carry out full length experiments such as OECD test guidelines. For a 
single experiment, test organism usage would be reduced by > 70 % as well as a 
reduction in experimental material and labour efforts required. The approach was 
robust as steady state does not need to be achieved in the test system and BCFs were 
not affected by changes in exposure medium concentration. One of the most 
significant findings is that the minimised design appears to work well across a range 
of species (including both terrestrial and aquatic), chemicals and different exposure 
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mediums offering a suitable alternative for BCF calculation in variety of 
environmental chemical exposure scenarios. 
Using the minimised design, further research (Chapter 4) went on to establish that 
soil properties can also affect BCF calculations for pharmaceutical exposures in E. 
fetida. The largest differences in pore water based BCFs between the five soil types 
were observed in the diclofenac and orlistat studies with BCFs ranging between 7.02 
- 69.57 and 30.51 - 115.92 respectively. Little deviation in BCF values was found 
between the soil types in the fluoxetine exposure (16.78 – 20.42) and the 
carbamazepine exposure (1.05 – 1.61). Largest BCFs obtained for each 
pharmaceutical were obtained in different soil types and no pattern of uptake 
corresponding to particular soil types was observed. Similarly, no relationships 
between soil pH, pore water pH, organic carbon content and pore water based BCFs 
were found, demonstrating that no single parameter can explain pharmaceutical 
uptake into earthworms. Numerous factors and processes appear to be governing the 
rate and amount of pharmaceutical uptake into earthworms. 
Consistent with previous research findings which have demonstrated species traits 
are important in determining chemical uptake in organisms (Kelsey et al., 2005) 
differences in BCFs between E. fetida and the larger earthworm, Lumbricus 
terrestris were observed in Chapter 5. However contrary to previous research 
findings which observed larger BCFs for the smaller earthworm E. fetida, 
carbamazepine, diclofenac and fluoxetine accumulated to a greater extent in this 
experiment and resulted in larger L. terrestris BCFs. Conversely, in the orlistat 
study, BCFs were 50 % smaller in L. terrestris than in E. fetida. Disparities in uptake 
between the two species may be a result of varying lipid contents, differences in 
burrowing behaviour in the soil or species size. 
Species differences governing the uptake of pharmaceuticals were also observed in 
plant experiments (Chapter 6). Certain pharmaceuticals accumulated to a greater 
extent in the radish roots (fluoxetine) in comparison to the leaf material 
(carbamazepine). Variations in uptake factors were also observed for the same 
chemical in the radish leaf and ryegrass. Differences in lipid content of the plant 
species or hydrophobicity (log Kow /log Dow) of the chemical are likely to be 
affecting the degree of uptake in the plant leaf and below ground root material. 
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The research presented in this thesis generated knowledge on the fate of 
pharmaceuticals in the soil environment, looking at the distribution of 
pharmaceuticals between the soil and pore water. It appears the fate of 
pharmaceuticals, similarly to the uptake of pharmaceuticals, is dependent both on 
pharmaceutical physico-chemical properties and soil parameters. Concentrations of 
pharmaceuticals in the soil and pore water changed over time. Larger decreases in 
soil concentration were observed for diclofenac in comparison to the more persistent 
pharmaceuticals such as carbamazepine in a range of soil types (Chapter 4). 
Similarly to soil, pharmaceutical pore water concentrations generally decreased over 
time, however interestingly in the initial earthworm studies (Chapter 2) fluoxetine 
increased in concentration. Through combustion of the exposure soils from the 
earthworm studies (Chapters 2 and 4) research established the formation of 
irreversibly bound residues of diclofenac and orlistat in a range of soil types. The 
degree of formation of non-extractable residues (NERs) was dependent on soil type 
and pharmaceutical compound (2.4.3.4).  
The fate of a pharmaceutical in soil is important with regards to controlling any 
potential uptake into terrestrial species. The distribution of the pharmaceutical 
between the soil and pore water can regulate the bioavailable fraction for uptake. For 
example, in the plant study (Chapter 6) triclosan rapidly dissipated from the soil 
however remained fairly persistent in the pore water throughout the length of the 
study. Therefore if soil was sampled to check for pharmaceutical residues initial 
indications would suggest that there is no chemical present for uptake. However as 
the pore water fraction facilitates uptake into both into plants and earthworms 
pharmaceuticals may well accumulate in these organisms.  
The experimental research presented in this thesis demonstrates that the uptake of 
pharmaceuticals into terrestrial species is a complex interaction of pharmaceutical 
physico-chemical properties, soil parameters and species traits. The fate and 
distribution of the pharmaceutical between the soil and pore water can also regulate 
the bioavailable fraction of the pharmaceuticals which has been shown to change 
between soil types. 
  
 
Table 7.1 Summary of bioconcentration factor and fate data for test pharmaceuticals obtained in experimental chapters.  
  Chapter Species Fate in soil Fate in pore water 
Pore water 
based BCF / 
UF 
Soil based 
BSAF / UF 
Carbamazepine 
2 E. fetida Persistent Slight dissipation 2.21 Not calculated 
4 E. fetida Persistent in all soil types Slight dissipation all soil types (< 10 %) 1.05 - 1.61 0.36 - 0.97 
5 L. terrestris Persistent Slight dissipation 6.69 Not calculated 
6 Radish leaf Persistent Fairly persistent 7.71 60.59 
6 Radish bulb Persistent Fairly persistent 1.05 8.28 
6 Ryegrass Persistent Fairly persistent 8.31 65.26 
Diclofenac 
2 E. fetida Dissipation and formation of NERs Relatively constant 21.5 Not calculated 
4 E. fetida Dissipation and formation of NERs Fairly persistent, soil 2.1 dissipation 7.02 - 69.57 1.01 - 12.36 
5 L. terrestris Dissipation and formation of NERs Relatively constant 83.79 Not calculated 
6 Radish leaf Complete dissipation (< 3d) Rapid dissipation but traces remain at end 0.93 11.53 
6 Radish bulb Complete dissipation (< 3d) Rapid dissipation but traces remain at end 0.43 5.39 
6 Ryegrass Complete dissipation (< 3d) Rapid dissipation but traces remain at end 0.55 6.82 
Fluoxetine 
2 E. fetida Persistent Increase in concentration 30.8 Not calculated 
4 E. fetida Persistent in all soil types Fairly persistent 16.78 - 20.42 0.19 - 0.37 
5 L. terrestris Fairly persistent Relatively constant 66.9 Not calculated 
6 Radish leaf Fairly persistent Fairly persistent 0.011 0.1 
6 Radish bulb Fairly persistent Fairly persistent 0.043 0.36 
6 Ryegrass Fairly persistent Fairly persistent 0.01 0.08 
 
  
  
 
Table 7.1 Summary of bioconcentration factor and fate data for test pharmaceuticals obtained in experimental chapters continued. 
  Chapter Species Fate in soil Fate in pore water 
Pore water 
based BCF / 
UF 
Soil based 
BSAF / UF 
Propranolol 
6 Radish leaf Fairly persistent Fairly persistent 0.011 0.91 
6 Radish bulb Fairly persistent Fairly persistent 0.015 1.2 
6 Ryegrass Fairly persistent Fairly persistent 0.14 11.04 
Sulfamethazine 
6 Radish leaf Complete dissipation (< 3d) Rapid dissipation but traces remain at end < LOQ < LOQ 
6 Radish bulb Complete dissipation (< 3d) Rapid dissipation but traces remain at end < LOQ < LOQ 
6 Ryegrass Complete dissipation (< 3d) Rapid dissipation but traces remain at end < LOQ < LOQ 
Triclosan 
6 Radish leaf Rapid dissipation Persistent 0.0008 0.1 
6 Radish bulb Rapid dissipation Persistent 0.001 0.12 
6 Ryegrass Rapid dissipation Persistent 0.31 37.59 
Orlistat 
2 E. fetida 
Slight dissipation (< 20 %) and 
formation of NERs 
Slight dissipation 51.5 Not calculated 
4 E. fetida 
Slight dissipation (< 20 %)and 
formation of NERs 
Some dissipation (< 30 %) 30.51 - 115.92 0.48 - 1.54 
5 L. terrestris 
Slight dissipation and formation of 
NERs 
Slight dissipation 33.21 Not calculated 
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7.1.1 Wider implications of research findings 
The research presented in this thesis demonstrates that pharmaceuticals can be taken 
up by, and accumulate in, earthworms and plants from soil contaminated with 
pharmaceutical residues. The potential for this to cause secondary poisoning in 
higher tier predators or to present a risk to humans is evaluated in the sections below. 
7.1.1.1 Risks of secondary poisoning 
As pharmaceuticals can be taken up by earthworms this may present a risk to birds 
which feed on them. The predicted environmental concentration (PEC) in a worm 
was calculated using results obtained in Chapter 2 to estimate the potential for 
secondary poisoning. For this analysis a starling was used as a representative bird 
species which eats approximately 30 g of invertebrates per day (Markman et al., 
2008). By extrapolating a human threshold value, calculated from the maximum 
therapeutic dosage for a human, a threshold value for the starling was computed. The 
daily dose is between 1.02 and 9.97 ng depending on the compound (Table 7.2). The 
results would infer the risk to be minimal for all of the pharmaceutical compounds as 
a starling would have to eat thousands of worms to reach the threshold dose, 
however these calculations should be used with caution as they involve a 
considerable amount of estimation and extrapolation. The compound with most risk 
is fluoxetine as 8000 worms would have to be eaten instead of over 250 000 to 
receive a greater than predicted threshold dose for carbamazepine. 
Currently the risk of secondary poisoning to birds is minimal based on the BCF 
values obtained in this study, however further calculations involving less 
extrapolation and estimation would confirm these findings 
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Table 7.2 The risks of secondary poisoning to a starling, evaluated by consumption of worms containing 
predicted environmental concentrations of pharmaceuticals used in this study. The daily dose (DD) to a bird is 
compared to the threshold dose to provide the margins of exposure. 
a
 PEC is the predicted environmental concentration in the worm and calculated from 
the TGD Part 2 where the total concentration in the worm = PECworm 
b
 Markham et al., 2008 – 30 g wet weight of invertebrates eaten per day for startlings 
(Markman et al., 2008). 
 
 
7.1.1.2 Human exposure 
Uptake into plants, especially edible crops, may represent an important exposure 
pathway of these chemicals into the food chain and thus present a risk to humans and 
livestock which feed on them (Boxall et al., 2006; Sridhara Chary et al., 2008; 
Zhang et al., 2007; Zohair et al., 2006). An acceptable daily intake (ADI) value can 
be used calculate the amount of a substance, for example pharmaceuticals, which can 
be consumed by a human without resulting in appreciable risk to health. For a full 
explanation of calculated methods to determine the risk to humans from consuming 
contaminated crops from results in the present study see Appendix 19.  
Results show that if all crops consumed were grown in soil containing the selected 
pharmaceuticals then humans would not consume levels greater than the ADI for any 
Pharmaceutical  PEC 
(mg/kg 
wwt 
worm
-1
) 
a 
 
Daily food 
consumption 
(g)
b
 
DD to 
bird 
(mg/bird/ 
day)  
Threshold 
dose for 
bird 
(mg/day)  
Margin of 
exposure  
Carbamazepine  0.0228 30 6.86 E-06 1.83 266 225 
Diclofenac  0.0278 30 8.34 E-06 0.11 13 699 
Fluoxetine  0.0339 30 1.02 E-05 0.09 8 979 
Orlistat  0.0326 30 9.79 E-06 0.14 14 007 
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of the pharmaceuticals in this study (Table 7.3). It should also be noted that all crops 
eaten must be grown in the contaminated soil as our analysis assumed ryegrass and 
radish bulb to be representative of all above and below ground crops consumed, 
which is not currently the case. A safety factor of 100 was also applied to the 
minimum therapeutic dose to calculate the ADI and for a large proportion of the 
population this is not needed which would make the actual ADI higher than the 
current threshold. 
Table 7.3 Results from a comparison of acceptable daily intake (ADI) values for study chemicals and theoretical 
crop concentration (based on measured soil concentrations and UFsoil calculated in this study) shown as a 
percentage of ADI. With exception of sulfamethazine as plant concentrations were below LOQ. Ryegrass was 
used as a representative above ground crop species and radish as a representative below ground crop species.  
  Ryegrass Radish 
 Soil
a
 
(mg/kg) 
% of ADI in 
359.5 g crop 
% of ADI 
in 159 g 
crop 
Carbamazepine 0.0065 3.81 0.21 
Diclofenac 0.00054 0.18 0.06 
Fluoxetine 0.0067 0.09 0.19 
Propranolol 0.0004 0.20 0.01 
Triclosan 0.019 83.80 0.12 
a =Duran-Alvarez, 2009; Dalkmann et al., 2012; Vazquez -Roig et al., 2012 
 
To date the health risks from pharmaceuticals in drinking water have been reviewed 
and several papers have also computed levels in crops fit for human consumption 
(Boxall et al., 2006; Bruce et al., 2010; Schwab et al., 2005). For fluoxetine, a 
comparison of measured concentrations in drinking water and predicted no effect 
concentrations in children yielded a ratio of 2.8 x 10
-4
 which would infer the risk to 
humans drinking water contaminated with fluoxetine would be minimal. Indeed, for 
all pharmaceuticals evaluated, approximate margins of safety for potential exposures 
ranged from 30 – 38 000 (Schwab et al., 2005). Presently, the risk to humans in 
terms of contaminated crops is therefore similar to drinking water exposures, in that 
it is very low. 
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However an important note for the future is with the growing demand for alternative 
irrigation resources in water stressed regions and projected increases in the 
application of sewage sludge on land, pharmaceutical loadings in soil will inevitably 
increase. The threat posed by pharmaceuticals taken up into crops may therefore be 
of more concern in the future than based on current exposure levels. 
7.1.1.3 Risk assessment 
Bioconcentration factors are important in the risk assessment of chemicals in the 
environment as they can be compared to threshold values to determine if there is a 
potential risk. The research presented in this thesis demonstrates that further 
refinement of previously accepted BCF estimation techniques, such as quantative 
structure relationships (QSARs), are needed for earthworm pharmaceutical exposure.  
Work by Belfroid et al., (1993) and Jager (1998) both utilise log Kow as the primary 
determinant in calculating BCFs however results show both estimation techniques 
consistently overestimated the pore water BCFs calculated in this study for 
diclofenac, fluoxetine and orlistat. For orlistat estimated BCFs were some 6000 
times greater than obtained in this research (Chapter 2). This may be explained by 
the fact these QSAR’s were not specifically designed for pharmaceutical exposures 
and highly lipophilic compounds; for example the work by Belfroid et al., (1993) has 
a limited log Kow window of 4.2 – 5.7 (which was later extrapolated from 2 -7) and 
was based on a water only exposure scenario. The results suggest that the uptake of 
highly hydrophobic compounds such as orlistat do not scale according to log Kow, 
implying a cut off point for a linear relationship between Kow and BCF above which 
increasing log Kow value does not appear to correlate with elevated bioconcentration. 
There is therefore a need to improve the accuracy and applicability of currently 
available QSARs and models for the prediction of earthworm BCFs whereby 
parameters other than log Kow are utilised to estimate pharmaceutical uptake. New 
models would need to account for physico-chemical properties (including potential 
ionisation), soil parameters (important in governing the fate of pharmaceuticals) and 
species traits, all of which have been shown to affect earthworm uptake. Similarly, 
results from Chapter 6 suggest that plant uptake models need to take into account the 
Chapter 7                                                                                                                                  Discussion 
170 
 
ionisation state of the chemical and crop type, part of which has already been 
explored by Trapp (2000). 
Refining models to calculate accurate BCFs may however not be necessary for 
general risk assessment. BCFs computed in this study were generally low and all 
BSAF values were < 1. Based on the current environmental scenario the measured 
internal concentrations of all four pharmaceuticals in E. fetida present little risk in 
terms of the wider threat of bioaccumulation and secondary poisoning (section 
7.1.1.1). Similarly the results from the plant uptake study indicate that the present 
risk concerning of humans consuming food crops contaminated with pharmaceutical 
residues is very low (section 7.1.1.2). However with the projected increase in use 
and subsequent disposal of pharmaceuticals in the coming century this threat may 
develop into a more significant issue in the future and thus should be continually 
monitored and reassessed to account for the changing world we live in. 
Interestingly through analysis of the fate study data we observed that the presence of 
pharmaceuticals in the soil matrices can affect soil chemistry. Changes in soil and 
pore water pH were noted which appeared to be dependent on soil type and 
pharmaceutical properties. Significant differences were also found between the 
internal pH of E. fetida exposed to pharmaceuticals and the internal pH of control 
earthworms. These differences were also dependent on soil type and in some 
circumstances after an initial increase during the exposure phase the internal pH 
decreased back to pH measurements similar to the controls after exposure in the 
clean soil. Significant differences in internal worm pH measurements were also 
recorded in the L. terrestris study. These results hold far wider reaching implications 
in terms of risk assessment and modelling as currently no attempt to account for 
changes in pH during exposure to chemicals is made. This may be important for 
pharmaceuticals, as many of which are ionisable chemicals, and changing pH may 
alter the bioavailability of the chemicals in the environment. 
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7.2 Conclusions 
In conclusion, this thesis has demonstrated that that a combination of species traits, 
pharmaceutical physico-chemical properties and soil parameters are key to 
determining the uptake of pharmaceuticals from soil into terrestrial species. 
Currently used, generalised models for estimating earthworm BCFs are unable to 
adequately estimate the uptake of pharmaceuticals. Further refinement of these 
models is required, as it is necessary to account for these factors including species 
size, soil pH, log Kow and pore water bioavailability. 
It appears that pore water concentrations are important in regulating the amount of 
chemical available for uptake into earthworms. When comparing between the five 
soil types, greatest uptake into the earthworm, E. fetida occurred in the soil type 
which had the highest average pore water concentration throughout the uptake phase, 
and this was true for all four study chemicals. The closeness of the model fit to the 
measured earthworm data in Chapter 2 also supports the importance of pore water 
regulating the uptake of pharmaceuticals into earthworms, as the model was based 
on a pore water exposure only, and the contribution of uptake from ingestion of soil 
particles was ignored. Pore water concentrations have also previously been shown to 
be important for regulating the uptake of chemicals into plants.  
Whilst pharmaceuticals can be taken up by earthworms and plants from residues in 
the soil matrices the potential for bioaccumulation through the food chain currently 
appears to be minimal.  
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7.3 Recommendations for further research specific to this thesis 
The research presented in this thesis has generated novel information on the fate and 
uptake of pharmaceuticals in the terrestrial environment. However, it has also 
highlighted a number of additional research questions. In the future, work should 
consider the following aspects: 
1. In the current studies (Chapters 2, 4, 5), for modelling purposes and 
bioconcentration factor calculations, uptake was based on the diffusion of 
chemicals across earthworm skin via pore water exposure as demonstrated in 
the Jager et al., (2003) study. However it would be useful to understand the 
percentage of uptake from the gut, specifically as a result of pharmaceutical 
exposure, to refine model fits and to provide better uptake and 
bioconcentration estimates. A series of experiments could elucidate the main 
uptake pathways of pharmaceuticals.  
2. The research presented in this thesis has demonstrated different earthworm 
species (Eisenia fetida and Lumbricus terrestris) can affect uptake and 
bioconcentration factor estimates (Chapter 5). It would be useful to further 
understand the influence of species traits on the uptake of pharmaceuticals 
into soil organisms. A series of experiments could evaluate pharmaceutical 
uptake into additional species for example: 
 Organisms that primarily reside on the soil surface such as land snails 
(Helix pomatia) and slugs (Limax maximus), this would also provide 
an interesting comparison between species with and without a shell. 
 Soil dwelling organisms with an exoskeleton such as woodlice 
(Oniscus asellcus) to see if this restricts pharmaceutical uptake. 
 Nematode species to see if typically small and slender works (2.5 
mm) can also take up pharmaceutical residues in soils. 
3. Research from this thesis indicates some pharmaceuticals (diclofenac and 
orlistat) form irreversibly bound residues to the soil (Chapter 2). Experiments 
were unable to ascertain whether any uptake into E. fetida occurred from 
these non-extractable residues or if it was all from the soil and pore water. 
Additional research could explore this by exposing earthworms to soil 
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containing only non-extractable residues to investigate if these fractions can 
be taken up by earthworms. 
4. The two main pathways by which pharmaceuticals enter, and become 
omnipresent in the soil environment, are via the application of sewage sludge 
and use of wastewater effluent as an irrigation tool. Rather than adding the 
compound directly to the soil via stock solution spiking (as described in 
Chapter 2, 4 and 5) it would be interesting to instead spike irrigation water 
and sewage sludge with the pharmaceuticals and apply this to the soil. 
Uptake into plants via this indirect exposure route has previously been 
investigated (Wu et al., 2010) however uptake into soil dwelling organisms 
such as earthworms is an area which still needs exploring. Changing the 
application method may change the bioavailability of pharmaceuticals, rate of 
uptake into earthworms and subsequent bioconcentration factor calculations. 
A series of experiments have already demonstrated that the presence of 
sewage sludge has been shown to affect pharmaceutical fate and behaviour in 
soils (e.g. Monteiro, 2009).  
5. In terms of plant experiments, additional research could explore the risk to 
humans from pharmaceutical residues in vegetable crops in a stimulated gut 
bio-accessibility study. Evaluating this would provide better estimates as to 
the levels of pharmaceuticals that would be available and thus a risk to 
humans.  
6. The results in Chapter 3 demonstrated that the minimised design, originally 
proposed by Springer et al., 2008, is a suitable alternative to full length 
uptake and depuration studies to estimate bioconcentration factors. Whilst the 
results demonstrated this approach works well for both aquatic and terrestrial 
species, data could only be obtained for four compounds in the terrestrial 
environment. Therefore the generation of new data (additional species and 
compounds) to test the comparison between BCFminimised and BCFtraditional 
would be useful to fully validate this approach for use in terrestrial studies. 
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7.4 General recommendations for further research: 
1. To date, a majority of reseach has focussed on parent compounds and more 
research is required into the occurrence, fate, uptake and effects of 
metabolites and transformation products. Parent compounds can be altered in 
their chemical structure at various stages; in the human body after 
administration to a patient; during the STP process or once released into the 
environment. Also, more research is needed to explore the fate and uptake of 
mixtures of chemicals. Pharmaceuticals do not occur by themselves in the 
environment, other pharmaceuticals and pesticides amongst other chemicals 
may also be present and the interaction between these different chemicals 
may alter their behaviour in the environment.  
2. Human pharmaceuticals are prescribed and taken for a reason; they are 
designed to elicit an effect at a given concentration. In the terrestrial 
environment, little research has investigated the effects of pharmaceuticals on 
species. In comparison, several studies in the aquatic environment have 
observed effects in aquatic organisms (LOEC’s) (Cleuvers, 2003; Fent et al., 
2006; Ferrari et al., 2003; Skolness et al., 2012) such as reproductive failure 
in fish (Nash et al., 2004) and the feminisation of male fish (Jobling et al., 
2006, 1998; Sumpter and Johnson, 2008). We now know that 
pharmaceuticals are taken up by soil dwelling species such as earthworms 
and plants so research must now progress to evaluate any potential toxic 
effects.  
3. The use of reclaimed wastewater effluent for irrigation purposes and sewage 
sludge application to land is set to increase on a global scale and thus the 
loading of pharmaceuticals to the soil will subsequently increase. Projections 
for future concentrations of pharmaceuticals both in the soil and aquatic 
environment are needed to ascertain whether there may be problems as a 
result of this such as secondary poisoning, based on the results from current 
research. 
4. Further research is required to establish the effect of chemical residues on 
soil and aquatic chemistry. Research presented in the previous chapters 
demonstrated that the presence of pharmaceuticals in the soil can affect pore 
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water and soil pH. Other soil or water quality parameters may also be altered 
as a result of the presence of pharmaceuticals in the environment. This may 
change the bioavailability or fate of chemicals for example and therefore 
needs investigating. Results from this may hold wider implications in 
modelling scenarios for example where changes in pH are currently not 
accounted for.  
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Appendix 
Appendix 1 Eisenia fetida gut purge experiment 
A preliminary experiment was performed to assess how long earthworms, E. fetida, 
required purging their gut contents on moist filter paper to ensure that a majority of 
soil is removed from the gut before analysis. 
Methods: 
Earthworms, E. fetida, were incubated under test conditions (see section 2.3.3) for 72 
hours then removed from the soil, rinsed in deionised water and placed in individual 
petri dishes on moist filter paper. At various time sampling points (0, 4, 6, 8, 24, 30 
and 48 hour) earthworms were removed (six replicates) from the filter paper, 
weighed to the nearest 0.0001 g then dried in an oven for 24 – 48 hour at 60oC until 
no further change in weight loss was recorded. Dried earthworms were then re-
weighed before being placed in a muffle oven at 500
o
C for a minimum of four hours 
to burn off all the combustible parts of the earthworm (everything except the gut 
contents). The ash was then re-weighed and used to calculate the gut contents 
remaining in E. fetida at various stages of sampling. Below is is a figure of 
percentage of gut contents eliminated from Eisenia fetida after being removed from 
soil and placed on moist filter paper. Average value provided (± standard deviation). 
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Results: 
The amount of soil recovered in the earthworm samples over 24 hours decreased. 
After 24 hours of gut purge 77 % of the soil had been removed from the earthworm 
gut. At sampling 30 and 48 hours earthworms appeared to become distressed and 
started eating the filter paper. A gut purge of 24 hours was therefore chosen as an 
appropriate length of time, and measured concentrations pharmaceuticals in the 
earthworm samples were corrected for the 23 % of soil-associated pharmaceutical 
remaining in the gut in experiments detailed in Chapter 2 and Chapter 4. 
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Appendix 2 Literature search summary of known diclofenac metabolites and 
transformation products, including molecular weights provided (Huber et al., 2012; 
Kallio et al., 2010; Scheurell et al., 2009). 
Diclofenac metabolites 
/ transformation 
products Matrice 
Molecular 
weight 
(g/mol) Reference 
acyl glucuronide of 
diclofenac Fish bile 472.275 Kallio et al., 2010 
acyl glucuronide of 4'-
hydroxydiclofenac Fish bile 486.0364 Kallio et al., 2010 
acyl glucuronide of 5-
hydroxydiclofenac Fish bile 486.0364 Kallio et al., 2010 
ether glucuronide of 4'-
hydroxydiclofenac Fish bile 486.0364 Kallio et al., 2010 
sulfate conjugate of 4'-
hydroxydiclofenac Fish bile 389.9611 Kallio et al., 2010 
sulfate conjugate of 5-
hydroxydiclofenac Fish bile 389.9611 Kallio et al., 2010 
monosulfate conjugate 
of dihydroxydiclofenac Fish bile 405.9561 Kallio et al., 2010 
4'-hydroxydiclofenac 
Fish 
bile/effluent/rat 
liver/plants 312.15 
Kallio et al., 2010; Scheurell 
et al., 2009; Huber et al., 
2012; Stülten et al., 2008 
acyl-migrated isomers of 
acyl glucuronide of 3'-
hydroxydiclofenac Fish bile 486.0364 Kallio et al., 2010 
acyl-migrated isomers of 
acyl glucuronide of 
diclofenac Fish bile 470.0415 Kallio et al., 2010 
5-hydroxydiclofenac 
Fish bile/ 
Sewage effluent 312.15 
Scheurell et al., 2009; Kallio 
et al., 2010 
3′-Hydroxydiclofenac Effluent 312.148 Scheurell et al., 2009 
1-(2,6-Dichlorophenyl)-
1,3-dihydro-2H-indole-
2-one Effluent 278.13 Scheurell et al., 2009 
1-β-O-acyl glucuronide 
of diclofenac Rat liver 472.275 Lee et al., 2012 
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Appendix 3 Modelling the dissipation of test pharmaceuticals in exposure beakers 
from Chapter 2. Measured soil concentration data from uptake phase for 
carbamazepine (A), diclofenac (B), fluoxetine (C) and orlistat (D) fitted with a single 
first order (SFO) model. 
 
  
 
  
A B 
C D 
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Appendix 4 LC-MS/MS parameters used for the analysis of the test pharmaceuticals 
in metabolism study. 
Compound Parent ion 
(m/z) 
MRM product ions 
(m/z) 
Collision 
energy (V) 
Collision 
cell exit 
potential 
Retention 
time (min) 
Carbamazepine 237.3 
(M+H
+
) 
194.3 13 15 1.83 
Carbamazepine 
d10 
247.5 
(M+H
+
) 
204.2 13 15 1.83 
Fluoxetine 310.3 
(M+H
+
) 
148.3 25 12 1.4 
Fluoxetine d5 315.2 
(M+H
+
) 
153.2 25 12 1.4 
Diclofenac 296.2 (M-
H
+
) 
250.0 15 11 4.1 
Diclofenac d4 298 (M-
H
+
) 
254.1 15 11 4.1 
 
 
 
 
Appendix 5 Calibration plots for standards of carbamazepine, diclofenac and 
fluoxetine.
  
 
Appendix 6 Collation of bioconcentration factor data used in analysis of minimised design.Table of key points from studies used in this analysis 
including log Kow, chemical use, test species, uptake and depuration period and BCF provided in the literature  
 
Test compound 
 
 
Log Kow 
a
 
Pesticide (P) / 
Pharmaceutical 
(Ph) Use Test species 
Uptake tu 
(days) 
Depuration 
td (days) BCFtraditional Author 
4-Nitrobenzyl-
chloride 
2.61 
P   Gammarus pulex 1 6 184.6 (1) 
2,4-dichloroaniline 
2.78 
P 
biodegradative intermediate 
of contact type herbicides  Gammarus pulex 1 6 55.73 (1) 
2,4-dichlorophenol 
3.28 
P 
Preparation of herbicide 2,4-
D  Gammarus pulex 1 6 4466 (1) 
4,6-Dinitro-o-cresol 1.96 P Herbicide  Gammarus pulex 1 6 36.72 (1) 
1,2,3-
trichlorobenzene 
4.05 
P   Gammarus pulex 1 6 190.6 (1) 
2,4,5-trichlorophenol 3.95 P Fungicide, herbicide  Gammarus pulex 1 6 2635 (1) 
Aldicarb 1.13 P Insecticide  Gammarus pulex 1 6 1.64 (1) 
Carbofuran  P Insecticide  Gammarus pulex 1 6 65.14 (1) 
Diazinon 3.81 P Insecticide  Gammarus pulex 1 6 82 (1) 
Ethylacrylate 
1.32 
P 
Polymer production (resins, 
plastics, rubber, and denture 
material)  Gammarus pulex 1 6 86.97 (1) 
Hexachlorobenzene 5.31 P Fungicide  Gammarus pulex 1 6 2915 (1) 
Imidacloprid 0.33 P Insecticide  Gammarus pulex 1 6 7.35 (1) 
Malathion 2.36 P Insecticide  Gammarus pulex 1 6 114.3 (1) 
Sea-nine 2.80 P Biocide   Gammarus pulex 1 6 1732 (1) 
Chlorpyrifos  4.70 P Insecticide Gammarus pulex 3 3 1660 (2) 
Pentachlorophenol 
2.75 
P 
Herbicide, insecticide, fungi
cide, algaecide Gammarus pulex 3 3 51 (2) 
Carbaryl 1.85 P Insecticide Gammarus pulex 3 3 87 (3) 
  
 
Test compound 
 
 
Log Kow 
a
 
Pesticide (P) / 
Pharmaceutical 
(Ph) Use Test species 
Uptake tu 
(days) 
Depuration 
td (days) BCFtraditional Author 
Chlorpyrifos 4.96
c
 P Insecticide Anax imperator 2 5 100 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Asellus aquaticus  2 5 3242 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Chaoborus obscuripes  2 5 2428 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Cloeon dipterum  2 5 1782 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Culex pipens 2 5 13930 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Daphnia magna  2 5 541 (4) 
Chlorpyrifos 
4.96
c
 
P Insecticide 
Gammarus pulex 
juvenile  2 5 3083 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Gammarus pulex adult  2 5 2039 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Molanna angustata 2 5 5331 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Neocaridina denticulata  2 5 1291 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Notonecta maculata 2 5 407 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Parapoynx stratiotata 2 5 1601 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Plea minutissima  2 5 654 (4) 
Chlorpyrifos 
4.96
c
 
P Insecticide 
Procambarus sp. 
juvenile  2 5 280 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Procambarus sp. adult  2 5 1295 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Ranatra linearis 2 5 392 (4) 
Chlorpyrifos 4.96
c
 P Insecticide Sialis lutaria 2 5 9625 (4) 
5-fluoruracil -0.81 Ph Anti-cancer Notonecta glauca 2 2 0.132 (5) 
  
 
Test compound 
 
 
Log Kow 
a
 
Pesticide (P) / 
Pharmaceutical 
(Ph) Use Test species 
Uptake tu 
(days) 
Depuration 
td (days) BCFtraditional Author 
Carbamazepine 2.25 Ph Anti-epileptic Notonecta glauca 2 2 0.244 (5) 
Carvedilol 3.05 Ph Beta-blocker Notonecta glauca 2 2 1.596 (5) 
Diazepam 2.70 Ph Sedative Notonecta glauca 2 2 0.98 (5) 
Fluoxetine 4.65 Ph Anti-depressant Notonecta glauca 2 2 1.387 (5) 
Moclobemide 1.16 Ph Anti-depressant Notonecta glauca 2 2 0.334 (5) 
5-fluoruracil -0.81 Ph Anti-cancer Gammarus pulex 2 2 6.48 (5) 
Carbamazepine 2.25 Ph Anti-epileptic Gammarus pulex 2 2 7.094 (5) 
Carvedilol 3.05 Ph Beta-blocker Gammarus pulex 2 2 270.8 (5) 
Diazepam 2.70 Ph Sedative Gammarus pulex 2 2 37.47 (5) 
Moclobemide 1.16 Ph Anti-depressant Gammarus pulex 2 2 4.55 (5) 
Carvedilol 3.05 Ph Beta-blocker Planorbarius corneus 3 3 57.3 (5) 
Fluoxetine 4.65 Ph Anti-depressant Gammarus pulex 3 3 185900 (5) 
Chloramphenicol -0.02 Ph Antibiotic Lumbriculus variegatus 2 2 2 (6) 
Fluoxetine 4.16 Ph Anti-depressant Lumbriculus variegatus 2 2 911 (6) 
Salicylic acid 2.30 Ph NSAIDb /skin care product Lumbriculus variegatus 2 2 82 (6) 
Caffiene pH 5.5 1.03 Ph Stimulant Lumbriculus variegatus 2 2 1 (6) 
Caffiene pH 7 1.03 Ph Stimulant Lumbriculus variegatus 2 2 1 (6) 
Caffiene pH 8.5 1.03 Ph Stimulant Lumbriculus variegatus 2 2 1 (6) 
Diclofenac pH 5.5 4.13 Ph NSAID
b
 Lumbriculus variegatus 2 2 623 (6) 
Diclofenac pH 7 4.13 Ph NSAID
b
 Lumbriculus variegatus 2 2 30 (6) 
  
 
Test compound 
 
 
Log Kow 
a
 
Pesticide (P) / 
Pharmaceutical 
(Ph) Use Test species 
Uptake tu 
(days) 
Depuration 
td (days) BCFtraditional Author 
Diclofenac pH 8.5 4.13 Ph NSAID
b
 Lumbriculus variegatus 2 2 8 (6) 
Fluoxetine pH 5.5 4.16 Ph Anti-depressant Lumbriculus variegatus 2 2 49 (6) 
Fluoxetine pH 7 4.16 Ph Anti-depressant Lumbriculus variegatus 2 2 562 (6) 
Fluoxetine pH 8.5 4.16 Ph Anti-depressant Lumbriculus variegatus 2 2 218500 (6) 
Triclosan pH 5.5 5.42 Ph Antimicrobial Lumbriculus variegatus 2 2 568400 (6) 
Triclosan pH 7 5.42 Ph Antimicrobial Lumbriculus variegatus 2 2 646400 (6) 
Triclosan pH 8.5 5.42 Ph Antimicrobial Lumbriculus variegatus 2 2 559300 (6) 
Triclosan 5.42 Ph Antimicrobial Lumbriculus variegatus 2 2 700900 (6) 
Naproxen 3.36 Ph NSAID
b
 Lumbriculus variegatus 2 2 72240 (6) 
Carbamazepine 2.25 Ph Anti-epileptic Eisenia fetida 21 21 2.21 (7) 
Diclofenac 4.02 Ph NSAID
b
 Eisenia fetida 21 21 21.46 (7) 
Fluoxetine 4.65 Ph Anti-depressant Eisenia fetida 21 21 30.8 (7) 
Orlistat 8.19 Ph Weight loss aid Eisenia fetida 21 21 51.53 (7) 
a
 log Kow as reported in publications.  
b
 NSAID – Non-steroidal anti-inflammatory drug 
c
 Specific log Kow for chlorpyrifos not provided therefore Bowman and Sans (1983) reference used 
(1) (Ashauer et al., 2010) (2) (Ashauer et al., 2006) (3) (Ashauer et al., 2007) (4) (Rubach et al., 2010) (5) (Meredith-Williams et al., 2012) 
(6) (Karlsson, 2013) (7) Chapter 2. 
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Appendix 7 Bioconcentration factors removed from minimised design analysis. 
BCFs were unable to be estimated using the minimised approach when the 
concentration in the organism at the end of depuration phase was greater than 
internal concentration measured at the end of the uptake phase. For these situations 
the minimised design calculated a negative BCF value and thus were removed from 
the analysis. 
Test 
compound 
Pesticide (P) 
or Pharma-
ceutical (Ph) Use Test species 
Uptake 
tu 
(days) 
Depuration 
td (days) 
Literature 
BCF Author 
Chlorpyrifos P Insecticide Sialis lutaria 2 5 9625 
Rubach 
et al., 
2010 
Chlorpyrifos P Insecticide Culex pipens 2 5 13930 
Rubach 
et al., 
2010 
Fluoxetine 
pH 8.5 Ph 
Anti-
depressant 
Lumbriculus 
variegatus 2 2 218500 
Karlsson, 
2013 
Triclosan pH 
5.5 Ph 
Anti-
microbial 
Lumbriculus 
variegatus 2 2 568400 
Karlsson, 
2013 
Triclosan pH 
7 Ph 
Anti-
microbial 
Lumbriculus 
variegatus 2 2 646400 
Karlsson, 
2013 
Triclosan pH 
8.5 Ph 
Anti-
microbial 
Lumbriculus 
variegatus 2 2 559300 
Karlsson, 
2013 
Triclosan Ph 
Anti-
microbial 
Lumbriculus 
variegatus 2 2 700900 
Karlsson, 
2013 
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Appendix 8 Deming regression with associated regression line and additional details 
on slope and intercept for individual data sets analysed in Chapter 3. 
 
 
  
 
 
Ashauer et al., 2010 
Equation Y = 0.8885*X -0.2931 
Slope 0.8885 
95 % CI 0.8214 – 0.955 
Intercept  -0.2931 
95 % CI -0.7265 – 0.1403 
Slope sig. not zero? p = < 0.0001 
Rubach et al., 2010  
Equation Y = 0.9630*X + 
0.04606 
Slope 0.9630 
95 % CI 0.5111 – 1.415 
Intercept  0.04606 
95 % CI -3.232 – 3.324 
Slope sig. not zero? p = 0.0005 
Meredith - Williams et al., 2012  
Equation Y = 124.0*X - 7673 
Slope 124 
95 % CI 91.91 – 156.0 
Intercept  -7673 
95 % CI -22553 – 7208 
Slope sig. not zero? p = < 0.0001 
Karlsson, 2013  
Equation Y = 0.2623*X + 33.62 
Slope 0.2623 
95 % CI 0.1940 – 0.3307 
Intercept  33.62 
95 % CI -56.08 – 123.3 
Slope sig. not zero? p = <0.0001 
Chapter 2 (this thesis)  
Equation Y = 0.7668*X + 1.394 
Slope 0.7668 
95 % CI 0.4268 – 1.107 
Intercept  1.394 
95 % CI -12.23 – 15.01 
Slope sig. not zero? p = < 0.0105 
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Appendix 9 Results from Deming regression analysis on individual data sets 
comparing BCFminimised to BCFtraditional  
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Appendix 10 Validation of extraction methods for pharmaceutical analysis in five 
soil types. 
Experiments were carried out to determine the recovery of carbamazepine, 
diclofenac, fluoxetine and orlistat from five soil types using solvent extraction. For 
each soil type and each pharmaceutical 5 g of soil was prepared in triplicate and 
spiked with a known amount of pharmaceutical compound. 
Average recoveries for each soil type and compound provided ± standard deviation 
provided in table below. 
Pharmaceutical Soil type Solvent 1 x extraction  
(% recovery ± 
S.D.) 
2 x extraction 
(% recovery  ± 
S. D.) 
Carbamazepine 2.1 Methanol 85.68 ± 10.12 93.65 ± 12.22 
Carbamazepine 2.3 Methanol 79.25 ± 6.71 86.79 ± 5.00 
Carbamazepine 2.4 Methanol 84.88 ± 1.94 92.61 ± 2.93 
Carbamazepine 5M Methanol 86.50 ± 2.84 93.00 ± 2.99 
Carbamazepine 6S Methanol 83.15 ± 2.81 94.72 ± 3.96 
Diclofenac 2.1 Ethyl Acetate 93.05 ± 2.31 93.52 ± 2.00 
Diclofenac 2.3 Ethyl Acetate 90.71 ± 1.79 94.67 ± 1.97 
Diclofenac 2.4 Ethyl Acetate 90.11 ± 1.71 92.36 ± 0.70 
Diclofenac 5M Ethyl Acetate 77.04 ± 1.55 86.37 ± 4.31 
Diclofenac 6S Ethyl Acetate 83.72 ± 5.52 90.17 ± 5.89 
Fluoxetine 2.1 Acetonitrile:Water (7:3) 73.96 ± 5.19 82.19 ± 5.07 
Fluoxetine 2.3 Acetonitrile:Water (7:3) 66.16 ± 2.21  76.52 ± 1.48 
Fluoxetine 2.4 Acetonitrile:Water (7:3) 61.33 ± 0.60 74.93 ± 1.31 
Fluoxetine 5M Acetonitrile:Water (7:3) 66.26 ± 0.80 78.06 ± 1.65 
Fluoxetine 6S Acetonitrile:Water (7:3) 36.78 ± 0.68 72.43 ± 1.61 
Orlistat 2.1 Acetonitrile 84.36 ± 4.52 88.11 ± 2.19 
Orlistat 2.3 Acetonitrile 82.00 ± 2.37 82.84 ± 1.94 
Orlistat 2.4 Acetonitrile 79.07 ± 1.75 82.25 ± 2.04 
Orlistat 5M Acetonitrile 80.57 ± 2.59 82.28 ± 1.00 
Orlistat 6S Acetonitrile 81.83 ± 3.69 83.13 ± 3.62 
  
 
Appendix 11 Combustion analysis results, the concentration of orlistat (A) and diclofenac (B) after solvent extraction are shown by the white 
diamonds and the combined residue concentration of combustion analysis and solvent extraction are shown by the black diamonds. 
 
A 
A 
2.1 2.3 2.4 
5M 6S 
  
 
 
B 
2.1 
B 
2.3 2.4 
5M 6S 
  
 
Appendix 12 Percentage of ionised and neutral species in different soil types, pore water and worm samples for diclofenac exposure at 0H (start 
pH) and 21 d (end pH) (Chapter 5). Percentage ionisation calculated using Henderson-Hasselbalch equation: log Dow = log Kow - log 
(1+10
A(pH-pka)
), where A is -1 for basic and 1 for acidic compounds. 
Diclofenac 
        
 
pore water 
 
pore water 
 
start pH anion:neutral 
% 
neutral % ionic 
 
end pH anion:neutral 
% 
neutral % ionic 
Soil 2.1 9.57 279683.38 0.0004 100.00 
 
9.70 377282.50 0.0003 100.00 
Soil 2.3 9.22 126862.52 0.0008 100.00 
 
9.62 313809.92 0.0003 100.00 
Soil 2.4 9.78 453593.34 0.0002 100.00 
 
9.86 549540.87 0.0002 100.00 
Soil 5M 9.43 202612.70 0.0005 100.00 
 
9.72 401174.51 0.0002 100.00 
Soil 6S 9.66 346736.85 0.0003 100.00 
 
9.74 420081.28 0.0002 100.00 
          
 
soil 
 
soil 
 
start pH anion:neutral 
% 
neutral % ionic 
 
end pH anion:neutral 
% 
neutral % ionic 
Soil 2.1 6.70 377.28 0.2644 99.74 
 
6.69 368.69 0.2705 99.73 
Soil 2.3 7.03 812.83 0.1229 99.88 
 
7.00 758.58 0.1317 99.87 
Soil 2.4 7.72 4011.75 0.0249 99.98 
 
7.52 2531.24 0.0395 99.96 
Soil 5M 8.14 10471.29 0.0095 99.99 
 
8.12 10000.00 0.0100 99.99 
Soil 6S 7.92 6358.19 0.0157 99.98 
 
7.90 5979.52 0.0167 99.98 
  
 
 
worm 
 
 
worm 
 
end uptake pH anion:neutral 
% 
neutral % ionic 
 
end dep pH anion:neutral 
% 
neutral % ionic 
Soil 2.1 6.84 518.80 0.1924 99.81 
 
6.86 551.65 0.1809 99.82 
Soil 2.3 6.68 363.08 0.2747 99.73 
 
6.78 459.20 0.2173 99.78 
Soil 2.4 6.91 614.23 0.1625 99.84 
 
6.99 744.16 0.1342 99.87 
Soil 5M 6.89 582.10 0.1715 99.83 
 
6.83 514.83 0.1939 99.81 
Soil 6S 6.79 465.59 0.2143 99.79 
 
6.96 683.91 0.1460 99.85 
  
  
 
Appendix 13 Percentage of ionised and neutral species in different soil types, pore water and worm samples for fluoxetine exposure at 0H (start 
pH) and 21 d (end pH) (Chapter 5). Percentage ionisation calculated using Henderson-Hasselbalch equation: log Dow = log Kow - log 
(1+10
A(pH-pka)
), where A is -1 for basic and 1 for acidic compounds. 
Fluoxetine 
        
 
pore water 
 
pore water 
 
start pH anion:neutral 
% 
neutral % ionic 
 
end pH anion:neutral 
% 
neutral % ionic 
Soil 2.1 9.33 1.60 38.50 61.50 
 
9.51 1.05 48.85 51.15 
Soil 2.3 9.28 1.76 36.17 63.83 
 
9.04 3.11 24.31 75.69 
Soil 2.4 9.40 1.35 42.57 57.43 
 
9.62 0.81 55.16 44.84 
Soil 5M 9.31 1.66 37.60 62.40 
 
9.09 2.78 26.49 73.51 
Soil 6S 9.78 0.56 64.01 35.99 
 
9.64 0.77 56.49 43.51 
          
 
soil 
 
soil 
 
start pH anion:neutral 
% 
neutral % ionic 
 
end pH anion:neutral 
% 
neutral % ionic 
Soil 2.1 6.19 2187.76 0.05 99.95 
 
6.84 493.55 0.20 99.80 
Soil 2.3 6.88 450.13 0.22 99.78 
 
7.16 236.23 0.42 99.58 
Soil 2.4 7.21 207.33 0.48 99.52 
 
7.68 70.79 1.39 98.61 
Soil 5M 8.10 26.92 3.58 96.42 
 
8.35 15.14 6.20 93.80 
Soil 6S 8.09 27.75 3.48 96.52 
 
8.04 31.14 3.11 96.89 
  
 
 
 
worm 
 
 
worm 
 
end uptake pH anion:neutral 
% 
neutral % ionic 
 
end dep pH anion:neutral 
% 
neutral % ionic 
Soil 2.1 7.03 316.23 0.32 99.68 
 
6.91 418.47 0.24 99.76 
Soil 2.3 6.83 503.11 0.20 99.80 
 
6.66 503.11 0.20 99.80 
Soil 2.4 6.96 368.69 0.27 99.73 
 
6.73 368.69 0.27 99.73 
Soil 5M 6.81 530.88 0.19 99.81 
 
6.66 530.88 0.19 99.81 
Soil 6S 6.84 489.78 0.20 99.80 
 
6.77 489.78 0.20 99.80 
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Appendix 14 Preparation of Ruakura nutrient solution for use during plant growth. 
General method: 
The solution is prepared by combining three prepared stock solutions (A, B, C) to 
1.75 L of deionised water. Add 200 mL of stock B, then 200 mL of stock A and 100 
mL of the micronutrient supplement, to make a final volume of 2.25 L. 
5 mL of Ruakura solution per 250 g of soil (Smith et al., 1983) was applied twice 
weekly, (for three weeks), from the day that 50 % emergence is counted. After 3 
weeks of additions, continued with 1 x 5 mL/250 g soil of nutrient solution per week. 
Note: Pots were maintained to 60 % of the MWHC on a daily basis using deionised 
water (DI) or the nutrient solution on the prescribed one or two days per week.  
Table below provided Nutrient stocks required for Ruakura solution. 
 
 
 
Macronutrient Stock A (g/L) 
Chemical Weight (g) 
Mg(NO3)2.6H2O 4.94 
Ca(NO3)2.4H2O 16.78 
NH4NO3 8.48 
KNO3 2.28 
Macronutrient Stock B (g/L) 
Chemical Weight (g) 
KH2PO4 2.67 
K2HPO4 1.64 [or 2.149 g of K2HPO4.3H2O] 
K2SO4 6.62 
Na2SO4 0.60 
NaCl 0.33 
Micronutrient Supplement C (mg/L)   
Chemical Weight (mg) 
H3BO3 128.8 
CuCl2.2H2O 4.84 
MnCl2.4H2O 81.1 
(NH4)6Mo7O24.4H2O 0.83 
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Appendix 15 LC-MS/MS parameters used for the analysis of compounds in plant 
study. 
a
 
37
Cl isotope of TCS and TCS D3 
Appendix 16 Analytical lower limits of quantification (LOQs) for the LC-MS/MS 
method used and within the plant and soil matrices in µg/L. 
Compound LC-
MS/MS 
Soil Ryegrass 
leaf 
Radish 
leaf 
Radish 
bulb 
Propranolol 1 2.6 5.3 4.4 5.9 
Sulfamethazine 0.5 0.6 4.6 6.7 10 
Carbamazepine 0.5 0.7 4.2 5 2.6 
Fluoxetine 2.5 7.1 7.1 8.1 6.6 
Diclofenac 2.5 2.7 2.1 3 4 
Triclosan 5 17.9 11.1 7.3 6.3 
 
Compound Parent ion MRM 
product ions 
Collision 
energy (V) 
Retention 
time (min) 
Propranolol 260 (M+H+) 116 
183 
25 
25 
5.25 
Propranolol D7 267 (M+H+) 116 
188 
25 
25 
5.23 
Sulfamethazine 279 (M+H+) 92 
124 
35 
35 
5.09 
Carbamazepine 237 (M+H+) 193 
194 
40 
30 
5.41 
Carbamazepine 
D10 
247 (M+H+) 202 
204 
40 
30 
5.44 
Fluoxetine 310 (M+H+) 44 
148 
20 
20 
5.33 
Fluoxetine D5 315 (M+H+) 44 
156 
20 
20 
5.38 
Diclofenac 294 (M-H+) 214 
250 
20 
20 
5.97 
Diclofenac D4 298 (M-H+) 217 
254 
20 
20 
5.93 
Triclosan 287 (M-H+) 
289 (M-H+)a 
287 
289 
2 
2 
6.09 
Triclosan D3 290 (M-H+) 
292 (M-H+)a 
290 
292 
2 
2 
6.16 
  
 
Appendix 17 Validation of extraction methodologies for plant material. 
Radish, ryegrass and soil were spiked with a known amount of each pharmaceutical and different extraction methods and clean up steps were 
followed to obtain the highest percentage recoveries. Plants were freeze dried prior to extraction (soil was not) and then either extracted with 2 x 
methanol, followed by 1 x acetone or three extractions of a 70:30 (v/v) acetonitrile and water solution. A comparison between using SPE and no 
SPE as a clean up step was also made. Results presented below indicate the methods which generated the highest recoveries for the different 
matrices and thus were adopted in the extraction techniques in this study. 
  % Relative 
Matrix Extraction Carbamazepine Diclofenac Fluoxetine Propranolol Sulfamethazine Triclosan 
Leaf ACN:H20 (SPE) 100.5 ± 4.7 118.7 ± 5.8 89.1 ± 4.3 98.8 ± 4.2 82.4 ± 4.9 117.2 ± 19 
Root ACN:H20 (SPE) 106.8 ± 4.1 139 ± 10 92.6 ± 5.2 103.9 ± 4.8 75.4 ± 1.7 181.8 ± 48 
Soil MeOH/Acetone 90.42 ± 7.12 85 ± 6.3 68.53 ± 10 109.40 ± 23 91.54 ± 7.54 98.57 ± 4.9 
 
Results show that a ACN:H20 extraction followed by SPE clean up yielded the best recoveries for radish and ryegrass (both leaf and root) for the 
range of pharmaceuticals and therefore this method was adopted to analyse plant samples. Best recoveries were obtained for the soil samples 
using a combination of methanol and acetone extractions. 
  
 
Appendix 18 Soil and pore water dissipation: model parameters for plant study data. 
Statistical indices for single first order (SFO), first order multi-compartment models (Gustafson and Holden, 1990) (FOMC) or bi-exponential 
models (BFO) using to model the degradation rates of the pharmaceuticals in the soil and pore water.  
Soil: 
Pharmaceutical Model DT50 DT90 SSRes RMSE χ2        
(tabulated χ2)  
Model 
error 
Rate constant (k1)or (α/β) r2  
Carbamazepine * > 40 d > 40 d       
Diclofenac SFO 0.50 1.64 0.51 13.68 0.084 (9.49) 29.59 (1.4) 0.99 
Fluoxetine * > 40 d > 40 d       
Propranolol * > 40 d > 40 d       
Sulfamethazine SFO 0.99 3.29 119.16 67.16 3.63 (9.48) 223.67 (0.7) 0.99 
Triclosan SFO 11.55 38.38 195.66 37.36 3.36 (9.49) 152.78 (0.06) 0.97 
* No significant difference between 0 d and 40 d measured concentrations therefore data was not modelled to determine degradation rates 
  
  
 
Pore water: 
Pharmaceutical Model DT50 DT90 SSRes RMSE χ2        
(tabulated χ2)  
Model 
error 
Rate constant 
(k1/k2,C01/C02,α/β) 
r
2 
 
Carbamazepine * > 40 d > 40 d       
Diclofenac FOMC 19.65 2.57E+03 61.47 8.75 7.58 (7.81) 40.81 (α = 0.79, β = 0.34) 0.88 
Fluoxetine * > 40 d > 40 d       
Propranolol * > 40 d > 40 d       
Sulfamethazine BFO - - 45.43 0.12 5.94 (5.99) 6.65 C01 = 91, C02 = 9, k1 
=0.85, k2 = 0.0174) 
0.99 
Triclosan * > 40 d > 40 d       
* No significant difference between 0 d and 40 d measured concentrations therefore data was not modelled  
Equation for DT50/DT90: 
For BFO models no solution exists. 
Time for 50 % or 90 % decrease in chemical concentration can be modelled for the SFO using the rate constant (k): 
DT50 = ln2/k  and DT90 = ln10/k 
For results using the FOMC model: 
DT50 = β*(2(1/α)-1) and DT90 = β*(10(1/α)-1)
  
 
Appendix 19 Human exposure calculations. 
The human risk of consumption from crops grown in pharmaceutically contaminated soil was calculated. Calculations were based on DEFRA 
statistics(Holmes et al., 2007) which estimate that in the United Kingdom an adult (70 kg) consumes 395.5 g of above ground crops and 159 g of 
below ground crops per day. Therefore ryegrass was assumed representative of an above ground crop species and radish bulb was representative 
of a below ground crop species. Acceptable daily intakes were based on the minimum therapeutic dose (mg/person/day) with a safety factor of 
100 applied. Using calculated UFsoil and measured soil concentrations(Dalkmann et al., 2012; Durán-Alvarez et al., 2009; Vazquez-Roig et al., 
2010) we could estimate realistic crop concentrations and thus how much would be in a human diet. A percentage of the ADI for each 
pharmaceutical was then calculated for each pharmaceutical. As sulfamethazine uptake was below LOQ this was removed from the analysis. 
Ryegrass - assumed representative above ground crop
 Soil 
conc. 
(mg/kg) 
UF soil Plant 
conc. 
(mg/kg) 
Plant 
conc. 
(mg/g) 
Consumption 
per person 
(g/day) 
Conc. in 359.5 
g of crop 
(mg/day) 
Min. therapeutic 
dose 
(mg/person/day) 
ADI 
(mg/person/day) 
% of ADI 
in 359.5 g 
crop 
CBZ 0.0065 65.26 0.42 0.00042 359.5 0.1525 400 4 3.81 
DCF 0.0005 6.82 0.0037 3.68E-06 359.5 0.0013 75 0.75 0.18 
FLX 0.0067 0.076251 0.0005 5.11E-07 359.5 0.0002 20 0.2 0.09 
PRL 0.0004 11.04 0.0044 4.42E-06 359.5 0.0016 80 0.8 0.20 
TCS 0.0186 37.59 0.70 0.00070 359.5 0.2514 30 0.3 83.8 
 
  
 
Radish - assumed representative of below ground crop
 Soil 
conc. 
(mg/kg) 
UF soil Plant 
conc. 
(mg/kg) 
Plant 
conc. 
(mg/g) 
Consumption 
per person 
(g/day) 
Conc. In 159 g 
of crop 
(mg/day) 
Min. therapeutic 
dose 
(mg/person/day) 
ADI 
(mg/person/day)  
% of ADI in 
159 g crop 
CBZ 0.0065 8.28 0.05 5.38E-05 159 0.00856 400 4 0.21 
DCF 0.0005 5.39 0.00 2.91E-06 159 0.00046 75 0.75 0.06 
FLX 0.0067 0.36 0.00 2.43E-06 159 0.00039 20 0.2 0.19 
PRL 0.0004 1.20 0.00 4.79E-07 159 0.00008 80 0.8 0.01 
TCS 0.019 0.12 0.00 2.26E-06 159 0.00036 30 0.3 0.12 
                                                                                                                    List of Abbreviations 
202 
 
List of Abbreviations 
API   Active pharmaceutical ingredient 
CBZ   Carbamazepine 
DCF   Diclofenac 
DOM   Dissolved organic matter 
DW   Dry weight 
FLX   Fluoxetine 
Kd   Soil sorption distribution coefficient (L/kg) 
LOEC   Low observed effect concentration 
Log Kow Octanol-water partition coefficient (measure of 
hydrophobicity) 
OM   Organic matter 
ORL   Orlistat 
pKa Negative base-10 logarithm of the acid dissociation constant 
of a solution 
PRL   Propranolol 
SOM   Soil organic matter 
SMZ   Sulfamethazine 
STP   Sewage treatment plant 
WW   Wet weight 
WWTP  Wastewater treatment plant 
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